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Sixty-six c ompound~ including carc inogens, related compounds and nc~-
carci 11oge11 s were dissolved in dimethyl aulphoxide or saline and inj~cterl 
iral!'adermally into c57 Black male mice. Localised areas of depigment-
ation 0 c~urred with some chemi cals . The effect was related to tumour-
promoti o n with 56% of known tumour-promoters tested producing d~pigment-
ation compared with 24% of carcinogens and 17% of substances not lcno1o1n 
to be carcinogenic. Direct carcinogens ouch as alkylating agents which 
have both initiating and. twnour-promoting activity produced c.epigment-• 
ation. ~ndirect carcinogens such as the polycyclic aromatic hydrocarbons 
a nd aromatic amines which require metabolic activation were not active. 
Some compounds known to cause occupational leukoderma were active. 
Amongst the tumour-promoters, tetradecanoyl phorbol acetate (~PA). 
carbon dioxide snow and croton oil produced the most prominent depigment-
ation. 'l'lie dose producing the effect in !l&lf the injected sites (i.e. 
E050 ) was 0 . 018 µg for TPA, 0.18 µg for nitrogen mustard and 101 pg for 
chlor~form. Other tumour-promoters causing slight or moderate depigment-
ation included Tween 20, saccharin and dodecane. The promoters 
a nthralin and phenobarbitone did not produce depigmentation when 
injected in tolerated doses. Histological examination and electron 
mi croscoµ y of depigmented areas showed loss of pigment in affected hair 
An<.l ., ,1ecrei,:.:;e in melnnocytes at the hair bulbs. 'l'hc latent per.i.od 
for depi~mentation was usually betwetn thre& to six weeks, but ground 
'"·ocidolit'l. fi.bres prod•1cecl dcpigmentation after sixteen \leeks. Other 
1\ n ·m,; i,!' usLestos fibres caused no depigrnentation. The depigmentation 
of 10:1: r m1,r.11t be developed as 11 ~hort-term ucrtoening teet for turnour-
prornot i.>r:1. 
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IN'I'RODUCTION 
The term ' co.ncer ' (Latin fol' crab ) means any ma lignant neoplasm or 
new growth . It is not one specific disease entity but in reality 
has to b e considered ~s a group of different diseases with di fferent 
causative factors poss essing a few features in common. The main 
feature is the ability of cancer cells to exhibit excessive autono-
mous, progressive and usually irreversible g rowth. There is also a 
tendency for such cells to spread both locally as well as via lym-
phatic and blood vessels to other parts of the body as metastases. 
In the process of spreading, surrounding ti s sues are compressed, 
invaded and destroyed and often the eventual outcome is death. 
Histologically, cancer cells show abnormal mitotic figures, with 
considerable variation in the cell and nuclear size and shape as well 
as an increase in size and number of nucleoli per cell. The nuclear 
DNA tends to be coarsely aggregated and distributed near the nuclear 
membrane. The cellular cytoplasm is scanty and more deeply basophilic 
staining. Cancer cells are often immature and not well differenti,ated. 
There are a few exceptions where cancer cells do not show all of these 
characteristics. Malignant rodent ulcers and argentaffinomas are 
relatively slow growing and thyroid carcinomas often show well-
differentiated cells on histological examination and can continue to 
function and produce thyroglobulin, 
Cancer is now the second most frequent cause of death in western 
countries - the leading cause of death being heart disease. In the 
United States in 1900, tuberculosis was the most common cause of death, 
with heart disease fourth and cancer eighth. By 1970, heart disease 
had becume the most frequent cause followed by cancer, cerebra-vascular 
16 
diseases anu a ccidents (Levin.£!. a l 1974) . The same trend is als o 
apparent in mortality sta tistics from developine countries. Part of 
this is due to the diminished problems of tuberculosis and other 
infective conditions as a result of the advent of new, effective 
pharmaco l oeical agents and improvements in environmental sanitation 
and hygiene aiding in reducing mortality due to these di seases . An 
increasing expectation of life with a larger proportion of people 
over forty years of age in the gener a l population also contributes 
to the increase in cancer incidence. People are now living long 
enough to be in the age group where most malignancies occur. In the 
past, the infective illnesses caused death before this age group was 
reached. 
There are as yet, few effective cures for cancers. Choriocarcinomas 
can be treated with a 7Cf}{, cure rate (Galton 1978) and Burkitt's 
lymphoma has a 20 - 5Cf}{, successful cure rate and as high as 8Cf}{, 
complete remission rate. Greater than 50~ cure rate after a single 
dose of cyclophosphomide has been reported for Burkitt's lymphoma and 
the prognosis is especially good if detected early and the lesions are 
localized (Scott 1978). However, for a large majority of the malig-
nancies, the efficacy of treatment is considered in terms of three or 
five year survival rates rather than cure rates. Cancers are usually 
treated either surgically, by radiotherapy, by the use of anti-cancer 
drugs or by a combination of these. Surgery has the major disadvantage 
of being disfiguring, as in radical mastectolQY for carcinoma of the 
breast. Radj ?therapy can cause side effects such as radiation burns, 
hair lo~s and radiation sickness. Chemothe rapy is not specific enough 
and drugs acting against actively dividing cells do not distine-uish 
between tumour cells and normal cell8. Hence. actively dividing 
17 
normal cells such as those of the bone marrow, eonads and the gut a re 
affect ed . Cancer patients on chemotherapy can su ffer complications 
such as bleeding from the gastro-intcstina l tract and loss of hair. 
In spite of these side effects, the cure rates are low. Hence, the 
emphasis should b e on the prevention of cancer, as effective treatment 
appears to be lacking . Efforts directed towards prevention would b~ 
financ ially more worthwhile than those directed towards cure. However, 
before an attempt is made to put prevention into practice, what is 
first needed is knowledge of the aetiology of cancer. Prevention can 
only be fully effective if it can be directed at the specific aetio-
logical agent or agents. Unfortunately, in the case of cancer, know-
ledge of specific aetiology is inadequate. There are some identifiable 
causes of cancer and these include:-
(a) Genetic factors 
(b) Viral factors 
(c) Physical factors 
(d) Chemical factors 
These factors are relevant only in a small proportion of cancer cases. 
In the majority of cases, specific causes are unidentifiable. 
1. GENETIC FACTORS 
Several cancers exist where an autosomal dominant or recessive or 
sex-linked gene appears to be primarily responsible. Retinoblastoma 
is an example where autosomal dominance is the probable mode of 
inheritence. This malignant tumour is responsible for 1% of all 
cancer deaths in infants and approximately 5% of childhood blindness 
(~nch _!l.!l 1976). Albinism is an example of an autosomal 
recessive condition where there ie a related increased risk of 
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basal m,ct s qu,,mow, cell carcinor.1:-i. o f the skin . 
Chromosomal abnormc1lities can a li:o be linked to o.n increased risk 
of cancer (Lance t 1977) . In mongoli sm (Down' s Syndrome ) trisomy 
of chromosome 21 e ;cists with an increased risk of acute leukaemia . 
In patients with the Pnilad~lphia chromosome there is micro-
scopi cally visible loss of chromosomal material. This is related 
to an increased risk of developing chrnnic myeloid leukaemi a 
(Nowell et al 1960 ; Baikie et al 1960 ). 
2. VIRAL FACTORS 
Viruses can cause warts or po.pillomas of the skin i n huma."ls. 
Burkitt•s lymphoma, a malignancy of lymph nodes first described 
by Burkitt in 1958, is related to exposure to the Epstein-Barr 
virus (Epstein and Achong 1973). There is also evidence of virus 
related tumours in animals. Rous (1911) showed that an RNA 
(ribonucleic acid) virus rela ted to the myxoviruses caused sarcomas 
in fowls. The papova ,iruses (including the papilloma, polyoma and 
vacuolating agent) are DNA (deoxyribonucleic acid) viruses which 
cause a variety of tumours in rats, rabbits, mice and hampsters. 
3. PHYSICAL FACTORS 
Radiation is a cause of leukaemia. It was within a few years of 
the discove~y of x-rays that its indiscriminate use was linked to 
numerous superficial squamous carcinomas. Later, chronic myeloid 
leukaemia was noted as a major occupational risk in radiologists . 
X-rays, 'l( -raya, alpha and beta particles and radio-isotopes can 
all cause cancer. Besides the carcinogenic effects, radiation also 
has mutagenic effects as has been shown on experiments with 
Drosophila (Fahmy and Fahmy 1970 and 1972). 
4. CHEMICAL CAUSES 
Chemica ls used in the workplace have been linked to various cancers 
and examples of these occupational r.ancers are well-documented. 
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One of the earliest description,s of s uch cancer is tha t of carcinoma 
of the scrotum in chimney sweeps described by Sir Percival Pott in 
his class ic pape r 'Chirurogical Observations' in 1775. The scrotal 
cancers were thought to be a result of the consta nt deposition of 
soot from the chimneys into the folds of the scrotal skin. Follow-
ing Pott's clinical observations, Yamagiwa a nd Ichigawa in Japan 
in 1917 were able to produce tumours by repeated applications of 
coal tar to the ear of rabbits. Kennaway an1 associates in 1924, 
isolated the first carcinogen, 3,4-benzpyrene from coal tar and 
later identified other carcinogens in the polycyclic hydrocarbons 
group. Benzpyrene is believed to be responsible for the carcino-
genic activity of t~r and soot. The term carcinogen was first 
used by Sir James Paget in 1853 in his book 'Lectures on Surgical 
Pathology' to mean a cancer-producing agent. Since then, many 
such agents have been identified and isolated. Rehn in 1895, 
described the first cases of bladder cancer due to exposure to 
aromatic amines in German workers in the synthetic dye industry. 
2-Naphthylamine and benzidine have been implicated as causative 
carcinogens. More recently, cases of the rare tumour angio-
sarcoma of.the liver have been linked to exposure to vinyl chloride 
monomer (Creech and Johnson 1974, Tabershaw and Gaffey 1974). 
There are many theories on how agents bring about the carcinogenic 
process e.g. the immunological theory (Green 1954) and the genetic 
regu1ating mechaniams theory (Jacob and Monad 1961). Theories 
on chemical carcinogenesis may be grouped into those based on a 
genetic effect and those based on an epi~enetic effect . The 
somatic mutation theory (Boveri 1914 ) belon~s to the former group . 
It suggests that DNA modification is an important step in the caus-
ation of cancer. Chemical carcinogens act by altering the DNA to 
a form characteristic of a malignant cell. Such DNA alterations 
are somatic mutations which may include frame-shift mutations as 
well as base-pair deletions. In studies on Dros0phila (Fahmy and 
Fahmy 1970) carcinogens have been shown to caus e small gene dele-
tions, resulting in mutants. The hypothesis that mutation is a 
critical event in carcinogenesis is also supported by statistical 
studies on retinoblastoma (Knudson 1971). There is considerable 
evidence that, _with few exceptions, carcinogens are mutagens (Aines, 
McCann and Yamasaki 1975; Sugimura ~&_ 1976). 
The epigenet~c theories are concerned not with the genetic infor-
mation in the cell but with the expression of that information. 
Some genetic effects may be repressed by carcinogens. 
This could lead to an upset in the hormonal balance or immune 
capacity and thereby stimulate proliferation of the neoplastic cell. 
Thia could also explain increases in foetal antigens and ieoenzyme 
patterns seen in certain cancers e.g. increasedoc1-foetoprotein in 
primary hepatocarcinomas of the liver, teratomas and carcinomas of 
the gastro-intestinal tract; human placental lactogen and placental 
alkaline phosphatase in carcinoma of the bronchus; the foetal sulpho-
glycoprotein antigen in gastric carcinoma (Lowing 1977). 
Several similar theories divide the carcinogenic process into 
2 1 
stages (Berenblum 1941, Rous and Beard 1935, Mottram 1944a and 1944b, 
Kline and Rusch 1944). Rous (1941) adopted the terms 'initiation' 
and 'promotion' to describe two stages in carcinogenesis. Initiation 
is the first stage where normal tissue cells are converted into 
'latent tumour cells' or 'sensitized cells ' by initiating agent s . 
Such agents have included a sub-threshold dos e of a carcinogen 
such as 9 ,10-d imethyl-1,2-benzanthracene, 3 ,4-benzpyrene and 
;7-~adia tion. The initiat ed cell then needs to be transformed 
into tumour cells by regular exposure to a tumour-promoter. 
Tumour-promoters are by themselves non-carcinogenic. They act 
slowly and prolonged treatment to an initiated cell is needed ior 
effective promotion. Table 1 summarize s the differentiating 
features between initiators and promoters. 
TABLE 1 
A COMPARISON OF BIOLOGIC PROPERTIES 
OF 
INITIATING AGENTS AND PROMOTING AGENTS 
(from Weinstein 1978) 
Initiating Agents 
1. Carcinogenic by themselves 
'Solitary Carcinogens' • 
2- Must be ~iven before 
promoting agen_t __ _ 
3. Single exposure is 
sufficient 
4. Action is 'irreversible' 
and additive 
5. No apparent threshold 
6. Yield electrophiles -
bind covalently to cell 
macromolecules 
7. Matagenic 
Promoting Agents 
1. Not carcinogenic alone 
2. Must be given after the 
initiating age~ 
3. Require prolonged exposure 
4. Action is reversible (at 
early stage) and not 
additive 
5. Probable threshold 
6. No evidence of covalent 
binding 
7. Not mutagenic 
• Van Duuren (1976) refere to some initiating agents that are 
.. 
non - carcino~enic to mouse skin e . g. chrysene , urethane, 
epichlorhydrin and chloromethyl methyl ether (CMME ). However , 
chrysene is considered a borderline carcinogen U!artwell 195·1 ) 
and uret hane has br,cn shown to cause lung tumours in mice (Salaman 
and Roe 1953) . Epichlorhydrin and CMME induced sarcomas in mice 
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by subcutaneous injections (Van Duuren ~ & 1974). So, in general, 
initiating agents are carcinogenic. 
In addition to initiation and tumour-promotion, a third term often us ~d 
is co-carcinogen. Shear (1938) a nd Cabot.!:!_ al (194o) introduced the 
term to cover the enhancement of skin tumour formation by creosote in 
conjunction with 3,4-benzpyrene. Wolf (1952) defined it as a substance 
which, though not in itself carcinogenic, can enhance tumour incidence 
and shorten the latent period when applied together with or shortly 
after the carcinogen. Since then 'co-carcinogen' has been used to cover 
all factors that in some way promote the formation of tumours. It, 
therefore, includes tumour-promoters. However, it has also been used 
as a term quit~ separate from tumour-promotion (Van Duuren 1976). A 
restricted definition confines co-carcinogen to chemicals which when 
applied simultaneously with initiators will increase the yield of 
tumours formed. Tumour-promoters only enhance tumour-formation by 
regular application after initial exposure tothe initiating agent. 
Thia latter definition has been adopted for this thesis. 
Chemical carcinogens can also be divided into direct-acting carcinogens 
(or primary or complete carcinogens) and pro-carcinogens (or secondary 
carcinogens). Direct acting carcinogens usually act at the site of 
application and do not require metabolic activation. Pro-carcinogens 
must undergo metabolic activation before they can exert their carcino-
genic activity. Such activation is often the resu1t of action by liver, 
akin or other tissue enzymes converting the pro-carcinocen into an 
activo met3bolite - the ultimate carcinogen. Pro-carcinogens do not 
usually act at the point of application . Table 2 shows examples of 
direct-acting carcinosens and pro-carcinogens. 
TABLE 2 
DIRECT- AC'l'ING CARCINOGEJ'IS AND PRO- CARCINOGENS 
Direct-Acting Pro-Carcinogens Carcinogens 
1. HN2 (Methyl-bis-(2- 1 . Polycyclic Aromatic Rydrocarbons 
chloroethyl)-amine) . 
(a) Dibenzanthracene 
2. Methyl Iodide 
(b ) Dimethylbenzanthracene 
3. Benzyl Chloride 
(c) Benzanthracene 
4. Benzoyl Chloride 
(d) Benzpyrene 
5- Benzotrichloride (e) 3-Methylcholanthrene 
6. Dimethyl Sul phate 
I 
2. Aromatic Amines 
(a) 2-Naphthylamine 
(b) Benzi dine 
(c) Phenanthrene 
3 . Dialkyl Hydrazines 
(a) Dimethyl hydrazine 
The Health, Education and Welfare Secretary of the United States has 
estimated that at least 2C/J(, of all cancers in the United States may 
be work-related (Califano 1978). This implies that in a majority of 
cases, chemical carcinogens may be involved. The estimate was based on 
studies by the National Cancer Institute and the National Institute for 
Environmental Health Sciences and ie higher than earlier estimated 
figures of 1 - 5% of cancers being attributable1D occupational exposure 
t o carcinogens (Higginson and Muir 1976, Doll 1977, Wynder and Gori 1977i 
Ea timotes moy vary but the over-riding fac tor is that the causative 
agent or acents in such occupational cancers can oft en be identifi ed 
and efforts direct ed to such identification would be useful before 
preventive measures are instituted . 
Methods u::;cd for identification of carcinogens have included 
epidemiological studies - these are studies based on human e>..--perience. 
They can be either:-
(a) Descript ive, where one describes a cluster of similar rare 
cancers occurring under similar circumstances or a change in 
cancer incidence following introduction of a new chemical or 
process. 
(b) Prospective, where a defined group of workers subject to exposure 
to specific chemicals is followed up and the effects noted over 
a given period of time. 
(c) Retrosuective, where cancer cases are defined and are then traced 
to obtain specific information regarding exposure to various 
agents, previous occupations and other points in the past history 
to try to find out whether there is an excess of such factors in 
these cancer cases. 
The disadvantage of epidemiological studies is that they can be very 
time-consuming and costly. Retrospective studies have the disadvantage 
of relying on memory of interviewees and prospective s tudies have the 
problem of loss to follow up. They still afford the most conclusive 
method of deciding whether a chemical is a possible human carcinogen. 
In view of the mruiy disadvantages and limitations, other methods of 
identifying carcinogens are needed. 
One method is by examining the chemical structure of compounds and 
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comparine; this with that of known carcinogens. Chemicals which r.;how 
similarity in structure can be expected to exert similar effects. It 
is possible that carcinogenicity of compounds may be predicted from 
their structure. The following examples show chemicals with similar 
chemical structure all with some degree of carcinogenic potential. 
(see Table 3 overleaf). 
Chemical 
Vinyl Chloride 
Trichloroethylene 
Perchloroethylene 
TABLE 3 
CARCINOGfflIC CITTHICALS li!TH SIMILAR CHDIICAL STRUCTURE 
EXAMPLE 1 - CHLORINATED HYDROCARBONS 
Formula 
H .,,c1 
' c = C 
H"'' ' H 
H Cl 
' c = c,.. 
c1 " ' ci 
Cl Cl 
' c = c,.. 
Cl " ' c1 
Carcinogenic Stat\18 
Cal18es angiosarcomas of the 
liver in humans 
Reference 
Creech and Johnson 1974 
Tabershaw and Gaffey 1974 
Carcinogenic in mice and rats I ~laltoni and Lefernine 1974 
following exposure by inhalation Viola , Bigotti and Caputo 1971 
Produces liv~r t\lltOurs in mice 
but not rats after oral 
administration 
Carcinogenic in mice 
Lloyd, ~!<lore and Breslin 1975 
NIOSH Current Intelligence 
Bulletin 1978 
Chemical 
Benzidine 
3,3'-Dichlorobenzidine 
'+-Alli.no bi phenyl 
(xenylamine) 
TABLE 3 
CARCINOGffilC ClIDtICALS WITH SIMILAR CHEMICAL STRUCTURE 
EXAMPLE 2 - AROMATIC AHINIB 
Formula 
H N-0-0-0 NB 2 2 
Cl Cl 
H2N~ NH2 
0-0-KH2 
Carcinogenic Status 
Carcinogenic to mouse, rat, 
hamster and possibly dog 
Evidence of carcinogenicity 
in humans 
Carcinogenic to rat after 
oral and and subcutaneous 
administration. Also to 
hamsters after oral 
administration 
Carcinogeni c to mouse, rat 
and dog 
Exposure in man linked to 
bladder cancer 
Bonser, 
Spitz , 
1950 
Boyland, 
19.54 
Reference 
Clayson and Jull 19 
guigan and Dobriner 
Harr is and Horning 
Saf f iotti, Cefis a."!d. ~:ontesano 
1967 
Case, Hosker and McDonald 19.54 
Pliss 1959 
Safiotti , Cefis and 1-:0nt'!sano 
1967 
Clayson, Lawson and Pringle 
1967 
Walpole, Williams and Roberts 
19.54 and 1952 
Melick !!_ al 1955 
Chemical 
BeD%.8.llthracene 
5,6- Dimethyl-
benr.anthraeene 
5,9,10-Trimethyl-
benzanthracene 
TABLE "3 
CARCINOOOOC CHDITCAIS WITH SIMILAR CHOOCAL STRUCTURE 
POLYCYCUC AROMATIC HYDROCARBONS 
Formula 
~ 
'~ c.,f , 
effl 0 
) .. , 
Carcinogenic Status 
Complete carcinogen for mouse 
skin and carcinogenic to rouse 
No epidemiological evidence 
for carcinogenicity in oan 
but coal tar and other 
materials known to cause 
cancer in man may contain 
benzanthracene 
Carcinogenic in mice 
Reference 
Kennaway 1930 
Bock and King 1959 
IARC Monographs n the 
Evalua.tion of Carcinogenic 
Risk of Chemicals to man Vol III 
P6 56 - 57 (1972) 
Haddow and J(.on 1947 
Haddow and Kon 1<Jll7 
However, there are exceptions to the link between similarity in 
chemical structure mid carcinogenic activity. The following examples 
illustrate such exceptions:-
Exrun le 1 
2-Naphthylamine is carcinogenic but 1-naphthylamine is not (Boyland 
1978a). 
Example 2 
Anthracene is non-carcinogenic but 9,10 dimethylanthracene is 
carcinogenic (Boyland 1978a). 
Example 3 
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2-Methyl-4-amino-biphenyl is not carcinogenic though it is structurally 
similar to the earlier examples benzidine, 4-amino biphenyl and 2-methyl 
benzidine which are carcinogens (Miller,!!,.!.!_ 1956). 
Example 4 
C\ C\ 
'\. I 
C.=C 
Ii/ '\. H 
1,1-Dichloroethylene and 1,2-Dichloroethylene are both structurally 
similar to vinyl chloride, trichloroethylene and perchloroethylene. 
They are treated as au3pect carcinogens because of this similarity in 
structure but a:, yet there are no definite reports on their CD.rcino-
genicity (Fairchild 1978 ). 
Example 5 
~ 
Benzanthracene D.lld some of its dimethyl derivatives are carcinogenic 
( see Table 3 page 29 ) but the addi tion of a phenolic (OH) group or 
hydrogenation of individual rings results in loss of carcinoeenicity 
(Haddow and Kon 1947). 
Hence, it i .s not just similarity in structure alone, but the nature, 
number and position of the side-chains as well that seems to determine 
carcinogenic status. It has been suggested that carcinogenic activity 
depends on an optimal molecular complexity (Haddow and Kon 1947). 
However, existing structure-activity studies of structural association 
with carcinogenicity have not produced any generally applicable 
principles common to various series of carcinogens (Ashby 1978). This 
lack of inter-series consistency limits the use of structure in pre-
dicting carcinogenicity. 
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Long-term animal studies are widely used for predicting carcinogenicity. 
Test animals under laboratory conditions are regularly dosed with sus-
pected chemicals and if they produce significantly more tumours than a 
similarly trea ted control group, then the chemical concerned is deemed 
carcinogenic. The extrapolation of these results of animo.l tests to 
humans is, however, difficult. Chemicals can exert different effect::; 
even amopgst related species of anim~ls. 2-Naphthylamino is a bladde r 
carcinogen in man, doge and in high doses to hamsters, but not in ro.t s 
or rabbits and only weakly carcinogenic to mice . Aflatoxin Bis 
suspected of causing liver cancer in man but does not elicit a neo-
plastic response i n mi ce, though newborn mice are af fe cted. Tri -
c hloroe thylene cau ses t umours i n mice but not in rat s . Ho wev e r, in 
g 'lnera l, t here is evidence that s ubstances which are carcinogenic 
to man as shown by epidemio l ogical s tudies will a lso produce t umours 
in l a bora tory a ni mals. In a recent review of e ighty-two chemicals 
with epidemiological evidence of human cancer effect, a ll were shown 
to be posjtive in anima l tests with the exception of a rsenic. 
(Altschuler 1978). At least six chemicals were shown to be carcino-
gens in animals before epidemiological studies confirmed their 
carcinogenicity in humans. These are, 4-aminodiphenyl, diethylstil-
boestrol, mustard gas, vinyl chloride, aflatoxin and bis-chloromethyl 
ether. In the absence of a better method, animal studies will need 
to be used, though care must be exercised in the interpretation of 
results so obtained. Another argument commonly used against animal 
tests is that the dose of test compounds used in such tests is too 
high and, therefore, inappropriate when extrapolated to man. There 
is a misconception though that at high enough levels, virtually any 
substance will be carcinogenic. Some pesticides and industrial 
chemicals have been tested at high doses and found to be negat i ve 
(Maugh 1978). The use of high doses increases the proportion of 
animals with tumours for carcinogens and, therefore, less animals 
need to be used for the tests. Also, high doses may compensate f or 
unknown cummulative effects, and for the shorter life span of some 
of the test a nimals. 
One of the limitations in the use of conventional anima l teats is 
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that existing world facilities only al lo~ some 200 - 500 new chemicals 
to be tested each year (Saffiotti 1976) . Such conventional tests a re 
also costly; approximately £500,000 for a full test on any sinele 
chemi cal and this takes one-and-a-half to three years (the life-span 
of ~h~ test animals ) before results are obtained. Hence, wha t is 
needed are short-term tests which are as specific and reliable i n 
detecting chemicals carcinogenic to man. These tests should be cheap, 
easy to perform and produce results in a relatively short period of 
time. A variety of such short-term tests are already in use. Some 
of them are based on empirical observations and others on possible 
carcinogenic effects. Most of the tests are still being evaluated 
and many need improvements and standardisation. Some examples of such 
tests are:-
1. The Ames Test (Ames et al 1973 and 1975) 
This test developed by Professor B N Ames of the University of 
California, Berkely, U.S.A. is based on the premise that mutagens 
and carcinogens are closely related. A histidine-dependant strain 
of Salmonella tvnhimurium is incubated with test chemicals and if 
such chemicals are carcinogenic, they will exert a mutagenic effect 
causing reversion of histidine-dependence to histidine-independence 
and thereby allowing the bacteria to grow in a medium lacking 
histidine. The chemically-induced reversion rate is compared to 
the spontaneous reversion rate and a two-fold increase is indicative 
of a positive response i.e. the test chemical is mute.genie and, 
therefore, likely to be a carcinogen. This test works well with 
direct carcinogens such an alkylating agents and nitrosamides but 
not with indirect carcinogens such as the polycyclic aromatic 
hydrocarbons and aromatic amines. Indirect carcinogens require 
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metabolic activation to the ultimate carcinogen before this exert s 
its cnrcinogenic effects . Hence, the addition of a supernatcm t 
from centrifuging rat or human tissue homogenates was incorporated 
into the test syst em. This supernatant known as the S -9 mix 
(because the rat or human tissue is minced and centrifuged at 
9,000r) theoretically provides the tissue enzymes for activating 
the indirect carcinogens under test. The yield of such enzymes is 
increased by injecting rat s with Aroclor before killing them a nd 
removing the liver fer preparation of the S-9 mix. Aroclor 
induces the rat liver enzymes and is the best available inducing 
agent for such use. Other inducing agents include 3-methyl-
cholanthrene and phenobarbitone. 
2. Styles Cell Transformation Test (Styles 1977) 
This is based on mammalian cell transformation in culture by 
carcinogens. Syrian hamster kidney cells and either human lung 
fibroblasts or human liver-derived cells are exposed to five doses 
of test compounds .:!11~ in a medium with S-9 mix. After incuba-
tion the cells are centrifuged and re-suspended and the growth of 
the transformed cultures counted. A 2.5-fold increase in colonies 
over the control is considered positive. 
3. Rabin's Test (Williams and Rabin 1971) 
Degranulation of rough endoplasmic reticulum (RER) from rat liver 
by carcinogens is the main feature of Rabin's test. Radio tracer 
techniques are used to quantitatively assay the degree of deeranu-
lation. 
4. Sebaceous Glnnd Test (Bock and Mend 1958) 
A decrease in the sebaceous gland/hair follicle ratio in mouse skin 
after direct application of a carcinogen is the basis of this test. 
5 . Tetra?:olium Reduction Test (Iversen and Evensen 1962) 
Mouse skin is exposed to the test compound and incubated in 
solut ions of tetrazolium red. Carcinogenic activity of the test 
compcunJ is indicated by reduction of the colourless tetrazoli um 
to coloured formazan. This colour change can be spectrophoto-
metrically measured. 
6. Implant Test (Oppenheimer et al 1959) 
This test is based on the tissue reaction to subcutaneous implants 
in mice. Implants of millipore-filter discs impregnated with a 
gelatinous suspension of the test compound are used. Histological 
examination is made after three months and lesions are scored on 
an arbitrary scale. The presence of a fibroblast capsule, its 
degree of thiclmess, the presence of necrosis are some features 
taken into account in the scoring. Such features appear to be 
related to carcinogenicity of the test compound. 
In an evaluation of these short-term tests, Purchase and associates 
found Ames' and Styles' tests to be the two best tests detecting over 
90% of the carcinogens and non-carcinogens tested (Purchase, Longstaff 
and Ashby 1978). 
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All these short-term tests do not have cancer induction as an end point. 
Instead they have some feature which appears with the use of carcinogens 
but not with non-carcinogens. The appearance of depigmentation of hair 
in mice following intradermal injections of various carcinogens appears 
""" .r.,, ... r-
to be a ·similar feature apparently common to carcinogens. Boyland~(1951) 
-~ 19f~~ noted that irradiation of black mice resulted in a permanent 
area of depii:;mento.tion both at the site o f entry and exit of the 
x-ro.ys . A similo.r effect was produced by single intradermal in jec-
tions of nitrogen- mustard (Boyland~ al 1 948 ). Both radiation and 
ni trogen-r~ust o.rd pi·oduce carcinogenic effects. Searle ( 1970) 
reported depigmentation following skin application of 8-hydroxy-
quinolinc in mice and .Schoental (1971) reported depigmentation 
followi ng injections of N-methyl-N-nitrosourethane in mice and rabbits 
and Mitsuyama (1966) described permanent depigmentation in C57 black 
mice followin g intr6dermal injections of chlorambucil, thio-TEPA and 
carzinophilin - all cf which are anti-cancer agents. 
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All these observations suggest that the production of localised areas 
of depigmentation in dark-haired mice following a single exposure to 
carcinogens may be a feature peculiar to carcinogens. This link 
between carcinogens and depigmentation is further supported by studies 
in the hamster when oral dosing with the carcinogen dibenzanthracene 
had resulted in permanent depigmentation (Aubert and Bohou_~ 1970). 
Lesker and Kaplan (1974) in a follow-up study on adult Mexicans showed 
a possible association between greyness of hair and mortality. Davies 
(1979) commenting on this study maintained that the possibility of an 
association between early greying of hair and cancer cannot be excluded. 
Hence, some evidence exists for laboratory animals as well as for 
humans, suggesting a connection between carcinogens and depigmentation 
of hair. This feature as a distinguishing point between carcinogens 
and non-carcinogens may be useful in a screening test for carcinogens. 
Hence, the main objectives of this study are:-
1. To inyestigate the relationship between chemical compounds, with 
particular emphasis on carcinogens, and the production of 
depi e;mcnt a t i on of hair in da rk-ha ired mi ce . 
2 . To investigate the f easibility of using such an effect in a short-
t erm screening t es t for carcinogens (or classes of cercinogens 
e.g. promoting agents) . 
3. To describe such depig:r.entation in terms of gross ar.d microscopic 
features and to discuss the possible mechanisms underlying the 
production of such an effect. 
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CIIAPI'ER 2 MATERIALS 
Chemicals 
Equipment 
Laboratory Animals 
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MATERIALS 
(A) CHEMICALS 
I ALKYLATING AGENTS 
1. Nitrogen mustard ['"Methyl-~-(2-chloroethyl)-amineJor HN2 
2. Dimethyl sulphate 
3. Methyl iodide 
4. Benzyl chloride 
5. Benzoyl chloride 
6. Benzotrichloride 
II POLYCYCLIC AROMATIC HYDROCARBONS 
1. 1,2:5 16-Dibenzanthracene 
2. 9,10-Dimethyl-1,2-benzanthracene 
3. 6,9,10-Trimethyl-1,2-benzanthracene 
4. Benzanthracene 
5. Benzo(a)pyrene (Benzpyrene) 
6. Phenanthrene 
7. 3-Methylcholanthrene 
III AROMATIC AMINES 
1. 2-Naphthylamine 
2. Benzidine 
3. Aniline 
IV CARBAMATES 
1. Methyl carbamate 
2. Ethyl carbamate (urethane) 
3. Propyl carbamate 
4. Sodium diethyldithiocarbamate 
V PHENOLS 
1. Pyrocatechol (Catechol) 
2. Methyl catechol 
3. 4-tertiary butyl catechol 
4. p-tertiary butyl phenol 
5. Dihydroxyphenylalanine (DOPA) 
6. Phenol 
7. Pyroga llol 
8. Butylated hydroxy anisole 
9. Hydroquinone mor.obenzyl ether 
10. 8-Hydroxyquinoline· 
11. Adrenaline hydrogen tartrate 
12. Histamine hydrochloride 
VI ASBESTOS FIBRES 
1. Chrysotile A and B 
2. Crocidolite 
3. Amosite 
4. Anthophyllite 
VII TUMOUR-PROMOTERS 
1. 12-0-tetradecanoyl-phorbol-13-acetate (TPA) 
2. Anthralin 
3. Dodecane 
4. Tween (R) 20, 40 and 80 
5. Limonene 
6. Croton oil 
7. Phenol 
8. Carbon dioxide enow 
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9. Iodoacetic acid 
10. Sodium deoxycholate 
11. Saccharin 
12. Griseofulvin 
13. 1,-fluoro-2,4-dinitrobenzene 
14. Phenobarbitone 
15. Sodium metabisulphite 
VIII MISCELLANIDUS 
1. Chloroform 
2. 1,1,1,Trichloroethane 
3. Dimethyl sulphoxide 
4. Dimethyl acetarnide 
5. Acetone 
6. Hydrochloric acid 
7. Sodium hydroxide 
8. Normal saline 
9. Putrescine 
10. Ethanol 
11. Arachis oil 
ERUIPMENT 
Standard laboratory equipment (including fume cupboard, appropriate 
glassware, forceps etc) and special facilities for the handling and 
disposal of carcinogens. Specific equipment used included:-
(a) ULTRAMATIC weighing balance, Model UM3 
Stanton Instruments Ltd, England 
(b) YALE MICROLANCE (B - D) hypodermic n~edles 
12G, 19G and 25G 
Becton, Dickinson & Co Ltd, Ireland 
{c) PLASTIPAK (B - D) disposable syringes 
1, 5 and 20 ml 
Becton, Dickinson & Co Ltd, Ireland 
{d) ISOMANTLE heater 
Isopad Ltd, Borehamwood, England 
(e) VOSS STIRRER 
Voss Instruments Ltd, Malden, Essex, England 
(f) BENCHKOTE polythene-backed absorbent paper 
Whatman Ltd, England 
( g) REGENT DISPO surgeons' gloves 
L.R. Industries Ltd, London, E4 
{h) BUR'N'BIN metal containers for disposal of chemicals waste 
Metal Box Ltd, Clayton, Manchester, England 
LABORATORY ANIMALS 
(a) c57 Black mice 
(b) Tyzzer Original White mice 
(c) CBA Brown mice 
All the mice used were pure-strain inbred mice of both sexes, age 
three to eight weeks, and weighing 20 - 30 gm each. The majority of 
the experiments were performed on male C57 Black mice. The mice were 
kept two to four in a cage measuring 13 cm (W) x 30 cm (L) x 13 cm (H) 
or 13 cm (W) x 44 cm (L) x 13 cm (H). They were fed a standard diet 
of Dixons 86 (Ref: Appendix Ia) before 30 August 1978 or B.P~ Expanded 
No 1 (Ref: Appendix 1b) after 30 August 1978, and tap-water. A 
specially prepared cis-retinoic acid diet and placebo diet 
(Ref: Appendix_ Ic) was used for one experiment. 
The cages were lined with saw-dust and kept in standard animal house 
conditions at a temperature of 21° - 25°c and a relative humidity of 
approximately 5()%. These cages were placed in different racks and 
different parts of the animal room. The positions of the cages were 
changed regularly to allow mice to be randomly exposed to environ-
mental conditions in different areas of the room in case there were 
any variations in such . onditions. Thia also helps in ensuring that 
when the mice are examined it will be done 'blind' i.e. without the 
examiner knowing which cage the particular mouse had come from. 
CHAPTE.:R 3 !1.TI!-!OD 
Prepara tion of test chemicals 
Preparation of test animals 
Intradermal injections 
Periodic examination of injected mice 
Microscopy 
DISCUSSION ON MEI'HODOLOGY 
Choice of C57 Black mouse as the model for study 
Choice of chemicals to te.!lt 
Choice of number of injection sites per mouse 
Choice of volume of solution per injection 
Choice of concentrations cf test solut i ons 
Choice of solvents/mediums 
ME1'1!0!) 
A standard basic procedure was adopted for tcstinc varioui; chemicals 
on the mice . The procedure consisted of single intrndermal injections 
of solutions of various chemicals . The mice were then periodically 
examined to see whether depigmentati on appeared at the injec t ion 
si te/s . 
(a) Preparation of Test Chemi cal s 
The test c hemicals were selected and appropria te solutions made 
using norma l sal i ne or dimethyl sulphoxi de as diluent. All 
solutions wer e prepared i m~ediately before use so as to prevent 
deterioration of unstable compounds in solution_!._ e.g. nitrogen 
mustard. The fume cupboard was used for preparation of solutions 
and any transport of chemicals within the laboratory was done 
using secondary contal nero to prevent spillage. A code of s afe 
practice for potentially carcinogenic materials (London School of 
Hygiene and Tropical Medicine - School Code of Safe Practice for 
Potentially Carcinogenic Materials) was adhered to. Extra care 
was taken in the handling and disposal of such materials. 
(b) Preparation of Test Animals 
An appropriate number of test animals, usually male C57 black mi ce , 
~ere selected and placed two to four in an a dequately labell ed 
cage. Each mouse was then coded by recording i ts tai l markings 
and/or by marking the ears using an ear-punch e.g. for four mice 
in a cage:-
Mouse No 1 - No ear-punch mark on either ear 
Mouse No 2 - Ear-punch mark on right ear 
Mouse No 3 - Ear-punch mark on left ear 
Mouse No 4 - Ear-punch mark on both ears 
( c) Int r:tctermal In;iec tions 
Single intrndermal injections of the test solutions were then 
made into the ventral surface of each mouse. A small syringe 
with 0.05 ml markings and a fine gauge needle (1 2G ) was used for 
the injections. Each mouse was held by gripping the skin behind 
the ears between thumb and forefinger of one hand, and fixing 
the tail between the thenar eminence and the remaining three 
fingers of the same hand ( Aw 1975 ) • The ventral surface was 
therefore exposed leaving the other ~and free to manipulate the 
syringe. To enable ease of penetration of the needle into the 
mouse skin, the injection site was first moistened using a ball 
of cotton wool soaked in absolute alcohol. The alcohol brings 
the hairs together, thereby exposing areas of bare skin for 
injection. The injections were prepared with the needle almost 
parallel to the skin surface so that the solution was introduced 
intradermally and not subcutaneously nor intraperitoneally. A 
successful intradermal injection was indicated by the appearance 
of a wheal. Following withdrawal of the needle, a pair of forceps 
was used to ~rip the p=cture site. This helped to prevent leak 
of injected solution out through the injection puncture wound. 
All injected mice were left in the laboratory for four hours 
before being returned to the animal house. No form of 
anaesthesia was used for the injections. 
(d) Periodic Examination of Iniected Mice 
After the initial injections, all mice were examined two to three 
times a week for any macroscopic changes at the injection sites. 
All examinations were done blind i.e. without the obs erver knowing 
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from which cage the mour;e had come and therefore not knowing the 
chemic11l the mouse had been injected with. Thi<: reduces observer 
bias. 
A hand lens was used under adequate lighting for closer scrutiny 
of the injection sites during exami na tion. In particular, 
depigmentation was the main feature looked for. The degree of 
depigrnentati on was recorded and a subjective scale used viz:-
+ + + marked depigmentation extending 1 mm from the margin 
of depilation o½ where there was no depilaticn,an area 
of 2 mm diameter 
+ + obvious depigmentation 
+ slight depigmentation 
: doubtful depigmentation 
no depigmentation 
In all instances where doubtful or slight depigmentation was 
recorded, the mice concerned were then examined daily to see 
whether further changes occurred. Only where there was slight 
depigmentation confirmed on at least three consecutive daily 
examinations was this considered positive depigmentation. Doubt-
ful cruses were considered negative . 
(e) Microscopy 
(1) For examination of skin sections under the light microscope, 
selected mice showing obvious macroscopic changes were 
killed by dislocation of the neck. The skin area for 
histological examination was then removed using a pair of 
I01-
scissors. This tissue was kept inAformal saline before 
fixing, preparing of slides and staining using haematoxylin 
and eo~in or toluidcnc blue stain . Minimal delay was 
allowed between killing the mice and remova l and preser-
vation of the excised skin area, to prevent excessive 
post - mortem a u tolytic changes in the c e l lul ar structure 
of t he tissue c o ncerned. 
( 2 ) Hai r specimens f or mi croscopy were obtained by u sing a 
p a ir of f o rc e ps to pluck the hair out from skin areas of 
interest . Thes e were then mounted on glass slides using 
euparol to form a permanent mounting . 
(3) Specia l sections were also taken for electron microscopy 
and the procedure is detailed in Appendix 2. 
DISCL'.:..SION ON m:T l [Ol'O W C\Y 
The meth od As des cribed was designed with specific reasons for the 
cho i ce of :-
1. C57 Black mouse as the model for study . 
2 . Chemicnls to test . 
3. The number of injectjon sites per mouse. 
4. The volume of solution per injection. 
5. Concentrations of test solutions to use. 
6. Solvents/mediums. 
1. CHOICE OF TEE C57 BLACK MOUSE AS THE MODEL FOR STUDY 
The mouse was chosen as the test animal because this was origin-
,..1. S..,9.,,t" 
ally used by Boyland,.(1951 aRa ~952), Searle (1970), Schoental 
(1971) and Matsuyama (1966) in their independant experiments on 
depigmentation by chemicals. Schoental also showed similar 
depigmentation in rabbits. The strains of mice used by the 
various researchers include C57, C3H, ddCF2 and CBA. Pure strain 
c57 Black mice was the test-strain chosen for this study because 
being a pure black mouse allows the depigmentation to show up 
easier. The size of the C57 Black mouse allows ease of handling 
by one person for the purpose of intradermal injections and 
regular e xamination. c57 Black mice also have a relatively low 
spontaneous disease rate (Innes~~ 1969) 
2. CHOICE OF CHEMICALS TO TEST 
Chemicals for testing were selected on the basis of their reported 
carcinogenic activity and chemical classification with an attempt 
to choose r epresentatives from each c lass of chemi cal car cinogen s 
( sec '£able 1f ). A theoretical ideal 1-1ay of selec ting co mpounds 
fo r investigating U."l effec t such as depigment a tion wr, ich a ppears 
to b e rela ted to carcinogens , is to prepare a list of carcinog ens 
and one of non-ca rcinogens . A s t a ti s tically random s a mple of 
equa l numbers of c hemicals from both lists can then be selected 
and tested according to the method described. The results regard-
ing1he appearance of depigmentation can be statistically tested 
to see whether the depigmcntation effect is significantly related 
to carcinogens. However, there are practical limitationB to this 
approach. This includes the difficulty of defining carcinogens 
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and non-carcinogens. Various attempts at producing a list of 
carcinogens have resulted in different chemicals and different 
numbers on the list depending on the criteria used. Rall (1978), 
Director of the National Institute of Environmental Health Sciences, 
lists 26 chemicals that have been firmly associated with cancer in 
man and 56 more where the epidemiological evidence is less definite. 
If a carcinogen is defined as one that has epidemiologic proof of 
causing cancer in man, then a list of carcinogens will contain 26 
to 82 compounds depending on how one assessed the epidemiologic 
evidence. According to National Ca.'tcer Institute sources (Ma.ugh 
1978) about~ chemicals have been tested for carcinogenicity in 
animals and a few more than 1000 have been reported to be carcino-
genic. A list of carcinogens based on such animal data will, there-
fore, include over 1000 chemicals. Based on chemicals used in U.S. 
workplaces, The Occupational Safety and Health Administration 
(OSHA) in 1978 (Chemical and Engineering News 1978) issued a 
tentative list of carcinogens consisting of:-
(a) 269 Category I carcinogens based on hur.1an data, tests in 
t~10 mammc1lian species or one species if replicated. 
(b) 218 Category II carcino6ens based on reports of carcino-
genjcity in only one species and with results not 
replicated . 
(c) 396 Category !II substances where there wa s no or meagre 
evidence of carcinogenicity. 
The National Institute for Occupational Safety and Health (NIOSH) 
has, however, been reported to have identified more than 2000 
substances where there is some evidence of tumourigenicity and 
carcinogenicity (Chemical and Engineering News 1978) • 
• 
The NCI in its survey of compounds summarizes data from published 
information relevant to chemical carcinogens. This information 
is regularly updated in the light of new evidence available. How-
ever, no pronouncement on carcinogenicity is made. An assessment 
has often to be made on the basis of the data provided. For 
example, in the 1972 - 73 volume a study by Van Duuren (1972) was 
summarized where 15 mice were given 4-nitrobenzene carboperoxic 
acid (p-nitroperbenzoic acid). Two mice developed sarcomas at 
the injection sites. No mention was made of any use of controls. 
Similarly in the same volume, a study by Malejke-Giganti and 
others (1973) reports six rats given N-hydroxY 3-fluorenamine 
of which three developed tumours. Studies such as these based 
on small numbers of experimental animals without the use of 
cont"rols are difficult to evaluate. 
• NCI - National Cancer Institute 
The I nternational Agency f or Research in Cancer also p roduces 
information on carcinogenicity of individual chemicals on the 
basis of data compiled, rev iewed and e valuated by i t s worki ng 
group of e xperts. Such dat a is revised from time to time. To 
-date, eight e en volumes of the I ARC Monogra phs on the Evaluati on 
of Carcinogenic Risk have been publi s hed. This includes data 
on some 350 chomicals. llcwever, the conclusion in many c a s e s is 
that 'the results are insufficient for evaluation' or 'no evalua-
tion can be made on the ba sis of avai1Bh1e data' or 'with regards 
human data, no caGe repo~ts on epidemiological studies are avail-
able'. Again, it would be difficult to compile a list from either 
the NIOSH data or the IARC data. One could attempt to produce 
such a list by defining specific criteria and then reviewing the 
data accordingly. Obviously the carcinogens with epidemiologic 
evidence of effects in humans would need to be included in this 
list. Purchase and others (1978) produced a list based on the 
following criteria:-
(a) Any materials shown to produce malignant tumours in any 
mammalian species as a result of application to the skin, 
i.p. or i.v. injection, or orally (including intragastrically) 
have been regarded as carcinogenic. 
(b) Initiating and promoting agents have been classified as 
carcinogens. 
(c) Tumours arising in the urinary bladder as a result of bladder 
implantation techniques have not been considered as meaningful. 
(d) Tumours arising at the site of subcutaneous injection (i.e. as 
sarcomas ) have been ignored unlecs accompanied by the 
appearance of tumours at other si tes. 
(e) Ne gative result s after s.c . injection or bladder implant-
atj_on have been regarrl.ed .:is significant, and were considered 
an ~r-dication of non-carcinogenesis. 
(f) Where there is only an increase in the incidence of common 
tumours in mice (e.g. of hepatomas or lung adenomas in 
susceptible strains) the data have been ignored, unless there 
have been concurrent appearances of other tumoul's at different 
sites. 
(g) Evidence based solely on the appearance of benign tumours has 
been considered insufficient for a positive classification. 
(h) Compounds which were negative in studies which have continued 
for the major part of the animal's lifespan have been classi-
fied as non-carcinogens. Where there is no reason to suspect 
carcinogenicity (e.g. natural products of mammalian systems) 
or on theoretical grounds (e.g. by analogy with a closely 
related chemical known to be positive) then the compounds 
in question have been classed as negative. 
The problem is even greater when one tries to compile a list of 
non-carcinogens. This would be a very extensive list if it is to 
include chemicals with no evidence of carcinogenicity since it has 
been estimated that there are over 4.3 million known chemicals 
(Culliton 19?8) and those that are considered not carcinogens by 
whatever criteria is used would be on a huge list of non-
carcinogens. This would obviously include so~e very rare chemicals 
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which are carcinogenic but have not been tested. Hence a 
statistically random sample from such a list , even if it is 
possible to compile one, would not necessa rily be a representa-
tive s ample as it could include potential c arcinogens and rare 
chemicals which are not easily avai lable for testing. 
Even in selected pairs of compounds (one carcinogenic and another 
similar structura lly but non-carcinogenic) which have been used 
for assessing short-term tests (Purchase ~ al 1978) there i s 
some doubt as to whether such classification for pairing is 
valid (Boyland 1978a). 
In view of the difficulties of this theoretical approach, the 
method, therefore, used for selecting chemicals for testing is 
based on the principle of practicality. Chemicals tested were 
those which were available including many which are known human 
carcinogens such as asbestos, benzidine, 2-naphthylamine and 
common compounds which appear to be obvious non-carcinogens such 
as HCl, NaOH, saline, and alcohol. If the depigr.ientation effect 
is to be of any use in differentiating between carcinogens and 
non-carcinogens, it must firstly be positive for obvious carcino-
gens such as 2-naphthylamine, nitrogen-mustard and the other 
examples mentioned. Therefore, rather than a random sample from 
a compiled list of carcinogens - which as discussed has practical 
difficulties - a selected sample from available carcinogens was 
used. A working list of carcinogens was compiled from available 
compounds, where literature reviewed showed either epidemiologic 
evidence of carcinogenic effect on humans or well-designed studies 
showed carcinoganic or tumourigenic effect in animals . 
'l'umour- promotero and co-cnrcinor;ens were classified as a separate 
group as they are by themselves non-carcinor;enic, but would not 
strictly f all into the non-carcinogenic group since they do under 
appropriate conditions increase tumour yield. Asbestos fibres 
were placed in a separate sub-group under carcinogens since there 
is little evidence as yet to indicate whether they are direct or 
indirect carcinogens. There is some suggestion that asbestos may 
be a co-carcinogen (Selikoff, Hammond and Churg 1968). 
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COMPOUNOO TIBTED BY THE DEJ>IGMENTATION TEST 
DIRIDI' CARCINOOEl~S 
A.llcylating Agents References 
Nitrogen mustard Boyland and llorning 1949 
(Hethyl-bis-(2-chloroethyl)-amine) Schmahl and Osswald 1970 
Dimethyl sulphate Druckrey ~ al 1966 and 1970 
Methyl iodide Druckrey ~ al 1970 
Ben~yl chloride Matsushita et al 1975 Sakabe, Matsushita and Koshi 1976 
Sakabe and F\ilcuda 19'n 
Benzo:,l chloride Matsushita~~ 1975 
Benzotrichloride Hat sushi ta et ~ 1975 
TABLE 4 (Continued) 
INDDUm' CARCINOGiliS 
Polycyclic Aromatic Hydrocarbons References 
1,2:5,6- Dibenzanthracene Kenna11a,y 1930 
9,10-Dimethyl-1 ,2-benzanthracene Haddo11 and Kon 1947 
6,9,10-Trimethyl-1, 2-benzanthracene Haddo11 and Kon 1947 
Benzanthracene Bock and King 1959 Kenna11ay 1930 
Ben7.o(a)pyrene IARC Monographa Vol Ill 
}-~ethylcholanthrene Rinkus and Legator 1979 Kataoka 1976 
TABLE 4 (Continued) 
INDIRrer CARCINOGlllS 
Aromatic Amines References 
2-Haphthylamine Case et al 1954 Goldvrle;: Rosso and Kleinfeld 1965 
Hueper 19'+2 
Hueper, Wiley and Wolfe 1938 
Ben:r.idine IA.RC Monographs Vol I 
Aniline BIBRA Information Bulletin 1978 
Carbamates References 
Ethyl carbamate IARC Monographs Vol Xll 
(urethane) 
Propyl carbamate larsen 19'+1 
TABLE 4 (Continued) 
CYI'HER CARCINOOENS 
Carcinogens References 
Chloroform Eschenbrenner and Miller 1945 
1,2-Dimethylhydrazine Hawks , Farber and Magee 1r;-?1/72 
Toth and Wilson 1r,/1 
Asbestos Doll 1955 
Glynne 1935 
Wagner and Berry 1969 
Reeves et al 1r,/1 
HancusoandCoulter 1963 
Selikoff , Churg and Hammond 1965 
8-hydroxyquinoline Allen .!!. ,!l 1957 
Fliss and Volfson 1r,/0 
TASLE 4 (Continued) 
TUMOUR PROMarERS 
Tumour- Promoters 
12-0-TetradecM.oyl-phorbol-1}-acetate 
('!'PA) 
Anthralin 
Oodecane 
Tween 20, 40 and 8o 
Li.monene 
Croton oil 
Phenol 
Carbon dioxide snow 
Iodoacetic acid 
References 
Hecker 1968 
Van Duuren 1969 
Van Duuren and Sivak 1968 
Bock and Burns 1963 
Boutwell 1967 
Segal, Katz and Van Duuren 1971 
Safiotti and Shubik 1963 
Setala 1956 and 1960 
Roe and Pierce 1960 
Berenblwn 1941 
Boutwell and Bosch 1959 
Rusch, Bosch and Eoutwell 1955 
Berenblum 1930 
Gwyn and Salaman 1953 
Tumour-Promoters 
Sodium desoxycholate 
Saccharin 
Griseofulvin 
-Fluoro-2,4-dinitrobenzene 
Pyrocatechol (Catechol) 
Pheoobarbitone 
TABLE 4 (Continued) 
TUMOUR PROMOO'ERS 
References 
Marx 1978 
Boyland 1979 
Cohen et al 1978 
Mondal-;-Brankow and Heidelberger 1978 
Barich, Schwartz and Barich 1962 
De Matteis, Donnelly and Runge 1966 
Weston Burst and Paget 1963 
Bock et al 1969 
IARC Monographs Vol XV 
Van Duuren, Katz and Goldschmidt 1973 
Clemensen, Frederiksen and Plum 1974 
Periano et al 1971 and 1973 
Walker , Thorpe and Stevenson 1973 
Weisburger et ~ 1975 
Tumour- Pr01110ters 
Hydroquinone 
Sodium metabisulphite 
TABLE 4 (Continued) 
TUMOUR PROl-m'ERS 
Refuences 
Boyland !!_ al 1964 
Roe und Salaman 1955 
Laskin !!_ al 1970 
TABLE 4 (Continued) 
CYl'HERS: NON-CARCINOGrnS 1 NON-TUMO!JR-POOM<Yl'ERS, 
AND OOKPOIJNDS NCYl' YEl' TffirED FOR CARCINOGllHC NOR TUMOUR-PHO~ING ACTIVITY 
Compounds 
Phenanthrene 
Pyrene 
ethyl carbamate 
Diethyldithiocarbamate 
Dimetnylsulphoxide (™50) 
Dimetbylacetamide (DHAC) 
Acetone 
lormal Saline 
1,1,1, Trichloroethane 
Arachis oil 
References - Available only for tested compounds 
Dipple 1976 
Dipple 19?6 
Van Duuren 19?6 
IARC Monographs Vol XII 
IARC Monographs Vol XII 
National Cancer Institute Report 19?7 
'l'ABLE 4 (Continued) 
arnras: NOO-CARCINO(IffiS. NON-TlJMOUR-PROMorERS. 
AND COMPOUNDS Nor U:l' TESTED FOR CARCINOCIDlIC NOR TU!-llUR- PRC)!IDrING ACTIVITY 
Cocrpounds 
References - Available only for tested compcunds 
Hydrochloric acid -
SodiUl!I hydroxide -
-Ethanol 
Pyrogallol Van ~uren 1976 
4- tertiary butyl catechol -
p-tertiary butyl phenol -
Methyl catechol -
Butylated hydroxyanisole -
Putrescine -
Di-hydroxy phenJ'lalanine (OOPA) -
C, 
TABLE 4 Continued) 
arHrn!> : NON-CARCI!lO<H'NS 1 NON- TUMOUR- PROMC7rEits, 
AND coMroUNDS Nor YEl' TIBTED FOR CARCINOOfll!C NOR TUMOUR- PROl'm'ING ACTIVITY 
Compounds 
References - Available on].J for tested compounds 
Adrenaline hydrogen ta.rtrate -
Histamine hydrochloride -
3 . CHOICE OF NllMRE:fl OF INJECTION SITES Pli:R MOUSE 
Theoreti.cally , ony number of injections can be performed on the 
ventral surface of the mouse. The practical limitations to the 
number of sites would be:-
(a) Difficulty in identifying the site of injection during 
subsequent examinati ons if there are more than six or eight 
injection,.,. 
(b) A large number of injections would mean a large total volume 
test solution injected per mouse. This could be lethal to 
the mouse. 
The ideal number of injection sites per mouse appears to be one 
to six (see Fig 1 ) • 
FIG 1 
NO /\ND POSITION OF IN.JECTION SITES PER MOUSE 
No of Iniection Sites 
One 
Two 
Three 
Four 
Six 
Position cf In;i'i?ction Siter; 
on Ventral Surface 
~ . CHOICE OP VOLTJm.: OF c,OLU'l'ION PER INJECTION 
In makints the choice of volume of test Golution per injecti on, 
the principle followe d was to give just sufficient o dose to pro-
duce a visible wheal which would indicate a successful intradcrmol 
injection. A large volume would limit the m1mber of injections 
per mous e because of the possibility of toxic or lethal effects. 
With large volumes, there is also an increased likelihood of 
leakage of injected solution out through the hypodermic needle 
puncture wound in the mouse skin. 
The ideal volume was 0.05 mls. Volumes of less than 0.025 mls 
were too small and more than 0.1 ml too lar~e to ensure certainty 
of successful intradermal injections. 
5. CHOICE OF CONCENTRATIONS OF TEST SOLUTIONS 
At least three concentrations of each test chemical were prepared. 
An assessment of the toxicity of the compound was first made from 
published data (the MERCK Index) or by toxicity testing on groups 
of C57 black mice. The highest concentration used was one just 
below the minimal lethal dose or,if the compound was not very 
soluble, a saturated solution was used. Ten-fold dilutions of 
this were then prepared. Thus a range of concentrations of the 
chemical was tested. The depigmentation effect may be best 
elicited by a particular concentration of the teat chemical. Hence, 
using this wide range of concentrations decreases the likelihood 
that such an effect might be missed because of use of the wrong 
concentration. 
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6. CHOICE OF SOLVf:NTS/MEDIUNS 
The compounds used for animal testing were avai l able in one of 
the following forms: -
(a) Powder - fine or coarse e.g. Tetradccanoyl phorbal acetate 
(TPA) 
(b) Crystals e.g. Nitrogen-mustard 
(c) Liquid e.g. Benzyl chloride 
(d) :1<.,mulsion e.g. Dimethyl benzanthracene 
(e) Fine fibre s e.g. Asbestos 
An appropriate s olvent/medium had to be selected for preparing the 
test compounds into solutions or suspensions of different concen-
trations for the intradermal injections. 
The following solvents/mediums were considered:-
(a) Distilled water 
(b) Normal saline 
( c) Dimethyl acetamide 
( d) Dimethyl sulphoxide 
( e) Acetone 
(f) Arachis oil 
(a) Distilled Water 
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Distilled water was not considered suitable because a positive 
result occurred with the use of 0.05 mls of distilled water 
(Aw 1975). Boyland and Sargent (1951) noted a similar effect 
in 19% of injected sites. This was attributed to a possible 
cellular che.nge following exposure to the hypotonic solution. 
(b) Normal Saline 
Only some of the substances used were soluble in normal 
saline . No positives were however produced and this could 
be due to its isotonicity com~ared with disti lled water. 
(c) Arachis Oil 
This was usefu l as a solvent for hydrocarbons such as 
3-methyl cholanthrene but its viscosity made it difficult 
to use, especially when injecting solutions ma de with this 
oil through a fine gauge needle ("i2 G) using micro-syringes .. 
It was difficult to accurately inject a small amount, 
(0.025 mls) of the viscose solution but warming reduced the 
viscosity and allowed easier injection. 
(d) Acetone , Dimethyl Acetamide (DMAC) anct Dimethyl Sulnhoxide 
(~) 
Most of the test compounds were soluble in these three 
solvents.however, in terms of toxicity, dimethyl acetamide 
is the most toxic followed by acetone, with dimethyl 
eulphoxide being the least. 
TABLE 5 
cm-n=.I\Rll.TIVE TOXICITY OF SOLVENTS TESTED 
I.D50 Rats Lethal dose in 2/3 Solvent (Published data in C57 black mice 
Merck Index) (intradermal) 
DMSO 20 mg/kg (oral) 13.2 gm/kg (2/3) 
Acetone 8.45 gm/kg (oral) 6.3 gm/kg (2/3) 
DMAC 3.8 gm/kg (1/p) 3.8 gm/kg (2/3) 
Dime thyl s ulpho:dde was , therefore , used a s s olvent /medium 
for preparing mo s t of the test flolu tions because of:-
(i) The l a r ge numbe r of compounds s oluble in it. 
(ij_) The low t oxicity - when compared with acetone or 
dime thy l c.c e tamide. 
(iii) I ts miscibility with water. 
0.05 ml s injec t ions at four sites was the upper limit of the 
volumes and t h e number of sites for injection used in each 
C57 black mou~e wa s:-
(i) 0.05 mls at two to four sites per mouse. 
or 
(ii) 0.025 mls at four sites per mouse. 
CHAP~ER 4 RESDLTS 
Macroscopic features 
General effects 
Local effects 
Discussion on observed depigmentation 
Latent period before depibmentation 
Dose-response relationship 
Overall results 
The link between tumour-promoters and depigmentation 
Specificity and sensitivity of the depigmentation test 
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H&SUI.:rS 
1 . MACWSCOPIC FE,\'l'URF;S 
General effects :-
( a ) Death cf the Mice 
This occurred when the maximum concentration of the test com-
pound used was too hig h. The choice of the maximum concen-
tration of solution used for a."ly test chemical was based on 
its solubility in the solvent and its documented toxicity -
as expressed by an JJJ50 (see methodology). If the reported 
LD50 pertains to rats, rabbits or guinea-pigs with no specific 
data for mice, then the choice of the highest concentration of 
test solution based on an estimated LD50 for mice according to 
proportional body weight, may cause death in the C57 Black mice. 
This would be so if the compound is actually more toxic for mice 
than for the other species of animaJ.s mentioned. 
Even when the published LD50 re~ers to mice, because of strain 
differences the susceptibility of the c57 Black may be differ-
ent. Death of the mice due to a high concentration of chemica l 
used, usually occurred within 36 hours of injection, with the 
animal becoming progressively unwell after the injection. In 
the event of this occurring, the experiments were repeated with 
the lethal concentrations omitted. Surviving mice from the 
initial experiments were kept and regularly examined for dep ig-
mentation. 
Death of mice also occurred because of illness, In such 
instances, death may occur several weeks or months from the 
time of injection, depending on when the onset of illness 
started . On rei;ular examination of the mice , any such 
ruiimals were isolated cind observed dai ly . Mice dying four 
weeks after the last appearance of depigmentation in the 
group of mice similarly injected would have the depigmentation/ 
non-depigmentation results included in the results for that 
~ x periment. Death of a mouse before the last appearance of 
depigmentation in any other mice in the same group or within 
four weeks after the last appearance of such depi gmentation 
will mean exclusion of the dep igmentation/non-depigmentation 
results for the dead mouse from the results for that group of 
mice. This is because it may be possible that had thi s mouse 
survived it may have shown depigmentation a t any injected 
sites which are not depigmentated at the time of death. 
Instances of death of mice in the course of the various experi-
ments are surnmariz.ed in Table 6 • 
No 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
TABLE6 
COMPOUNOO ™ ro c57 BLACK MICE FULIDWING INTRADERMAL mJrerIONS 
Concentrations Injected Total Amount No of De:iths Compound Per Mouse Injected C»g) Total tlo of Mice (gm/100 ml) 
Croton Oil 10, 1, 0. 1, 0. 01 5,555 4/4 
5, 0. 5, 0.05 2,775 5/14 
1, 0. 1, 0.01 555 1/4 
Anthralin 2, 0. 2, 0.02 1,110 6/8 
Phenobarbitone Sodium 20, 2, 0.2, 11,100 4/4 
10, 1, 0. 1 5,550 4/6 
Tween 8o 1, 0.1 550 1/4 
p-tertiary Butyl Phenol 10, 1, 0. 1 5,550 3/8 
Chloroform 10, 1, 0. 1 5,550 5/8 
Benzyl Chloride 10, 1, 0. 1 5,550 1/11 
Dimethyl Sul phate 10, 0. 1 5,050 4/4 
. 
..:: 
'-~ 
TABLE 6 (Continued) 
Concentrations In jected Total Amount No of Deaths 
No Compound 
Per House Injected (l.lg) Toto.l Ne of Hice 
(gm/100 ml) 
9. Adrenaline 
2, 1, 0.1, 0.01 1,555 
4/4 
1, 0.1, 0.01, 0.001 I 1,555 4/4 
10. Sodium Metabisulphite 
10, 1, 0. 1 5,550 
2/4 
11 . Dimethyl Sulphoxide 
1Cl0% soln. (110 gin) 330 ~ - 2/3 
at 6 sites 
12. Dimethyl Acetamide 
1oo% soln . (94 g111) 188 ~ - 8/8 
at 4 sites 
13. Acetone 
1~ soln . (79 gm) 158 ~ - 2/ 3 
at 4 sites 
14. 1-nuoro-2,4-dinitrobenzene 
1, 0. 1, 0.01 555 
4/4 
(b) Anaesthetic Effect 
An immediate anaesthetic effect was noted followin g intrader-
mal inj ec tions of phenobarbi tone sodium and chloroform. 
Anaesthe tised mice were kept in a warm area of the l aboratory 
during the period of anaesth£sia and were returned to the 
ani,nal house on full recovery. 
Local Effects 
(a) Wheal Formation 
Each suc~~6sful intradermal injection resulted in a whea l at 
the site which gradually disappeared as the injected solution 
dispersed. In previous experiments using arachis oil as 
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solvent the wheals persisted for more than three weeks (Aw 1975) .. 
Compounds which are oils produce viscous solutions which do 
not disperse easily and therefore result in persistence of 
wheals at the injection sites. Croton oil is an example where 
the wheals remained but within a week there was ulceration at 
the site due to the highly irritant nature of croton oil 
Injection of asbestos fibre suspension - both ground and 
unground, also resulted in a persistent swelling at the site. 
This is due to the insoluble fibres remaining at the site of 
injection. 
Disappearance of the wheal may be due to ulceration of the 
skin when irritant compounds were used or it may be followe d 
by no further observable change as when non-irritants such as 
saline and absolute alcohol were injected. 
(b) Ulceration and Abs cess Formation 
The following compounds in the concentration., us ed cauoed 
ulceration at the sites of injection. 
~ 
COMPOUNDS CAUSING ULCERATION AT IN.ra:TlON SITF.S 
No Compound 
1. I Tveen 8o 
2. 
4. 
9 ,10-Dimethyl-1,2-benzanthracene in fat emulsion 
6,9,10-Trimethyl-1,2-benzanthracene in fat emulsion 
Acetone 
5. I Nitrogen mustard (HN2) 
6. I Croton oil 
7. I 1-Fluoro- 2,4-dinitrobenzene 
8. I Sodium metabieulphite 
Concentration 
10 100 ml 
1oo% emulsion) refer to page for 
) 
1e>a.' emulsion) constitu~nts of emulsi on 
1c:>0% 
At concentration > 1 mgm/100 ml 
At concentration) 0. 5 miv100 o1 
At concentration ) 0. 1 £1ll/100 ml 
At concentration) 1 glll/100 ml 
At concentration ) 0.002 gm/100 ml 
9. I 12-0-Tetradecanoyl-phorbol-13-acetate (TPA) 
-~ I I 
..,: 
Most of these sulist:mces are strong skin irr itants or 
vesicants cu1d c1:1used skin ulceration . Ulceration was 
followed by either:-
(i) Hea l ing with scarring and permanen t ha ir loss a t t he 
site. 
(ii) Abscess forma tion - This was noted in two out of four 
sites when sodium metabisulphite was injected ~t a 
, 
concentration of 10 gm/100 ml s alin:t. The aqueous 
solution injected was acidic and the abs ces ses led to 
death of two mice on the fifty-seventh and fortieth 
day. This may be due to bacterial infection. 
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The irritant nature of these chemicals is not related to the 
effectiveness in producing depigmentation. Only four compouncil 
nitrogen mustard, croton oil, 1-fluoro-2,4-dinitrobenzene and 
TPA caused ulceration and definite depigmentation. The remain-
ing five compounds caused ulceration but no distinct depigment-
ation. 
( c) Det>ila tion 
Loss of hair at the injection site occurred with irritant 
compounds and when dimethyl sulphoxide (DMSO) was used a s 
solvent. DMSO is locally irritat ive and when injected intra -
dermally caused small areas of depilation in ten to thirteen 
days. This appeared to be temporary with a re-growth of nor-
mal dark hair over the area within two to three weeks. How-
• ever, with a stronger irritant such as dimethyl acetamide or 
acetone, permanent areas of depilation resulted. This wns 
also true for t>MSO when irri ta.nt compounds were dissolved in 
it for injection , e.c;. with croton oil, 1-fluoro-2,4-
dinitrobenzene, nitrogen mustard a.nd sodium me tabisulphite, 
large areas of ulceration and perma.nen t depilation occurred. 
In general, the more irritant the test solution, the l ar ger 
the area of hair loss and the more likely it is to be per-
rnanent. 
(d) Tumour Formation 
Bo 
Papillomas occur·red in two out of twelve mice in,jected with 
3-methylcholanthrene . This was noted on the 110th and 125th 
day after injection with a concentration of 0.2 mg/ml. 0.05 ml 
of 3-methylchola.~threne in arachis oil was injected at three 
concentrations in twelve mice. One papilloma was noted in 
each of the two mice injected with the highest concentration 
of 0.2 mg/ml. Fig 2 shows one of the tumours still attached 
to the adjacent skin and cut to show the inside of the tumour. 
The tumours were fleshy, hard, well vascularized and well 
defined of 1 cm diameter. They were attached to the surround-
ing skin but not to the tissues below. No depii;mentation was 
noted at these sites injected with 3-methylcholanthrene 
3-methylcholanthrene is a polycyclic aromatic hydrocarbon. 
·pc.H3, 
0 0 0 
• 
3-methylcholanthrene 
It is a powerful indirect carcinocen and single doseo of 10 ug 
induced papillomas in two si tea. The results for 3-mcthyl-
cholanthr"lne are !1.E! oumm:i.rized in table 8 • 
FIG 2 P pillou du to }-M thylcholruithren 
1 
FIG -:, P pillo1~ du lo 3-!l thylchol 11nthr n 
FIG :;, P pillo11 d • Lo } -! u~hylc11ol nt r 
TABLE 8 
DEPIGMENTJ'\TION AND TlfMOUR FORMATION DUE TO 3-METHYI.Cl!OIJ\NT!,RF.NE 
No of Positive Sit,.s 
Concentration Amount Total No of Sites Injected 
(In Arachis Oil) }lP, 
Depigmentation Tumours 
0. 2 mg/ml 10 0/12 2/12 
0.02 mg/ml 1.0 0/12 0/12 
0.002 mg/ml 0.1 0/12 0/12 
(e) Depigmentation 
Depigmentation occurred with twenty out of the sixty-six 
chemicals tested. The degree of depigmentation was graded 
into+++ (marked depigmentation), ++(obvious depigment-
ation) and+ (slight depigmentation) according to the sub-
jective scale described in the methodology. This subjective 
grade for any chemical is based on the site showing maximum 
depigmentation out of all sites injected with the same 
compound. 
Figs 3 and 4 show the comparative difference before and after 
injection of nitrogen mustard (HN2). Two areas of marked 
depigmentation (++ +)are present in Fig 4 - one near the 
left fore-leg and the other near the right hind-leg . The 
latter also shows a small central area of depil:i.tion. 
Fig 5 shows a Tyzzer Original Whi te mouee injected with llN2 
Only a sm:i.11 area of depila tion is present on the vPntr~l 
surface near the fore-legs. No ch!:tn€;e in hair pigmenta tion 
occurred. 
FI G 3 Before Intradermal Injection of Nitrogen Mustard (HN2 ) 
FIO I+ At'ter Intradermal Injection of Nitrogen Huatard (HN2) 
I 3 Before Intradermal Inj ct ion of Nitrogen Mu e ard ( IIN2 ) 
fi'IO 4 Af er Intraderm l Inj ction of Nitro en Muet rd ( II N2 ) 
FIG Before In rad rmo.1 Injection of Nitro en ~u s a r d ( HN2) 
J,'l 4 Af er In r rm r j c i o or Ni ro n Mus rd (IIN2) 
FIG 5 Ty:z.zer Original White Mol18e Injected wi. th Nitrogen Mustard (H.N2 ) 
FIG 6 CBA Brown Mouse Injected with Nitrogen Mustard (HN2) 
FIG 5 Tyzzer Original White Mouse Injected with Nitrogen Mustard (HN2 ) 
FIG 6 CBA Brown Mouse Injected with Nitrogen Mustard (HN2) 
FIG 5 Tyzzer Original White Mouse Injected with Nitrogen Mustard ( HN2 ) 
FIG 6 CBA Brown Mouse Injected with Nitrogen Mustard (!IN2) 
FIO 7 C57 Black House Injected with Pyrocatechol 
no 8 C57 Black Mou•• Injected with 12-0-Tetradecanoyl-Phorbol-
1}-Acet•t• (TPA) 
FIO 7 C57 Black Mouae Inje ct ed with Py rocatechol 
FIO 8 C57 Black Mouse Injected with 12-0-Tetradecanoyl-Phorbol-
13-Acetate (TPA) 
Fl • 7 C57 Black Mouse Inje c d wi h Py roc techol 
Fl C ? Bl ck Mou Injec d wi h 12-0-T r c noy - f>hor ol-
1 -A c (Tl'A ) 
Fie G shows a CBA Brown mou::;e also injected with l!N2 . In 
this case there wvs sl ight depigrnentation (+) surrounding a 
centr~l area of depi l~tion (near th e richt hind-leg). The 
depi e;rr.entation was less obvious tha n for the C57 Black mice 
similsrly injected. 
Fig 7 shows a C57 Black mouse injected with pyrocatechol. 
Obvious depigmentation (++)is present at two sites - one 
near the left fore-leg and the other near the left hind-leg. 
Two other sites - one between thEe previ cus two and the other 
o~ the right side shQw slight depigmentation (+) . 
Fig 8 shows a C57 Black mouse injected with TPA. Marked 
depigmentation (+ + +) is present stretching from one 
injected site anterior to the right hind-leg to another site 
anterior to the left hind-leg. 
Table 9 summarizes the maximum degree of depigmentation 
caused by the twenty positive chemicals. 
TABLE 9 
CHEMICALS CAUSING DEP1CMF.N'rATION 
( ACCORDI NG TO HAXIMC1-I DEGhEE "' DEPIC:-1mT1\'r ION ) 
Maximum Degree 
o f Depigmentation 
+ + + 
+ + 
+ 
No 
1 . 
2. 
3. 
1 . 
2. 
3 . 
4. 
5. 
6 . 
1. 
2. 
3 . 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11 . 
Chemicals 
TPA 
HN2 
CO2 Sr:ow 
Croton Cil 
.Pyroca.techol 
p-tertia.ry butyl phenol 
4-tertiary butyl catechol 
Chloroform 
Dimethyl sulphate 
Methyl iodide 
Benzyl chloride 
Saccharin 
Tween 20 
Dodecane 
Phenol 
Griseofulvin 
Hydroctuinone monobenzyl ether 
Butylated hydroxyanisole 
Ground Croc i dolite 
1-fl•.ioro-2 , 4-dini t robenzene 
Discussion on Observed Deuirmentat ion 
Latent Period Before Deni -mentati on 
For most of the chemicals injected where positive depigmentation 
occurred , the latent period before the appearance of depigmentati on 
varied f'rc-m three weeks (as for TPA) to sixteen 1,1eeks (in mice pre-
treated with urethane &nd injected with crocidolite). The avera ge 
latent period was from three to six weeks. This latent period would 
be expected to vary considerably between chemicals and even for the 
same chemical injected in a number of mice. The reason for this is 
that the growth of hair in the mouse undergoes cyclical changes and 
synchronous groups of hair fol.l.icl.es al. ternate between a phase of 
active growth and an inactive resting phase. This causes successive 
growth waves over the coat of the mouse (Eaton 1976, Borum 1954). 
Dry (1976) divided the hair cycle into three stages:-
(a) Anagen - the growth phase. 
(b) Catagen - the short transitional phase when the follicle decreases 
in size. 
(c) Telogen - the resting phase when the hair is retained as club hair. 
Anaeen to telogen takes about nineteen days and telogen may last for 
several months. The latent period before depigmentation therefore 
depends on the stage that the injected site hairs are at during the 
time of injection. In telogen, this will lead to a prolonged latent 
period of depigment~tion and it will be shorter if the hairs are in 
anagen. 
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Dose-Resnonse RelRtionshin 
In the instances where depii:;mentation wc1s marked (+ ++ ) e. g . 
nitrogen mustard ( HN2 ), TPA, carbon dioxide snow, or obvious (+ +)e . g . 
croton oil, catechol, 4-tertiary butyl catechol and p-terti ary butyl 
phenol, chlcroform and dimethyl sulphat e, a sigmoidal rela tionship 
was obsetved between dose and proportion of sites showing depigment-
ation. 
100 
Percentage of sites 
showing positive 
depigmentat i on 
FIG 9 
SIGMOIDAL DOSE-RESPONSE CURVE 
- ;:::-,- - -
I 
I 
I 
I 
I 
o'--------1\-=a.---~----C----Do- s_e_ 
At low doses no effect is noted until the minimum effective dose is 
reached (A). At doses greated than this,some proportion of sites will 
show positive depigmentation. At point (C) 100"/4 effect is noted; all 
sites show depigmentation and this occurrs for all doses higher than 
(C), except when the lethal dose is reacted,when death of the test 
animals will result. Point (B) represents the ED50 i.e. the effective 
dose at which ;0% of the sites injected &low depigmentation. 
This effect is best demonstrated by the tests using TPA (See page 130). 
For the doses tested, the minimum effective dose was 0.008 .,µg TPA and 
the minimum dose needed to produce 100'% depigmentation (corresponding 
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to point (C) was 5.0 pg with the Eo50 estimated at 0.18)26 us ing a log1 t 
transformation analysis (Cox 1970). This is a statistical technl qu 
for converting a sigmoidal relationship into a linear rela tionship nnd 
the latter is easi er to use inferentially, especially i n the eatimnt ion 
of ED,o . 
For the che:nicala producinc only slisht dcpigmcntntion (+) most of 
them app~ared to have a sigmoid.'.ll relationship . The range of dones 
used is lirr.i ted and thic relationship i s not always obvious . However , 
for three tumour- promoters i.e. 1,fluoro-2,4-dinitrobenzene, saccharin 
and dodece.re , a different dose response was obtained . 
Percentage of Sites 
showing positive 
depigmentation 
FIG 10 
0 '-------"-=-------'Jl~ ... C..-...a.l>,,_ ___ _ 
These three compounds showed an 'optimal dose effect'. This is shown :in 
Fig 10 where dose A represents the minimum effective dose and B repre-
sents the dose which produced 100% effect. However, the interesting 
feature is dose C to D where as the dose is increased the effect 
decreases. Therefore, at a higher dose a lower proportion of sites 
showing positive depigmentation is noted. The graph could theoretically 
be extended so that beyond dose D no depigmentation occurs up to the 
lethal dose. This relationship could represent a toxic effect where 
beyond dose D, all melanocytes and hair cells in the area are destroyed, 
and therefore an a rea of depilation is noted without any depie;mentation . 
At the low&r doses A to D, some hair cells survive to produce depigment-
ation. The importance of this relationship is t hat a tested chemical 
may be recorded as not producing depigmentation even if it is capabl e 
of doing so. This will result if the doses selected for testing are 
inappropriate (i.e. if it does not f all within the A to D range as sho 1-:n 
in Fig 10. This range could poasi bly be very narrow for some chemicals ). 
The •optimal dose effect' relationship was noted for two weak tumour-
promoters; the depisment a tion obGerved w.:i.s o. lso :;light. It is for 
thi s group of tumour -promoter::; where the depigmentation test mny be 
limited in its ability to detect them as tumour-promoters. 
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A third dose-response relationship is when the minimum effective dose 
e::ceeds the l~thal dose . With such chemicals, tests done using any 
dose less than the lethal dose would produce negative results. Doses 
close to the effec tive dose will kill the test animals. Such instances 
will lead to negative depigmentation being recorded even if the theor-
etical possibility ~f producing depigmentation exists. Chemicals 
which are very toxic could come into this group. 
2 . OVJ~RJ\LL R.Ei>ULT:3 
No 
1. 
2. 
3. 
The link beL,cen tumour-promoters flnd denipmentation 
The sixty-six chemic!lls tested by the depigmentation test 
included carcinogens, tumour-promoters and compounds not known 
to be carcinogenic . The results are as shown in Table 10. 
TABLE 10 
Stn-IMARY OF RESUI:rs FOR ALL COMPOUNDS TESTED 
No of Chemicals Total No Of Categories Causing Chemicals Tested Depigrnentation 
Carcinogens 6 25 
Tumour-Promoters 10 18 
Compounds Not Known 4 23 
to be Carcinogenic 
Total 20 66 
% 
24 
56 
17 
Twenty (30%~ of the chemicals tested were positive. The effect 
occurred more frequently with tumour-promoters than for the other 
two groups i.e. 56% compared with 24% for carcinogens and 17% for 
compounds not known to be carcinogenic. The specific chemicals 
causing depigrnentation in each category are as listed in Table I/. 
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Carcinogens 
(a) Direct CarcinoRens 
1. H?l2 
2. Dimethyl sulphate 
}. Methyl iodide 
4. Benzyl chloride 
(b) Indirect CarcinoRens 
!lone 
(c) Undetermined Mode of 
Carcino~enic Act i on 
1. Chloroform 
2. Ground Crocidolite 
U ST OF ClIDITCA.I.S CAUSING DEPIGKml'ATION 
Tumour- Promoters Compounds Not K.~own to be Carcinogecic 
1 . Croton oil 1. Catechol (Pyrocatechol) 
2. TPA 2. 4-tert iary butyl catechol 
3. CO2 snow 3. 
p-tertiary butyl phenol 
4. Dodecane 4. Butylated hydroxyaniaole 
5. Tween 20 . 
6. Phenol 
7. Saccharin 
8. 1-nuoro-2,4-dinitro benzene 
9. Griseofulvin 
10. Hydroquinone monobenzyl 
ether 
TABLE 11 
\ J 
\ : ' 
TABLE 12 
LIST OF CIID4ICA.IS NOT CAUSING DEPIG:©'TATION 
Carcinogens Tun:our-Promoters Non-Carcinogens 
(a) Direct Carcinogens 1. Anthralin 1. Phenanthrene 
,. Benzoyl chloride 2. Tween 4o 2. Pyrene 
2. Benzotrichloride 3. Tween 8o 3. Methyl carbamate 
(b) Indirect Ca.rcino~ns 4. Li.monene 4. Sodium diethyl cithio 
carbamate 
1 . Dibenz(a ,h)anthracene 5. Iodoacetic acid 
5. Dimethylsu.lphoxide 
2. 7 ,12-Dimethylbenzanthracene 6. Desoxycholic acid 
6. Dimethyl acetnmide 
3. 5,7 ,12-Trimethylbenzanthracene 7. Phenobarbitone 
7. Acetone 
4. Benzanthracene 8. Sodium metabisulphite 
e. Saline 
5. Benzpyrene 
9. Arachis oil 
6. 3-Methylcholanthrene 
10. Hydrochloric acid 
7. 2-naphthylamine 
11 . Sodit:m hydroxide 
8. Benzidine 
':!-
TABLE 12 (Continued ) 
Carcinogens Tuoour-Promoters Non-Carcinogens 
(b) Indirect Carcino~ens 2. 1,1 1 11 Trichloroeth~~e 
9- Aniline 1}. Ethanol 
10. Ethyl carballlate 14. COPA 
11 . Propyl carballlate 15. Pyrogallol 
(c} Undetel"lllined Mode of 16. Methyl catechol 
Carcinogenic Action 17 . Putrescine 
1. 1 ,2- Dimethylhyclrazine 
8. Adrenaline hydrogen 
2. Chrysotile A tartrate 
}. Chrysotile B 19. Histamine hydro-
chloride 
4. Anthophyllite 
5- A::-.osite 
6. 8-Hydroxyquinoline 
\,i 
Four of the c:i.rcinor;ens c:->usinr; dcpir,mcntation nrc direct-nctinr; 
carcinogens and would , therefore, have both initiat ing a nd tumour-
promoting activity . Thus , the positive depi [\1'llentation obtained 
with these four chemicals could be at tributed to their tumour-
promoting activi ty . Hence , out of the twenty chemicals pro-
ducing depigmentat ion, fourteen have tumour-promoting activity 
(7o% ). A tot al of twenty-four chemicals with tumour-promoting 
activity ( ei ght een tumour-promoters and six direct-acting c arcino-
gens) were tested altogether and depigmentation was po~itive for 
sixteen of these (67%). This reflects the sensitivity of the 
depigmentation test for t umour-promoters i.e. its ability to 
identify tumour-promoters correctly. The specificity of the test 
is its ability to detect non-tumour-promoters correctly. Forty-two 
chemicals without known tumour-promoting activity were tested and 
six showed positive depigmentation. Two of these were carcinogens 
with undetermined mode of carcinogenic action i.e. chloroform and 
ground crocidolite. Their status as direct or indirect carcinogens 
is not known. If they are direct-acting carcinogens with tumour-
promoting activity, sixteen of the compounds producing depigment-
ation would have tumour-promoting activity (i.e. 8o%). 
Ground crocidolite is a form of asbestos. The mode of carcinogenic 
action of asbestos fibres is unY.nown but there is a possibility of 
it being a tumour-promoter ( see page164). The four non-carcinogens 
producing positive depigmentation belong to a group of chemicals 
known to cause occupational leukoderma in exposed workers. Further 
discussion of these compounds follo1e on page 175. 
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Table 13 summarizes the sensitivity and opecificity indices 
calculated a ccordins to different c r iteria used for ir.cludin5 
chemicals as tumour-promoters . 
No 
1. 
2. 
3. 
4. 
TABLE 13 
SPECIFICITY AND Sfil,SITIVITY OF DEPI GMENTAT ION TES'l' 
FOR TUMOUR- PROMarERS 
(USING DATA FROM INITIAL AND FOLLOW-UP EXPERIMENTS ) 
Criteria Sensitivity Specifici ty % % 
Tumour-promoters per se 10/18 = 56 38/48 = 79 
Tumour-promoters + direct-acting 14/24 = 58 36/42 = 86 
carcinogens 
Tumour-promoters + direct-acting 15/25 = 60 36/41 = 88 
carcinogens + chloroform 
Tumour-promoters + direct-acting 16/30 = 53 33/36 = 89 
carcinogens + chloroform+ 
asbestos 
Hence, the sensitivity of the depigmentation test for tumour-
promoters, based on the results of all tests done on all the 
compounds used,varies from 53% to 6096 and the specificity va ries 
from 79% to 89% depending upon the criteria used. 
The depigmenta tion test, therefore, i s a s pecific a nd rea sonably 
sensitive test for tumour-promoting activity. 
'I 
CHAPI'ER 4 RESULTS (Continued) 
Specific Exueriments 
(a) Alkylating agents 
(b) Polycyclic hydrocarbons 
(c) Aromatic amines and the carbamates 
(d) Other carcinogens 
(e) Tumour-promoters 
(f) Non-carcinogens and non-tumour-promot ers 
-~ SNY:JFIC F.XPERTMf•]fTS 
( a ) Alkvl~tin~ ~~ents 
An a l kylo.tinc; agent is one wh ich can readily introduce a lkyl 
groups at react ive s i tes i n protei n s a nd nucleic acids under 
p hysioloe ic ~l cond itions . An a lkyl group is a monovalent r ad ical 
obtained by s ubstituting one hydrog en atom from an aliphatic or 
aromatic hydroc a rbon. 
Table 14 compa res the efficacy of six alkylating agents in 
producing depigmentation. All six alkylating agents have pub-
lished evidence of carcinogenicity. Of these , nitrogen mustard 
and dimethyl sulphate produced very prominent depigmentation and 
methyl iodide and benzyl chloride only slight depigmentation. 
Benzoyl chloride and benzotrichloride were negative. Alkylating 
agents probably exert their carcinogenic effect by being absorbed 
into cell surfaces and then by slow diffuaion into the aqueous 
phase of the cell. This has been shown to occur for mustard gas 
in Ehrlich ascites cells ( Brookes and Lawley 1960) . The agen ts 
then alkylate proteins and nucleic acid. The guanine bases of 
deoxyribonucleic acid (DNA) are most susceptible to alkylation 
and an alkylated guanine moeity may be replaced by an adenine-
thymine pair during replication. This alters the DNA code and 
.1:-'roduces s. mutagenic effect which by the somatic mutation theory 
of carcinog enesis could lead to a carcinogenic effect. It is 
possible that the production of depigmentation by such agents is 
due to a mutagenic effect on the genes responsible for melanin 
sy~thesis or that the proteins involved in melano genesis are 
altered by alkylation resulting in defective, reduced or absent 
melanin production . This lack of normal melanin• in the hair 
cells cauces the depigmentation effect. 
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TARLE 14 
COMPARISON OF ALKYLATING AGENTS IN PRODUCING DEPJ 1·,.. A'rION 
Alkyla ting Amount 
Proportion of Sites I 
Agent Inj ected with Deni cment ~tion µg Total No oi' Si. tos ln.je ctect 
Nitrogen Mustard 3 4/4 
(IIN2 ) 0.3 4/4 
0.03 4/4 
0.003 o/4 
Control 0/4 
( DMSO alone) 
Dimethyl Sulphate 500 4/4 
50 3/4 
Control 0/4 
(DMSO alone) 
Methyl Iodide 50 4/4 
5 0/4 
0.5 0/4 
Control 0/4 
(D.MSO alone) 
Benzyl Chloride 5000 4/4 
500 3/4 
50 1/4 
Control 0/4 
(DMSO alone) 
Benzoyl Chloride 5000 o/4 
500 o/4 
50 0/4 
Control 0/4 
(DMSO alone) 
Benzotrichloride 5000 o/4 
500 o/4 
50 o/4 
Control 0/4 
(DMSO alone) 
However , no dcpii::;mcntation wcis seen with bcn::-,oyl chloriuc and bcuz o-
trichloride. Both ~1rc carcinoc;ens with a chemical structure similar 
to bcnzyl chloride which was positive . The reason for this may be 
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th<tt bcnzoyl c!1loride is hydrolysed in aqueous medium to benzoic acid , 
benzaldehyde and benzyl alcohol . Benzyl chloride is hydrolysed at a 
much slower r ate and there is therefore more of the parent compoW1d 
available to p roduce the depi gmentation effect seen. Bcnzotrichloride 
is a st rong mutagen but requires met abolic act i vation before it exerts 
such effects. This may account for the negative result in the depigmen-
tation test where benzotrichloride was injected without consideration 
of metabolic activation . Yasuo ~ a l (1 978) tested benzotrichloridc, 
benzoyl chloride and benzyl chloride for mutagenicity by using rec-
assay with Bacillus Subtilis and reversion assay with E.coli and 
Salmonella tY1Jhimurium. Benzyl chloride was positive, benzoyl chloride 
negative and benzotrichloride was positive only after metabloic act iv-
ation. These results are comparable to those obtained by the depigment-
ation test. 
Comparison of the efficacy of solutions of nitrogen mustard (HN2) in 
different diluents (viz saline and DMS0) in producing depigJ:lentation 
Saline and dimethyl sulphoxide were used as solvents for HN2 to see 
whether t he depigmentation effect was altered by the use of different 
diluents. Three concentrations of HN2 were prepared with each di luent 
and 0.05 ml of each solution injected into C57 Black male mice under 
similar conditions. 
TABI,E 15 
COMPARI80N OF DIFFERENT DILUENTG 
ON THE DEPIGMENTATION EFFECTS DUI!: ·ro NITROGE:t-1 MUSTARD (HN2 ) 
Amount Fropcrtion of Sites Solution De!)igment:i.tion with De~i~entation µg Tota l No of Sites I njected 
l!N2 in Saline 3.0 + + 4/4 
0 . 3 + 4/ 4 
0 . 03 
-
0/4 
0.003 
-
0/ 4 
HN2 in Dimethyl 3.0 + + 4/4 
sulphoxide c . 3 + 4/4 
( Dll.SO) 0. 03 + 4/4 
0.003 
-
0/4 
Wi th 0 .3 and 3.0 ;i.g of HN2, depigmentation occurred in all injected 
sites whether saline or DMSO was used as diluent. With 0. 03 )lg of 
-t--o"'r 
HN2 in DMSO, depigmentation again occurred in all W..- sites injected , 
but no depigmentation was observed with the same amount of HN2 in 
saline. This suggests that DMSO may increase the efficacy of HN2 in 
producing depigmentation. DMSO is a very hygroscopic liquid and is 
a primary skin irritant. These properties, absent for saline, may 
account for its enhancing the depigmentation effect of HN2. DMSO used 
by itself as a control did not produce any depigmentation whether used 
at 100%, 50%, 20%, or 1~ solutions. There was also no difference in 
the latent period before initial depigmentation appeared, whether DMSO 
or saline was used. This period was between three t o five weeks for 
both. 
10., 
I 
Compnrir,on of HN2- inclur.cd depir:mentation on different st rains of mice 
of both SC' XCS 
Four concentrations of l!N2 in Di-ISO were in jected under identical 
conditi0ns into the following groups of mice:-
( 1.) Four C57 Black male mice 
(ii) F'our C57 Black female mice 
(iii) Four <:BA Bro>m male mice 
( iv ) Four CBA Brown female mice 
(v) Four Tyzzcr Origin a l White male mice 
(vi) Four Tyz,zer Original White f e male mm 
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'!'ABU: 16 
I w; TO ,IITRO~r-1 MU TARI) (lfN?) 
0l DIF"F!· 
Amounl of Proport ion of Sites Mice l 2 (µg) D pi =ent ion with DcnionentoLion Total No 0 1 .Si tes Injected 
c57 Black 5.0 + + 4/4 
d" 0.5 + + 4/4 0.05 + 3/4 
0.005 + 0/4 
c57 Black 5.0 + + 4/4 
0. 5 + + 3/4 
i 0. 05 + 4/4 0.005 + 1/4 
CBA Brown 5.0 + 4/4 
d" 0. 5 + 3/4 0.05 
-
o/4 
0.005 - 0/4 
CBA Brown 5.0 + 4/4 
0. 5 + 2/4 
~ 0.05 - 0/4 0.005 - 0/4 
fyzzer 5.0 - 0/4 
Original 0. 5 - 0/4 
d" 0. 05 - 0/4 0. 005 - o/4 
Tyzzer 5 . 0 - o/4 
Or igin 1 0.5 - 0/4 
0.05 - o/4 
i 0.005 - o/4 
The results show no difference in effect whether male or female mice 
were u sed . !I01-1cver , with different strains of mice, there was an 
obvious difference . Tyzzer Orig inal mice are white and only depila-
tion was observed following the intradermal inject ions with no change 
in pi gmentation. The Brown CBA mice showeri some depigmentation which 
was not as distinct as tho.t due to eq~al amounts of HN2 in C57 Black 
mice. Hence , the depigmentat ion effect is best seen in C57 Black mice 
of either sex. Figs 4, 5, and 6 ( see p3.ges 83 and 84) show the effect 
of HN2 on different strains of mice. 
Effective dos e of HN2 in producin~ depii;:m~ntation 
Multiple experiments were performed in C57 Black male mice using 
d ifferent concentrations of HN2 in dimethy l sulphoxide. The results 
p roduced a dose-effect relationship from which the ED50 (effective 
d o se at which 50% of the test sites would produce positive depigmen-
tation) was statistically estimated. 
TABLE 17 
DEPIGMENTATION DUE TO NITROGEN MUSTARD (HN2) 
Amount of HN2 Proportion of Sites 
with DePivrnentation 
_ug Total No of Sites Injected 
·5.0 4/4 
3.0 4/4 
o.s 4/4 
0.3 4/4 
0 . 05 3/4 
0 . 03 4/4 
0.005 0/4 
0.003 0/4 
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The Ell
50 
for nitrogen mu::; ta rel [" mctllyl-bis-( 2-chlorocthyl )-amineJ 
was e"timated at 0 . 018 .UG u s ing a logit trannformati on analysis 
(Cox 1970 , Nelder 1975 ) . The approximate 95% confidence interval 
was 0.008 )lg to 0.04 ).l g . This r,50 is ten times less than that for 
the tumour- promoter 12-0-tetradecanoyl-phorbol-13-acetate (TPA) 
(see ;,age 13o). 
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(b) Pol:vcyc] i c Hydrocc,rbons 
The hydrocarbons listed in T.:ibl e 18 were similarly tested by the 
depigmentation test . 
TABLE 18 
COMPARISON OF HYDROCARBONS 
Carcinogenic Non-Carcinogenic 
Depigmentation Depigmentat ion 
1,2:5,6-
-
Phenanthrene -
Dibenzanthracene 
(DBA ) Pyrene -
9, 10-Dimethyl- : 
1 ,2-ben zanthracene 
( DMBA ) 
6,9 , 10-Trimethyl-
-
1 ,2-benzanthracene 
(TMBA ) 
1 ,2- Be nzanthracene 
-
Benzo( a )pyrene 
-
3-Methyl- -
cholanthrene 
10'/ 
All produced no depigmentation at various concentrations, with the 
exception of DMBA. Experiments using an old bottle of fat emulsion 
preparation of DMBA (containing 15% DMBA) produc ed the resul ts 
shown in Table 19 . The diluent used was normal saline . 
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TABLE 19 
INJECTION OT·' ') , ,O- DJ!-li,TiiYL- 1 , 2 - m:::irn t..NTl!RACENE ( DMEA) F.MUl.'_jJON 
Amount of DMBJ\ Degree of Proportion cf Sites Injected with De-pir::r.entation 
}lg Depi1,mentation Total No of Sites Injected 
18 .75 + 2/ 2 
3.75 ! 1/2 
0.75 - 0/2 
0.15 
-
0/2 
In view of DMBA being the only polycyclic hydrocarbon producing positive 
depigmentat ion, it was decided to investigat e this further . Analysis 
of the constituents in the fat emulsion preparation showed the 
following : -
1. Poloxalkol 0. 3% ) Special 15% fat emulsion with 
) 
2. Lecithin 1.2% ) 9,10-Dimethyl-1,2-benzanthracene 
) 
3. Cottonseed oil 15.05~ ) (5mg/gm) 
) 
4. Water ) Upjohn Co, Kalamazoo, Michi gan , USA 
) 
5. DMBA ) 
Repeat experiments were performed using DMBA in DMS0 i.e . without the 
other constituents of the emulsion. This produced the results in 
Table 20 . 
TABLE 20 
JiNJECTION Oi' 9 , 10-Dil1ET'lYL-1, 2 - Bi<:NZANTERAC!'.:t'l'E IN DMSO 
Amount Volume Proportion of Sites 
)lg Injected with Dep iP.;111entat ion ml Total No of Sites Injected 
50'.> ) 0/8 
) 
100 ) o/4 
) 
37.50 ) 0/4 
) 
18.75 ) 0/4 
) 0.05 
10.00 ) 0/4 
) 
3. 75 ) 0/4 
) 
0 . 75 ) 0/4 
) 
0.1 5 ) 0/4 
) I 
0. 03 ) o/ 4 
In addition to the four concentrations of DMBA previously used, five 
additional concentrations were used to widen the range of amounts of 
DMBA tested. These included three concentrations greater than the 
maximum of 18.75 )lg previously injected (37.50 µg, 100 pg and 500 )lg) . 
10 µg of DMBA was also tested as an intermediate concentration between 
18.75 and 3.75 )lg, the two concentrations which previously produced a 
positive depigmentation. A lower concentration of 0.03 ,ug was also 
tested. 
109 
In all cases, no depigmentation was observed. It was concluded that 
the depigmentation noted with the first emulsion preparation is due not 
to the OMBA but to the oth er constitutents present . To confirm thi s a 
prepara t i on of the fat emulsion without DMBA but with the other con-
stituents in the same proportions was obtained and tested. Different 
, t :, normal saline . 
TABLE 21 
:· . ro:r 01'' FAT EJ.IULSION ALONE 
--
Emul :; ion i ~ l \lo lume Proportion of Sites 
lfo n:i:11 Tnj ccted with De'r>ircmentati on • , · 1 L 1 !' l(~ 
ml Total No of Sites Injec ted 
100 ) 0/12 
) 
20~~ ) 0 .05 0/12 ) 
4,; 
' 
0/1 2 I 
) 
o. B;~ ) 0/12 
Suprisingly , the emulsion without the presence of DMBA also produced 
no depigmentation. Repeat experiments were then performed using the 
old bottle of emulsion 1-ri th DMBA and a new bottle of the same 
preparat i on (See Table 22 overleaf). 
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TABLE 22 
IHJID!'IOO OF Oill AND NEw l__i 10-D 
Amount Volume 
Dnulsion Injected µg 
ml 
Old O:<BA Dnulsion 100% e!!ll1lsion containing ) 
18.75 ug 00A ) 
) 
2<11, emulsion containing ) 
3.75 .ll6 IIIBA ) ) 0.05 
4~ emulsion containing ) 
0.75µg IJ4BA ) 
) 
. 
o.8~ emulsion containing ) 
0.15 ug I:l!BA ) 
Nev IJotBA Dlulsion 1~ emulsion containing ) 
18. 75 µg mBA ) 
) 
20% emulsio.n containing ) 
3. 75 µg IIIBA ) ) 0.05 
4~ emulsion containing ) 
0.75 >,ig OOA ) 
) 
o.8% emulsion containing ) 
0. 15 µg 00A ) 
ANTHRACENE 
Degree of 
Depig11:entation 
+ 
+ 
-
-
-
-
-
-
Proportion of Sites 
with De~irrnentation 
Total No of Sites Injected 
1/8 
2/8 
0/8 
0/8 
o/8 
o/8 
0/8 
o/8 
~ 
... 
~ 
'rhe old emulsion produced sligh t c!epigmentation when used at 100,'.,; 
Dnd 2<Y,; concentrntions . Depi1,mentation was only noted in one and two 
out of ei c;ht sites injected respectively . The new emulsion was 
ncsative 1vhen similar concentrations were tested . 
It is likely that the interaction of DMBA together with the poloxalkol, 
lecithin, cottons eed oil and water was responsible for the positive 
depigmentation seen. DMBA by itself or the other s ubstances wit hout 
DMBA will not produce depigmentation . It was noted that the depiG111ent-
ation, though present, was only slight and only pos itive in a small 
proportion of the sites injected. The result s will have to be treated 
with care, because of the age of the original emulsion which pro-
duced positive depigmentation. 
A similar emulsion containing the carcinogenic 6,9,10-trimethyl-1,2-
benzanthz·acene was tested using 0.05 ml of emulsion per injection. 
TABLE 23 
INJECTION OF 6,9,10-TRIMEI'HYL-1,2-BENZANTHRACENE (TMBA) 
Proportion of Sites 
TMBA in Fat Emulsion with Depi5!nentation 
Total No of Sites Injected 
100% containing 18.75 }lg TMBA 0/12 
20% containing 3.75 µg TMBA 0/12 
4% containing 0 . 75 µ g TMBA 0/12 
o.8% containing 0.15 ,ug Tt-mA 0/12 
11 2 
The results .showed th:it TMBA in a s.i.mila r emulsion did not produce 
any depiQllentation . Uence, the e ffe ct noted wi th o ld DMBA in emul sion 
de e d not hold for f resh preparations of other s i mi lar po]_ycyclic 
aromatic hydroca.rbons in emu:!_sion form. 
Two non-carcinogenic polycyclic hydrocarbons, phenanthrenc nI,d pyrene 
tested at the following concentr ations pro duced negative results . 
TABLE24 
INJECTION OF NON-CARCINOGENIC POLYCYCLIC AROMATIC HYDROCARBONS IN DMSO 
Amou nt Volume Proportion of Sites Hydroc arbon Inject e d wi th De oi"1) ,entat i on )lg 
ml Total No o f Sites I n.iected 
Phenanthrene 5000 ) -0/4 
500 ) 0/4 
50 ) 0.05 0/4 
Contro l ) 0/4 
(DMS0 a lone ) ) 
Pyrene 5000 ) 0/4 
500 ) 0/4 
50 ) 0. 05 o/4 
Control ) 0/4 
(DMS0 a lone ) ) 
11 ~ 
.Four carcinogenic polycyclic aromc1tic hydrocarbons, 1 , 2-b,:,nznnthr:icene , 
3 ,11-benzpyrene , 3-methylcholanthrene and 1 ,2: 5, 6-dibenznnthracene 
were also similarly tested. 
TABLE 25 
INJECTION OF CARCINOGEN IC RJLYCYCLIC AROMA'J'TC HYDROC AREONS IN DMSO 
Amount Volume Proportion of Sites Hydrocarbon µg Injected with Deni :rmentation 
ml Total No of Sites In j ec ted 
Benzanthracene 114 ) 0.05 0/4 60 ) 0/4 
Benzo(a)pyrene 126 ) 0.05 0/4 60 ) 0/4 
3-Methylcholanthrene 10 ) 0.05 0/16 2 ) 0/16 
1,2:5,6- 140 ) 0/12 
Dibenzanthracene 14 ) 0.05 0/12 10 ) 0/12 
7 ) 0/12 
Conclusion 
Polycyclic aromatic hydrocarbons - whether carcinogenic or non-
carcinogenic - produced no depigmentation. The carcinogenic aromRtic 
hydrocarbons are indirect carcinogens and need to be converted to the 
ultimate carcinogen to be active. Such conversion may also be needed 
for positive depigmentation to be produced. 
(c) Arom,tic ~mincn ond the c~rbamatcs 
The neg~tive results obtained for the polycyclic aromatic 
hydrocarbons as compared to the nlkylatinc agents may be due to 
the former being indirect carcinogens whereus the latter are 
direct carcinoi:;ens. Indirect carcinogens require metabolic 
activation before they are converted to tl1e ultimate carcinogen . 
In the case of 3-methyl cholanthre!le, 1,2: 5,6-dibenzanthracene, 
benzanthracene and 7-methyl benzanthracene, epoxide derivatives 
are ultimate carcinogens and these epoxides act as alkylating 
agents ( Lawley 1976) . Aromatic amines and carbamates are two 
different groups of indirect carcinogens and some examples fr om 
each group were tested. 
1 I '; 
TABLE 26 
INJimION OF CA.RCINOGillIC AROMATIC AMINES 
Concentration Amount Volume Proportion of Sites (W/V) µg Injected Iii.th Depi,::nentation 
,: (ml) Total No of Sites Injected 
2-Napbthylamine in DHSO 5.0 2.500 ) 0/8 
0.5 250 ) o/8 
0.05 25 ) 0. 05 0/8 
0.005 2.5 ) 0/8 
Benzidine in DKSO 2.5 1250 ) 0/8 
0.5 250 ) o/8 
0.05 25 ) 0.05 0/8 
0.005 2. 5 ) o/8 
Aniline in DHSO 5.0 2.500 ) 0/8 
0.5 250 ) 0/8 
0.05 25 ) 0.05 0/8 
0.005 2.5 ) 0/8 
.... 
.... 
C-, 
TABLE '2:/ 
IN.rrer:ION OF CARClNOGilHC CARBAMATES 
Concentration Amount Volume (W/V) Injected 
~ )lg (1111) 
Ethyl Carbamate 4.0 2000 ) 
(Urethane) in I»1SO o.4 200 ) 
o.o4 20 ) 0.05 
o.oo4 2 ) 
Propyl Carbaoate 4.o 2000 ) 
in I»1SO o.4 200 ) 
o.o4 20 ) 0.05 
o.oo4 2 ) 
Proportion of Sites 
with Depircentation 
Total No of Sites ln jecte;I 
0/8 
0/8 
0/8 
o/8 
0/8 
0/8 
o/8 
0/8 
... 
... 
.-., 
TABLE28 
INJEmION OF NOO-CARCINOGlllIC CARBAHATES 
Concentration Amount Volume Proportion of Sites (W/V) In jected with Depi l<l]!entation 
~ µg (ml ) Total No of Sites 'in jected 
Methyl Carbaoate in I»4SO 4.o 2000 ) 0/8 
o.4 200 ) 0/8 
o.o4 20 ) 0.05 o/8 
o.oo4 2 ) 0/8 
Diethyl Ditbiocarbamate 1.0 500 ) 0/8 
in IIISO 0.1 50 ) 0/8 
0.01 5 ) 0.05 0/8 
Control 0 ) 0/8 
( Ill.SO alone ) 
'l'he results show that all the aromatic amines and carcinogenic 
and non- card noc~nic caruamatcs chosen f or tenting did not pro-
duce depi gmcntation . ?.-Naphthylaminc , benzidine , ethyl carb(1mate 
and propyl corbamate a rc a ll i ndirect carcinogen s . While ethyl 
carbamate has produced lung t umours in mice (Sala'llan and Roe 1953) 
it is not carcinogenic fo r mouse skin (Van Duuren 1976) . There is 
no definit e animal or human data showing methyl carbamate to be 
carcinogenic ( IARC Monographs Vol 12). Diethyldithiocarbamate 
is also non-carcinogenic but is a chelating agen t (Merck Index 
1976). It has be~n suggested that metal chelation plays a role 
in chemical carcinogenesis (Weisburger !:,!_ al 1963, Willi ams 1971 
and 1972). 
Enzyme-inducing agents can increase the synthesis of some micro-
somal metabolising enzymes (Conney 1967). Such agents include 
3-methyl chola nthrene, barbiturates, steroids, polycyclic aromatic 
hydrocarbons and quinones. By increasing the microsomal enzymes 
the conversion of pro-carc inogens to ultimate carcinogens may be 
enhanced. 2-Naphthylamine and benzidine and three J polycyclic 
aromatic hydrocarbons were tested after pretreatment with pheno-
barbitone and 3-methyl cholanthrene as inducing agents. 
Phenobarbitone Pretreat ment 
Phenobarbitone sodium (0.5%) was given in place of drinking water 
to four C57 Black male mice two days before the intradermal 
injections of the polycyclic hydrocarbons and the aromatic aminc3 
and continued for a weei-; after the injections. 
On the basis of each mouse drinking approximately 2.5 ml of water 
1 1° 
a do.y , lhis would g ive 1 . 25 mg of phenob:irl>itone per mouc e 
per day= 50 mg per ke; body weight . This was the dos e pre-
viour;ly used for mice in similar experiments (Alberts and 
van Daalen Wett es 1976) . 
3-Meth:,lcholanthrene Pretreatment 
1 mg of 3-methylc!1olanthrene was dissolved in 0.2 ml of arachis 
oil and this was inj ected intra-peritoneally into each C57 
Black male mouse twenty-four hours before the intradermal 
injections of carcinogenic hydrocarbons or aromatic amines. 
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TABLE29 
INJWI'IOH OF INDnm:T CARCINOO»IS IN MICE PRE-TREATED WITH PffrnOBARBITO 
Proportio~ of SiteG 
with Denil'l!lent~tion 
Indirect Carcinogen Amount Total No of Sites Injected µg 
Pretreatment with No Pretreatc:ent Phen.obarbi ton~ 
Polycyclic Hydrocarbons 
1,2:5 ,6- Dibenzanthracene 139 0/4 o/4 I 
70 o/4 0/4 
25 0/12 0/12 
5 0/12 0/12 
9,10-Dimethyl-1,2- Benz.antbracene 250 0/4 0/4 
e:n.tlsion 125 0/4 0/4 
50 0/4 0/4 
:- 25 0/4 o/4 
5 0/4 0/4 
Benzanthracene 114 o/4 0/4 
Aromatic Al!lines 
2-Naphthylruri.ne 450 0/4 0/4 
Benzidine 5000 0/4 0/4 
1000 0/4 0/4 
500 0/4 0/4 
100 0/4 o/4 
TABLE 30 
INJml'ION OF INDI~ CARCINOGrns IN MICE PRE-TREATED \IITH ~-1,fM'llVTr.1 
Indirect Carcinogen 
Polycyclic Hydrocarbons 
1 ,2 :5,6- Dibenzanthracene 
9, 10-Dia:ethyl- 1 ,2- Be.nzanthracene 
emulsion 
Benzanthracene 
Aromatic Amines 
2- :laphthylacine 
Benz.idine 
Amount 
,ug 
139 
125 
70 
50 
25 
5 
250 
125 
50 
25 
5 
114 
450 
5000 
1000 
500 
100 
Proportion of Sites 
with Deoi(11!entation 
Total No of Si•es lnjecti-d 
Pretreatment with 
3-Methylchloanthrene 
0/12 
0/12 
0/12 
0/12 
0/12 
0/12 
0/4 
o/4 
o/4 
0/4 
0/4 
o/4 
0/4 
0/4 
0/4 
0/4 
0/4 
No Pretre.:itmen 
0/12 
0/12 
0/12 
0/12 
0/12 
0/12 
0/4 
0/4 
0/4 
0/4 
0/4 
0/4 
0/4 
0/4 
o/4 
o/4 
o/4 
I 
... 
~~ 
The u se of phcnobarbitone or 3-n:cthyl cholanthrcne as enzyme 
induc i ng ac;cnts did n ot a lter the re s ults o f t :1e depi c;mcntation 
wi th r egnr ds to 1 , 2 ; 5 , 6--dibenzanthra cene, 9, 10- dimethyl-1 , 2 -
b enzanthracenc , 2.-naphthyla mine and benzidine . All were n e gative 
at a r31lge of concentrations used . 
Severa l r easons may exist for t he n egative r esult s obtained. 
(a) Phcnobarb itone and 3 -- methylcholant hr ene a re ineffective as 
enzyme i n ducin g a g e nts for th e skin of C57 Black mi ce. 
Phenobarbit~ne increa ses liver microsoma l enzymes but not 
skin enzymes . 
(b) The amounts of phenobarbitone and 3-methylcholanthrene were 
either too small or not given for an adequate period of 
time. Increasing the period for which phenobarbitone was 
administered or repeated intra-peritoneal administrations 
of 3-methylcholanthrene may produce different results. 
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(d) Other Cclrc:i.noP"•~nn 
Chloroform (Tr:i.chloromet h:1n e) 
Cl 
H--C-Cl Mole cular weight 110. 39 
Cl 
This is a volatile, non-flammable heavy liquid with a sweet odour. 
It has been used a,;; an anaesthetic, as a solvent and cleansing 
agent, in pharmace'.lticals a nd toiletries and as a refrigerant and 
aerosol propellant. Chloroform is hepatocarcinogenic in mic e 
(Eshenbrenner and Miller 1945). No long term studies on similar 
effects in man have been reported. 
Chloroform dissolved in dimethyl sulphoxide (DMSO) was tested for 
depigmentation by intradermal injections in C57 Black mice. The 
results show positive depigmentation induced by chloroform. The 
dose-response relationship was sigmoidal and the ED50 was estimated 
by a logit transformation analysis (Cox 1979, Nelder 1975) as equal 
to 101 µg (Approximate 95% confidence interval being 48 µg to 
215 µg). 
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Concentration 
{V/V) 
% 
10 
1. 0 
0. 1 
0.05 
0. 005 
Control (™50) 
TABLE 31 
DEPICOONI'ATION DUE TO CHLOROFORM IN mso 
Amount Volume No of Hice No of Sites Injected )lg {ml ) Used Injected 
5000 0.05 ) 3 
) 
500 0. 05 ) 11 
) 
50 0. 05 ) 11 
) 19 
25 0. 05 ) 8 
) 
2. 5 0.05 ) 8 
) 
0 0.05 ) 19 
No of Sites With 
PGsitive Depigr.ientation 
3 
10 
2 
2 
0 
0 
~ 
f.J 
,.-
1, 2 - Di mc thy l h;vdr:17. inc ( Sy mmctl'ic,•, l di rncU,:, J.hyurazinc or .SDM!i ) 
H H II 
I I I 
H-C-N-N-
J 
H 
H 
I 
C- H 
I 
H 
Molecular wei g h t 60 . 1 
Ti1is is R c lear col ourless hye;r oscopic li quid which i s corros i ve 
to the skin. It is carcinogen ic to mice - producing colonic and 
rectal tumours wh en given subcutaneously ( Hawks et a l 1971/1972 ) 
and angio:c:arcoma s of the muscle, liver and p a r arena l tissues when 
given orally (Tot i~ 1:.nd Wilson 1971 ). No data is available on the 
carcinogenic risk to ml'ln. SDl-!H probably acts as a pro-carcinogen, 
requiring metaboli c ac ti ·ration to the ultimate carcinogen before 
exerting i t s carcinogenic effect (IARC Monographs). 
Solutions of SDMH (Aldrich Chemical Co) in dimethyl nulphoxide 
were injected intr a dermally in C57 Black male mice. No depigment-
ation was noted with SDMH and this is consistent with the results 
for other pro-carcinogens e.g. the polycyclic aromatic hydroca rbons, 
aroma tic amines and carbamates. 
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Concentration 
(W/V) 
~ 
1.0 
0 . 1 
0. 01 
Control(~) 
'U.BIB 32 
IHJD'.:TION OF 1,2- DD!mrYUlYDRAZINE IN ])'.SO 
Amount Volume No of Mice No of Sites I No of Sites With Injected µg (ml) Used Injected Positive Depigcientation 
.500 0.05 ) 10 0 
) 
50 0 .05 ) 10 10 0 ) 
5 0.05 ) 10 0 
) 
0 0.05 ) 10 0 
J 
-.:i 
Ce) 'l'umour-Fromotr.r!'l 
Tumour- promoters ore acents which nccclerate and increase tc1:nour 
i n c idence on r epeated appl icat ion followi ng exposure to an 
ini tia tini, ar;ent . The biologica l properties o f tumour-promoters 
ha v e been s ummarised (~ee page 22 ). Crot on oil t-,as the f irst 
tumour- promoter to be extcnsi vely studied (Bercnblum 1941). 'l'his 
i s an extr act from the seeds o f c r o t on ti gl i um J •• ( Euphorbiacea ). 
In the 196o •s the active princ iple in croton oil was isolated 
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by Van Duuren and Hecker i ndependently. It was t ermed TPA 
(tetra decanoyl phorbol ace t a te) or PMA (phorbol myri s tate acetatP.). 
This is t he mos t potent tumour-promoter known for mouse s ki n 
(Furstenberger and Hecker 1972, Hecker 1971 and Boutwell 1974 ). 
After the phorbol esters, anthralin i s the next most active 
tumour-promoter ('Ian Duuren 1976) but close analogues of e.nthralin 
such as anthrone, 1,8,dihydroxyanthra quinone and 18 dihydroxy-
anthracene are inactive. Setala (1956 and 1960) s howed Tweens 
and Spans as weak twncur-promoters. Other weak tumour-promoters 
are phenol (Boutwell and Bosch 1959), limonene, and iodoacet ic 
acid. Berenblum (1930) showed tha t carbon dioxide snow, when 
applied repeatedly to mouse skin after initial a pplication of tar, 
was a tumour-promoter. The list of suspected tumour-promo t ers 
continues to grow and included in s uch a list are the drug 
phenoba.rbitone, the a rtificial s wee teners - saccharin (Boyland 
1979) and s odium cyclama te, the bile a cids (Aries !.!, !l:_ 1969) 
and cholesterol (Cruse,Lewin and Clark 1979) which are thought to 
play a role in human colonic cancer. 
Several tumour-promoters were t est ed for t he i r efficiency in 
producine depigmentation. 
1. 
2 . 
3 . 
4. 
5-
6 . 
7. 
8. 
9-
10. 
11 . 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
TABU~ 33 
DEl'ICl-lF!:TATIOt! RY 'I'T.JMOUR-PROMO'rrns 
T,tmour-Promo t er DepiQ11entat ion 
Croton oil + + 
TPA + + + 
Anthralin 
-
Tween 20 + 
Tween 40 -
Tween 80 -
Dodecane + 
Limonene :!: 
Phenol + 
CO2 snow + + + 
Iodoacetic acid -
Deoxycholic acid -
Saccharin + 
1-Fluoro-2,4-dinitrobenzene + 
Griseofulvin + 
Phenobarbitone -
Hydroquinone monobenzyl ether + 
Sodium metabisulphite -
Ten out of the eighteen (56% ) tumour-promoters tested produced 
positive depigmentation. Thie is most marked for TPA a nd CO2 snow 
and crot_on oil. 
12-0-1.'ctrndccanoy1 p!torbol-·1 ::; - nc ct:.te (TPA) 
For 'l.'P/t , different concentr at ions injected in 0.05 ml volumes 
produced the following results :-
TABI.E 3lf 
PROPORTI ON OF DEPI GMENTED SITES DUE TO TPA 
Amount of TPA Inje~ted No of Positive Sites of Depip,-r,entation Total Number of Sites Injected 
50 µg 10/10 
5 p.g 19/19 
1 y.g 8/ 9 
0 .2 µg 3/9 
0.04 µg 2/10 
0 . 008 }lg 1/10 
0. 002 pg 0/10 
Control 0/19 
(Dimethyl Sulphoxide alone) 
TPA-induced depigr.ientati on was dose-related and the ED= estimated at 
---
0. 18 ~g using a legit transformation analysis (Cox 1979) . At doses of 
0.002 p g and below, no depi gmentation was noted . Sites injected with 
dimethylsulphoxide alone, as a control showed only localised depilation 
without any depigmentation. 
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Cro t·on Oi 1 
Croton oil is an irritant, clear , yellow oil which is soluble in 
dimethylsulphoxide ( DMSO ). Test in~ for depi cmentation with differ-
ent amounts of croton oil in DMSO produced the following result s :-
TABLE 35 
DEPIGMENTATION DUB TO CRO'l'ON OIL IN DMSO 
Pro port ion of Sites 
Amount of Croton Oil Showing 
Depigmentation 
-
250 }lg 4/8 
.50 }lg 0/8 
25 pg 0/8 
5 }lg 0/8 
Control (DMSO alone) 0/8 
Doses of 500 µg and above killed the mice used. Doses of 50 ),lg and 
less produced no depigmentation. Only when 250 µg of croton oil was 
used did depigmentation appear in four out of eight sites. The effect-
ive dose for producing depigmentation is therefore close to the lethal 
dose in C57 Black mice. The ED5v of 2.50 µg is more than 1300 times 
that of TPA where the estimated ED.50 was 0.18 }lg• Van Duuren et ~l 
(1973) obtained 1.0 g of TPA from 453 g of croton oil. Hence, one 
would expect the ED50 of croton oil to be at least 453 times that of 
TPA if the depigmentation effect is due solely to the TPA part of the 
croton oil. The fact that the ED50 is more than 1300 times that of 
'l'PA indicat es that much more croton oil is required to produce depi r.;-
mentation than its equivalent content of pure •rPA. 
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'rhe depiementation noted with croton oil was not as prominent (+ +) 
as that produced by TPA (+ + +) . There was also a delay in the latent 
period before depigmentation appeared . This was an average of fifty-
three days ( Range: thi rty-two to seventy-one days ) compared to twenty-
four days (Range: twenty to thirty-one days) for 'l'l'A . The latent 
period did not differ much for different concentrations of t he same 
compound. 
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Jin ti ,··• I , 
A.T'1thralin produced no depigmentRtion 1<hen used in the followinc; 
concentrat ions (t en sites injected for e3ch concentration) . 
TABLE 36 
INJECTION OF ANTHRALIN IN DMSO 
Proportion of Sites 
Amount of Anthralin Showing 
Depigmentation 
500 )lg 0/10 
250 µg 0/10 
50 )lg 0/10 
25 ,ug 0/10 
5 )lg 0/10 
2.5 )lg 0/10 
Control ( DMSO alone) 0/20 
When injected at a maximum concent ration of 2 gm/100 ml of DMSO 
(i.e. 1000 p.g of anthralin) this kill ed fo ur out of five mice used. 
The surviving mouse showed no depigmentation when observed regularly 
1~ 
f or thirty weeks. Anthralin is a fairly active tumour-promoter !.Uld 
while the results of the test showed 56 % of tumour-promoters tested 
produced positive depigmentation, anthralin was not amongst t hese. 
Anthralin is unstable in a solution and a dimer ia spontaneously formed 
which i~ inactive as a tumour -promoter (Segal.!!!!. 1971, Van Duuren 
1976 ). Such dimerization occurs in acetone and could occur in dimethyl-
eulphoxide . The loss of tumour-promoting activity would then correlat~ 
with the nece1.tivc depi (;rnente1.tion result. A further po m; i ble e xplana-
tion is that the effective dose of anthralin f or produc in~ depir:men-
to.tion a nd/or tumour promotion is higher than the letltC1. l dose and , 
therefore , in the concentrations used , anthro.l in produced no effect 
and a.t hi Gher concentrations death of the mice result ed . In experi -
ments on tumour promoti on using dimethylbenzanthracene ( DMBA ) for the 
first treatment and anthralin in ace tone for the second t reatment of 
female Swiss mice, Segal and others (1971) noted a tumour promotion 
effec t with 80pg of anthralin . However, this dose had to be a pp lied 
three times a week for fifty-nine days before the first squamous 
papillomas appeared . In a similar experiment using TPA instead of 
anthralin only 2.5 µ g applied three times weekly used under similar 
conditions produced tumours in fifty-four days. 
Anthralin was also used as a pharmaceutical agent in the treatment of 
psoriasis. It does not cause depigmentation nor has there been a 
reported increase in the malignancies in patients using this agent. 
However, it is a tumour-promoter in Swiss mice. The negative depig-
mentation in C57 Black mice may be due to a difference in species 
sensitivity and that perhaps it is not an effective tumour-promoter 
for C57 mice. 
Tween 
'l'he Tweeni:; are comme r cinlly-prep nred surfa ce active ai:;ents which 
together with surfact a r.t detergents and bile acids can he grouped as 
dipolic a g ents . Thes e are compounds which in a n electric field 
behave like molecular rods with two opposite electric charge s separ-
ated by a definite distance . Tweens are esters of various sorbi tels 
with ethy l ene oxide uni ts introduced into the free hydroxyl groups. 
e.g. Tween 20 - Poly oxye thylene sorbitar.. monolaureate 
Tween 40 - Poly oxyethylene sorbi tan moncp!l.lrl'i ta te 
Tween 80 - Poly oxyethylene sorbi tan 
Setala (1 960 ) showed that these Tweens(and related Spans ) exhibit 
tumour-promoting ac tivity. Of the three examples mentioned, he found 
Tween 40 to be the most active followed by Tween 80 and Tween 20. 
These three dipolic agents were tested by the depigmentation test. 
TABLE 37 
DEPIGMENTATION DUE TO TWEENS 
Amount of Proportion of Sites Solution Tween Used Showing Depigmenta tion 
Tween 20 in DMS0 5000 µg 2/4 
500 ),lg 1/4 
50 µg 0/4 
Tween 40 in DMS0 5000 µg 0/4 
500 )lg 0/4 
50 ,µg 0/4 
Tween 80 in DMS0 5000 )lg 0/4 
500 )lg 0/4 
50 µg 0/4 
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On l y Tweem 20 protlu ced slight depiQTientntion but neither Tween 110 nor 
Tween 80 did . This fits in wi th Setnla ' s f indinc that al l pro ducts o:f 
the Twe en group do not under sirr.ilar e xperimental condit ions possess 
obvious tumour- enhanc i ng p r operties . However wha t does n0t fit is 
tha t Setala found Tween 20 t o be the lea st a c t i ve of the t hree turnour-
properties , yet t his was the only Tween to produce p ositive d <lpigmcnt-
ation. This di ff erence ma y be due to different s tra i ns of mice us e d 
for Setala ' s studi es as opposed to the present stu dy. It has been 
argued ( Van Duuren 1976) tha t the Tween c ompoun ds tested by Setal a 
were not pure and were active only in massive dos es a.~d the Tween 
compounds use d f or the depigmentation t e st may have a better standard 
of purity but it still required very large doses to produce an effect. 
The degree of depi gmentation produced by Tween 2 0 was slight and a very 
high conce ntrat ion of 5000 µgin 0.05 ml of solution produced depigment-
ation in only 50% of test sites. 
Carbon Dioxide ~now 
Berenblum (1930) produced twnours by applying tar to the skin of mice 
followe d by repeated application of carbon dioxide snow. Such tumours 
did not occur when tar ~.nd carbon dioxide snow were applied together . 
Hence , carbon dioxide snow acts as a tumour-promoter but nc,t as a 
co-carcinogen . Local application of pieces o f carbon dioxide snow 
(about 4 mm diameter in size) to the skin of c57 Black mice produced 
the following results:-
TABLE 38 
DEPIGMENTATION DUE TO CARBON DIOXIDE SNOW 
Proportion of Sites 
Time of Application Showing Mean Latent Period 
Depigmentation 
i minute 0/3 -
1 minut e 3/ 3 32 days 
2 minutes 3/3 29 days 
The degree of depigmentation was more prominent with the two minute 
application compared with the one minute application. There was no 
d epigmentation with the half minute application. There was little 
difference in the latent period before appearance of depigmentation 
whether the application was for one minute or two minutes. This 
suggests that a minimum time of application is required before visually 
detectable depigmentation appears. Thie could be termed the 'threshold 
application time' . Once the threshold application time is excoeded, it 
takes about the same length of time for the change from pigmented hair 
to depigmented ha ir . This could be related t o the rate of hair growth 
in the mice. 
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Simi l<:tr r c!lult!l were produced by Boylo.nd a nd Sar r;cnt (1 951) u»ini; 
cc1rbon dioxide s now for two mi nutes in mi ce . 'l'hc latent period be fo re 
appearanc e of depi r,-rr.ent a tion wa s nine t e en days . '!.'his is shorter than 
the t wenty-nine days mentioned above and m-::iy be due to a difference in:-
( i ) The strain of mice used. 
(i i) The size of the piecea of carbon dioxide snow. 
(ii i) The definition of what constitutes positive depigmentation. 
In this study, where there is doubtful depigmentation this is con-
sidered negative. Slight depigmentation has to be observed as such 
on thre e consecutive occasions before being consj_dered positive . 
Boyland also applied carbon dioxide snow directly to the fur of mice 
and no depi gmentation occurred. This important observation indicates 
that it is an effect on the skin which ma nifests as depigmenta ted hair 
and not a direct effect on the hair itself. 
To test whether the depigmentation was due to some chemical reaction 
between the carbon dioxide snow and the skin or merely an effect of 
the decreased temperature produced by the carbon dioxide snow, the 
eXJJeriment was repeated using carbon dioxide snow in aluminium con-
tainers. This shielded the carbon dioxide snow from direct contact 
with the s kin but conducted the lowered temperature through to cause 
cooling of the a rea of skin in contac t with the container. The 
results obtained are as follows,-
TABLE 39 
DEPIC!-UJ'JTAT ION DUE TO CARBON DIOXI DE .SNOW IN ME.TAI. CONTAINERS 
Propor tion of Sites 
Time of Application Showing Mean L.-..tent Period 
Dep:i.gm!:ntation 
-;l- minute o/4 -
1 minute 2/4 34 days 
2 minutes 4/4 34 days 
The results show tha t the depigmentation due to cerbon dioxide snow 
is a temperature effect and not due to any chemical renction between 
carbon dioxide snow and the skin . The extent of depigmentation was 
less pronounced compared with that produced by direct application of 
carbon dioxide snow. 
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For the one minute applications, half of the sites produced no depi gmen-
tation even after observation for one hundred days. The use of the con-
tainers probably reduced the cooling effect on the skin so that it is 
less cold compared with direct application. Hence, even though it waG 
applied above the apparent threshold application time, some of the sites 
did not produce depigmentation because of the slightly higher tempera-
ture acting on the skin. The threshold for obvious depigmentation, 
therefore, dep~nds both on the application time as well as on the effect-
ive temperature . The latent period was not much different; it 1ws 
thirty-four days compared with thirty-two and twenty-nine days for 
direct application. 
Taylor (191i-9) produced similar depie;mentation in rat hAlr by trcczing. 
It was suc~ested thet the effect may be a result of the lowered 
temperature producing ischaerniG and that ctcpiemcntation result ed 
bcc~use of susceptibility of the melnnocytes to nsclrnemia . This 
view is supported by Selye ' s experimen ts ( 1967) where experimental 
ii;chaemia produced 1:>y clampjng a skin fold of a rat for eigh t honrs 
also resulted in depigrnen tation . It is possible that sudden e;reyi ng 
of hair following severe s tres~ may be t h e r esul t o f vasoconstric t i on 
of s upe r ficia l vessel s causing ischaemic chan ges to pigment cell s 
( Riley 1971). 
Adrenaline which is a vasocons tri ctor was test ed for thi s effect by 
single intra dermal injections il'.to C57 Black mice . 
Results 
Injection at four sites with 0.05 ml of adrenaline hydrogen tartrate 
(0.01%, 0.1%, 1.o% and 2.0% wt/vol) resulted in death of the tes t 
animals (four animals used) within twenty-four hours. Adrenali ne is 
the principal sympathomimetic hormone produced by the adrenal medulla. 
It is a cardiac stimulant and in excessive amounts can cause cardiac 
arrhythmias and death. 
A repeat eX])eriment was performed with reduced concentrations of 
adrenaline (0.001%, 0.01%, 0.1 % and 1. 0%) per mouse. This was also 
lethal to four mice used. A third experiment performed with only two 
sites per mouse inj ected with:-
(i) 0.01% ) 
) adrenaline hydrogen t a rtrate in distilled wa t e r. 
(ii) 0.001 % ) 
did not produce any depigmentation when observed weekly for more than 
six months. Since higher concentrations were lethal to C57 mice , 
smaller concentra tions had to be used and the negative depigm entation 
m11y be due to the dose u-:;ed being ineffective in producing vasocon-
striction or that the v.isoconstrict ion produced 1-Jaz not of sufficient 
duration or extent to r esult in damui;e to the mclanocytes. This 
result does not confirm the suge;estion that i schaemia may cause 
depi gmentation. 
Freezing r esults in tissue injury and h istrunine is released from most 
cells locally following tissue injury. It may be possible that the 
depi gmentation effect is mediated by histamine release. This may be 
the common link between tumour-promotion and depi ~mentation. Freezing 
by carbon dioxide snow acts as a tumour-promoter (Berenblum 1930). 
Cutaneous wounding a lso has a tumour-promoting effect as shown by 
experiments by Deelman and Van Erp (1927 ). They applied carcinogenic 
tars to mice and produced an initiating effect and then made cutaneous 
wounds which increased the incidence of tumours. Croton oil, TPA 
and 1-fluoro-2,4-dir.itrobenzene are all skin irritants and are effec-
tive in producing depigmentation. Nitrogen mustard, dimcthylsulphate 
and methyl iodide are all skin vesicants and also produced depigment-
ation. These three compounds are complete carcinogens and would, there-
fore, be expected to have both initiating and tumour-promoting activity. 
All of these compounds with tumour-promoting activity are capable of 
causing tissue injury. Freezing cutaneous wounding and chemicals 
cause tissue injury and hi s tamine release. Solutions of histamine 
hydrochloride in normal saline were therefore tested by intradermal 
injections into C57 Black mice . 
Solutions of histnmine hydrochloride i11 normal saline were, therefore, 
tested by intradcrmal injections into c:;;7 Black mice . 
TABLE 40 
INJECTION OF HISTAMINE HYDROCHLORIDE 
Concentration No of Sites Proportion of Sites 
(W/V) No of Nice with DeEi~mentation per mouse Total N0 of Sites Injected % 
1.0 4 4 0/16 
0.1 4 4 0/16 
0.01 4 4 0/16 
Hist amine hydrochloride did not cause depigmentation when single doses 
of 0. 0 1%, 0.1% and 1% solutions were injected intradermally so histamine 
is unlikely to be the mediat ing c ause of depigmentation. 
.Sn.cch.:ir in 
Sacchar i n is a n artifir. ial sweetener five hund r ed t imes as swee t as 
sugar and its swee t t a ste i s detect able in di l utions as low as 
1/100,000. The f i rst indics.tio:i tha t it was carc inogenic was in 1951 
when Fit zhu gh and co-workers described ' an increa s ed incidence of the 
ordinarily uncommon condi tion of abdomina l l ymphosarcoma in rats f ed 
saccharin'. Bladder i mplantat ion experiments wi th choles terol pellets 
impregnated with s a cc harin in mice a lso cause bladder tumours (Allen 
..=,! al 1957). Together with previous reports on its initia ting action 
on the skin (Sa laman and Roe 1956) it was then thought that saccharin 
was a direct carcinogen. However, later expe riments indicate it 
functions as a tumour-promoter (Hicks~!! 1975 , Cohen_!! al 1978). 
This is supported by the negative results obtained in the Ames test 
and with the Styles cell transformation test. There is also no evi-
dence that it is metabolised or that it reacts with DNA. Experiments 
indicate that as a tumour-promoter it is one thousand times less active 
than TPA (Mondal ~ ~ 1978). Boyland (1979) suggests that the dose 
required to induce bladder cancer in rats is of the order of 1 kg/kg 
body weight and therefore of very low risk in so far as carcinogenesis 
in man is concerned. This is supported by epidemiolo gic al evi dence 
that diabet i cs who ue e sacchari n as a s weetene r in place of s uga r 
much more than average do not s how an increase in bladder cancer 
(Armstrong a nd Doll 1975, Armstrong _!!~ 1976 , and Kessler 197G ). 
Saccharin wa s dissolved in sodium hydroxide and diluted with diDtillcd 
wa ter into solutions for tes ting by the depigmentation test. 
'rABLE 111 
DEPI GMENTA':'IOH 01m 'l'O SACC!IARIN IN DISTILLED WA'rER 
Depigmentation 
Concentration Ar.,ount of 
( W/V) Saccharin 
% µ g Degree Proporti on of Minimum Fositive Sites Latent Period 
15.0 7,500 + 1/6 36 days 
3.0 1,500 + 3/6 36 days 
o.6 300 
-
0/6 -
0.12 60 
-
0/6 
-
Only high concentrations of saccharin produced depigmentation. 
Saccharin is a weak tumour-promoter and if depigmentation in C57 
Black mice can be caused by chemicals with tumour-promoting activity, 
then the results obtained support this. It is interesting that 
saccharin at a concentration of 3 gms per 100 ml produced depigment-
ation in 50% of sites and yet at a higher concentration only one site 
ou t of six showed depigmentation. This may be due to the very high 
concentration destroying the hair cells and pigment cells, thereby 
suppressing the expression of depigmentation. At the appropriate 
optimal dose, the pigment cells are affected by the chemicals injected 
and the hair cells continue growing but are not pigmented. 
Dodecane and Phe!10l 01-1 
0 
N-dodecane is a compound with both tumour-promoting and co-carcinocenic 
activity (Van Duuren 1976). When tested by the depigmentation test it 
produced the following results:-
TABLE 42 
DEPIGMENTATION DUE TO OO~ECANE IN DMSO 
Degree of Proportion of Sites Amount with Denir:mentation Depigmentation Total No o f Sites Injected 
,5000 }lg + 1/4 
500 µg + 4/4 
50 }lg - 94 
Control ( DMSO alone) 
-
0/'+ 
Ve r y high concentrations produced depilation but depigmentation 
occurred in only one out of four sites injected. At 500 µg, this 
appeared to be the optimal concentration for depigmentation . 100% 
depigmentation occurred in the four sites injected. No depigmentation 
was seen for 50 µg or where DMSO was injected by itself as a control. 
The results with dodecane show an optimel dose type dose-response 
relationship (see page 90 ). 
Phenol ia o compound with tumour-promotinG activity t,ut no 
co-carcinogenic activity . Boutwell and Bosch ( ~959) showed tumour-
promoting activity on young odnl t albino mice by using 7 ,12-dimcthyl 
ben~anthracene (DMBA) as initiator followed by repeated applicat ions 
of phenol . In the depigment&tion test the followine results were 
obtained :-
Amount 
5000 p.g 
500 )lg 
50 pg 
TABLE 43 
DEPIGMENTATION DUE TO PHENOL IN DMSO 
Proportion of Sites 
Degree of with Deni,.,-:nentation 
Depigmentation Total No of Si tes In jected 
+ 2/4 
+ 1/4 
-
o/4 
Control (DMSO alone) 
-
o/4 
Phenol only produced slight depigmentation in two out of four sites 
with 5 mg doses. At lower concentrations, only one out of four sites 
gave a positive result (i.e. 500 }lg) and at 50 ,ig the results were all 
negative. Phenol is a weak tumour-promoter (Van Duuren 1976) and this 
weak positive depi gmentation effect correlates with its tumour-
promoting potential. The latent period before the appearance of 
depigmentation was fifty-six to eighty-four days which was loneer than 
for TPA or croton oil. 
Boutwell and Bosch (1959) showed phenol to have one twentieth of the 
potency of croton oil. The ED50 for depigmentation is 5000 p g for 
phenol; that for croton oil using the some technique is 250pr. which 
is one twentieth us effective . Hence, the efficacy of phenol us 
,,. tumour-pro~1oter and for producing depismcntution in mice appears 
to correlate well . 
Tumour->1romcters ~,itll nc r:ati ve depir:mentalion test results : 
lim0r.cr.e, j odoacetic acid and deoxycholic acid 
D-limonene is present in oils from lemons and ora nges. It is a skin 
irritant and a sensitizer. It has been sho~m by Roe and Pierce (1 960) 
to have tumour-promotion ac tivity in mice. Iodoacetic acid has a l so 
been shown t~ have tumour-promoting a ction in mouse skin (Gwyn and 
Salaman 1953). Deoxycholic acid does not appear to have been tested 
but lithocholic acid is a promoter of colon cancer in rats. Aries~~ 
(1969) suggested that bile acids may have a role in colon carcino-
genesis. Cruse~ al (1978) considered that cholesterol may be a 
more likely candidate as a colon tumour-promoter than the bile-salt 
derivatives. 
All three compounds with possible tumour-promoting activity were 
tested by the depigmentation test and all produced negative results 
in the concentrations shown. 
Limonene 
This produced no depigmentation when used at five site~ for each con-
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centration of 5µ g , 50 µg and 500 µg and 0 µg (Control using DMSO alone) 
Iodoacetic Acid 
This was also negative when used at eight sites for each concentrat ion 
of 5 µg
1 
50 µg 500 µg and Oµg (Control u sing saline). 
SadiU!!l JJcoxycho l'lte 
HO· ' ' 
Deoxycholic a cid is a s econdary bile acid which hns been shown to a ct 
as a colon tumour-promoter in rats (Reddy _!:.! ~ 1976 ). Studies on 
patients with colonic cancer have also shown high fecal levels of acids -
including lithocholic acid and cholesterol metabolites (Reddy et a l 1977). 
TABLE 41~ 
I NJECTION OF SODIUM DEOXYCHOLATE 
Concentration Amount Volume No of Sites ( W/V) Injected With Denip:mentation 
% ;µg (ml) Total No of Sites Injected 
10 5000 ) o/8 
) 
1.0 500 ) 0/8 
) 0 .05 0.1 50 ) 0/8 
) 
Control 0 ) 0/8 
(Normal Saline) ) 
The reason for the negative results could be tha t while deoxycholic acid 
is a tumour-promoter for rat and human colon, it may not be effective 
for mouse skin. 
Gri:> o "'•tl •. 
This is an antifungal agent isolated from a mould Penicillium 
ll:riseofulvum . Its tumour-promottne effect ir. mice was desc ribed by 
Barich and co-workers in 1960 and 1962. It has also induced hepatomas 
in mice when given parenterally (Eps tein-~ al 1967) and orally 
(Weston Hurst and Paget 1963) . 
Griseofulvin was dissolved in dimethylsulphoxide (DMSO) to prepare 
1%, 0.1% and 0.01 % ( W/V) solutions for testing for depigmentation in 
C57 Black male mice. The r esults are as shown in table ~3. 
TABLE 45 
DEPIGMENTAT ION DUE TO GRISEOFULVIN IN DMSO 
Concentration Amount Volume Proportion of Sites ( W/V ) Injected with DeniP;mentati.on 
% p g (ml) Total No of Sites Injected 
1.0 500 ) 6/8 
) 
0.1 50 ) ) 0 .05 6/8 
o.c1 5 ) 3/8 
) 
Control 0 ) 0/8 
( DV.SO alone) ) 
The degree of depigmentation produced was alight (+) with the menn lH tent 
period before depigmentation equal to 62 days. 
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1-nuoro-2, 4-nini tro llcn~cnc ( DNF'B ) 
p 
~ ·· 
NO,_ 
This is a vesicant and potent t umour- promoter . In skin painting 
experiment:, using 7 , 12-aimethyl benzanthracene as initiator, DNFB 
produced skin tumours in Swis:, mice (Bock _et -~ 1969 ) 
When t ested in the depigmentation t est , 0 . 05 ml ( 1%) of DNFB in 
dimethylsul phoxide ( D!V..SO) killed all four C57 Black male mice. The 
mice were inj ected a t three sites each u s ing 1% , 0 . 1% and 0. 0 1% 
concent r ations of DNFB. Omitting the h ighest concentrat ion (i.e. 1%) 
r esulted i n survival of mice in a repea t experiment . These results are 
as in table 't~ • 
Concentration 
(W/V ) 
% 
0.1 
0. 0 1 
0.001 
Control 
( DMSO alone) 
TABLE 46 
DEPIGMENTATION DUE TO DNFB IN DMSO 
Amount Volume Proportion of Sites I njected with DeEil':1llenta t ion )lg (ml) Total No of Sites In jected 
50 ) 1/8 ) 
5 ) 3/8 ) 0 .05 0.5 ) o/8 
) 
0 ) o/8 
) 
The optimal concentration was 0.01% producing slir;ht depir;rnentation 
(+) in three C\Ut of ei ght sites. The proportion of positive sites 
was reduced at higher and lower concentrations . This optimal dose 
effect was described on page 90 • The mean latent period for depig-
mentation was fifty-six days . 
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l-'henob,..rbitonc 
'rhis is a long-acting barbiturate with hypnotic and sedative proper-
ties and is used pharmacologically in the management of epi lepsy . It 
causes enzyrr.e induction in the mouse liver (Conney 1967) and has been 
used to increase enzyme yield in the preparation of S9 mix (rat liver 
homogenate m:i.croscrnal mix) for the Ames test (see page~ ). It causes 
liver tumours in mice (Walker, Thorpe and Stevenson 1973 ) but was not 
shown to be hepatocarcinogenic in epidemiological studies on man 
(Clemmensen,Frederiksen and Plum 1974). The repeated administration of 
phenobarbitone sodium after treatment with 2-acetylaminofluorene (AAE) 
increased liver tumours in rats but not when the two chemicals were 
administered simultaneously (Periano, Fry and Sta ffeldt 1971; Periano 
~~ 1973; Weisburger,Gr.antham and Weisburger 1963). Phenobarbitone, 
therefore, has a tumour-promoting effect but is not co-carcinogenic. 
Phenobarbitone was tested for its ability to induce depigmentation in 
C57 Black male mice. Solutions of phenobarbitone were prepared for 
testing by dissolving 100 mg phenobarbitone in 0.05 m N sodium 
hydroxide and diluting with dist i lled water. 
Concentrations of 20% (W/V), 2%, 0. 2% and 0% (control) killed four 
mice injected at four sites with 0.05 ml of each of these conc en-
trations. A repeat experiment using lower concentrations of 10?~, 1%, 
0.1% and 0% (control) killed four out of six test mice. The t\,/O 
surviving mice did not show any depigmenta.tion. A furt her repoat 
experiment using 0.1% and 0.01 % concentrationo a t two sites per rnou~c 
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produced no depii:;mentution in eight mice injectect . Tcl.ble -+7 
summarizes the results obtained . 
TABLE 47 
INJECTION OF PHENO~APBITONE IN DISTILLF:D WATER 
Concentration Amount Volume Proportion of Si tes (W/V) Injected wi th Denip:mentation 
% }lg (:nl) Total No of Sites Inje cted 
10 5000 ) 0/2 
) 
1.0 500 ) 0/2 
) 
0.1 50 ) o/8 
) 0.05 
0.01 5 ) 0/8 
) 
Control 0 ) 0/10 
(Distilled ) 
Water) ) 
It is possible that the effective dose for producing depigmentation 
is higher than the lethal dose for phenobarbitone in C57 Black male 
mice . 
(f) Non-C:trcinor-ens nncl Non-T:tmo:1r-Promo ters 
Twenty-three compounds with no evidence of carcinoe;enic nor 
tumour-promoting nctivi ty were tested . Some of these were com-
pounds with published evidence of a lack of carcinogenic activity 
e.g. phenanthrene and pyrene . Others have not previously becn 
tested fo r carcinocenic or tumour-promoting activity and the>re1·ore 
have no published evidence of such activity . These compounds 
included those with chemical structures similar to k.,own carcino-
gens. These have been dealt with earlier such as two aromatic 
hydrocarbons (phenanthrene and pyrene) and two carbamates (methyl 
carbamate and diethyl di thiocarbamate). Others were commonly used 
solvents such as dimethyl sulphoxide (DMSO),dimethyl acetamide 
(DMAC),acetone and ethanol. Hydrochloric acid and sodium 
hydroxide were selected as examples of 3ll acid and alkali. Saline 
and arachis oil were also tested. In addition, 1,1,1, trichloro-
ethane was chosen as a compound tested for carcinogenicity and 
found to be inactive (National Cancer Institute Report 1977). 
Dihydroxy phenylalanine (OOPA) was included as an amino-acid 
essential for melanin formation. Pyrogallol was selected as a 
co-carcinogen without tumour-promoting properties (Van Duuren 
1976). 
Nineteen of these selected compounds produced no dcpigmentation 
when tested in different concentrations. Table 48 summori?.es the 
tests on these compounds. Three compounds i.e. 4-tertiary 
butyl catechol, p-tertiary butyl phenol ~nd pyrocat echol pro-
duced obviou11 depigmentation (+ +). Butylated hydroxyanisole 
produced slight depigmentation ( +). These are clea lt with in 
the section on further experiment!! (see page175 ). All three 
compounds are chemical!! known to cause occupat ion,'ll leukoderm11. 
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TABLE 48 
NON-CARCINOGfflS PRODUCING NO DEPIGMENTATION 
-
Solvent/ Concentration Tested Amount 
Volume l!o of Sites 
No Compound (W/V) Injected No of i-:ice Medium ,: pg (au.) Injected 
-
1. Fhenanthrene IJ,IS() 10 5,000 
) 4 ) 
1.0 500 ) 4 ) 4 
0.1 .50 ) 0. 05 4 ) 
Control (IJ,IS() alone) 0 ) 4 ) 
2. Pyrene 
) 4 ) 
I 
IMS() 10 5,000 
1.0 .500 ) 4 ) 4 
0. 1 50 ) 0.05 4 ) 
Control (IJ,IS() alone) 0 ) 4 ) 
}. Methyl Carbulate IJ1SO 5 2,500 ) 8 
) 
CH}CXXlffl2 
0.5 250 ) 8 ) 16 
0.05 25 ) 0.05 8 ) 
0.005 2.5 ) 8 ) 
Control (0050 alone) 0 ) 16 ) 
TABLE 48 (Continued) 
Solvent/ Concentration Tested Amount Volume No of Sites l!o of !•:ice No Compound (W/V) Injected Medium ~ }lg (ol) 
4. Sodi1111 Diethyldithio- Il4SO , .o 500 ) 8 ) 
carbuate o., 50 ) 8 ) 8 
(c2tt5)2N csla 
0.01 5 ) 0.05 8 ) 
Control (I14SO alone) 0 ) 8 ) 
5. Dimethyl Sulphoxide Distilled 100 55 ,000 ) 32 8 
CH Water 50 27,500 ) 4 ) 
3'.s = o 25 13,750 ) 0.05 4 ) 4 10 5,500 ) 4 ) 
CH / Control (Distilled 0 ) 4 ) 
3 Water) 
(Ci3>io 
6. Dicethyl Acetaaide Distilled 100 47,000 ) 32 8 (All dead 
Cll3C011(~)2 Water ) -.ii tr.in 
) 24 !:ours) 
50 23,500 ) 12 3 (De!lth in 
) 2 out of ) c.05 3 Mice) 
25 11, 7,50 ) 4 ) 
10 4,700 ) 4 ) 4 1 470 ) 4 ) 
Control (Distilled 0 ) t+ ) 
Water 
TABLE 48 (Continued) 
Solvent/ Concentration Tested Amount Volume No Compound (W/V) Injected No of Sites No of Hice Medium 
,; )l8 (ml) 
7. Acetone Distilled 100 39,500 ) 12 3 (De~th in 
CHJ':O CH} 
Water ) 2 mice) 
so 19,750 ) 4 ) 
25 9 ,875 ) 0.05 4 ) 4 10 3,950 ) 4 ) 
Control (Distilled 0 ) 4 ) 
'iater ' ) 
8. Sal.ine Distilled 2N Saline 850 ) 4 ) 
Water N 425 ) 4 ) 4 NaCl 0. 5N 213 ) 0.05 4 ) 
0. 25N 1o6 ) 4 ) 
9. Ara.chis Oil 
-
100 45,500 0. 1 16 ) 
0.05 16 ) 4 
0.025 16 ) 
10. Hydrochloric Acid Distilled 2M 365 ) 4 ) 
Water M 183 ) 4 ) 4 HCl 0.5M 91 ) 0.05 4 ) 
0. 25M 46 ) 4 ) 
~ 
~ 
TABLE 4S(Continued) 
Solvent/ Concentration Tested Amount 
Volume 
llo Compound (W/V) Injected No of Sites r:o of Mice Medium % )lg (ml) 
,,. Sodium Hydroxide Distilled 2M 4oo ) 4 ) 
Water H 200 ) 4 ) I; 
NaOH 0 • .51'! 100 ) 0.05 4 ) 
0. 25M 50 ) 4 ) 
12. 1, 1, 1, Trichloroethane I»4SO , .o 670 ) 6 ) 
o. 1 67 ) 6 ) 6 
Cl H 0.02 1} 
) 0.05 6 ) 
I / Control (Il4SO alone) 0 ) 6 ) 
c1- c- c- e 
I 
' Cl H 
1}. Ethanol Distilled 100 39,500 ) 4 ) 
Water 50 19,750 ) 4 ) 4 
C2H50R 25 9,875 
) 0.05 4 ) 
10 },950 ) 4 ) 
TABLE 48 (Continued) 
Solvent/ Concentration Tested Amount VolU!!le I No Compound MediWII (W/V) In jected No of Sites lfo of :~ice I % )lg (ml) 
14. 3-(3 ,4- Dihydroxy Phenyl Saline o.6 300 ) 4 ) 
Alanine), OOPA o.o6 30 ) 4 ) 4 H~-CH,r~ o.oo6 } ) 0.05 4 ) Control 0 ) 4 ) 
HO flH2 
15. Pyrogallol IRS() 10 5,000 ) 4 ) 
1 500 ) 4 ) 4 Oil 0.1 50 ) 0.05 4 ) 
0=: 0.01 5 ) 4 ) I 16. Methyl Catecbol IK'iO 1.0 500 ) 8 ) 
0. 1 50 ) 8 ) 8 0. 01 5 ) 0.05 8 ) 
Control 0 ) R ) 
TABLE 48 (Continued) 
Solvent/ Concentration Tested Amount Volume No Compound (W/V) Injected No of Site3 !lo of !-lice Medi1.111 ~ )18 (ml) 
17. Putrescine Saline 10.0 5,000 ) 8 ) 
1.0 500 ) 8 ) 8 0. 1 50 ) 0.05 8 ) 
0. 01 5 ) 8 ) 
18. Adrenaline Hydrogen Saline 0. 01 5 ) 8 ) 8 Tartrate 0.001 0. 5 ) 0.05 8 ) 
19. Hist8lli.ne Saline 1.0 500 ) 16 ) 
Hydrochloride 0. 1 50 ) 0.05 16 ) 12 
0. 01 5 ) 16 ) 
The m:a.ximum conccntrution of methyl curb=:1te used was 5~.! (i . e . 
2,500 ug per injection site . With diethyl dithioc11rbame1t c the maxi.mum 
concentration used was 1% because it is a chelating age'nt and mo.y be 
lethal to the r:iice. 
100"/4 dimethylacetamide injected at four si tcs in 0.05 ml voh,mEs per 
site killed eight out of eight mice injected ( four sites per mouse). 
This is equivalent to a total dose of 7 . 5 g/kg dimethylacetamide per 
mouse which is about t wice the w 50 for r ats . Using a 50% solution 
injected again in 0.05 ml volumes at four sites, two out of three mice 
died (equivalent dose of 3.75 g/kg). With 25% solutions and more 
dilute solutions , no death resulted. 
In comparison 100% dimethyl sulphoxi de was not lethal when given at a 
total volume of 0.2 ml per mouse (i.e. 0.05 ml at four sites). 1oa,'6 
acetone given similarly killed two out of three mice. At 50% and 
lower concentrations acetone did not result in any deaths of the mice. 
Physiological saline (N saline= 0.85% NaCL in distilled water) 
produced no depigmentation. Neither did 2N, 0.5N and 0.25N saline. 
However, Boyland and Sargent in 1951 produced depigmentation in stock 
mice by using hypertonic saline. Depigmentat ion was also produced by 
sterile distilled water in one out of four C57 mice injected intra-
dermally. This observation was explained by greying resulting from 
cellular changes as a res ult of exposure to hypertonic and hypotonic 
solutions. It is interesting that Tatematsu _tl !!1, (1 975) in their 
etudies on experimental gastric cancers in rats, mentioned sodium 
chloride as a possible promoter -:.:i this wus ,-,t supported by their 
data obtained. 
Arachis oil wos not diluted , but injected int radermally in dif f'crent 
volumes i.e. 0.1, 0.05 nnd 0.025 ml . No dcpigmentation resulted. 
There was practical difficulty in injecting intraderrnnlly accurnte 
volumes of arachis oil in the small amounto needed. 
Pyrogallol was tested as there is no evidence of a carcinogenic effec t 
nor tumour-promoting activity but has been shown to be co-carcj.noe-enic 
(Van Duuren 1976) It also produced no depigmentation in the c on-
centrations tested. 
Four compounds which are not known carcino gens nor tumour-promoters 
produced positive depigmentation. 
These were:-
1. Pyrocatechol 
2. 4-Tertiary butyl catechol 
3. p-Tertiary butyl phenol 
4. Butylated hydroxyanisole 
Further details on these are discussed on page 175. All four are sub-
stances known to cause occupational leukoderma. This may be another 
group of compounds in addition to the tumour-promoters which will 
produce the depigmentation effect. If so, it will reduce the specif-
icity of the test for tumour-promoters. However, these compounds ha ve 
not been tested for tumour-promoting activity. It may be possible 
that, if tested, they may show complete carcinogenic or tumour-
promoting activity. 
CHA ER 4 RESULTS (Continued) 
Follow-up experiments 
1. Is the relationship valid for 
chemicals in solid form? 
2. Is the relationship affected 
by retinoids? 
3. Would depigmentation appear 
with the injection of putrescine? 
4. Would depigmentation appear with 
chemicals which are known to cause 
occupational leukoderma? 
5. Is the relationship valid for tumour-
promoters in gaseous form? 
6. Does the effect apply ta co-
carcinogens? 
1 3 
4. FOLI0\-1 - !ll' EXPERIMEflTS 
From the results obt~ined of tests performed en the chemicals 
selected , a link between tumour-promotion and depicmentation is 
indicated. Several questions may be posed regarding this observ-
ation and the followin g experiments have been deaigned to a.~swer 
them. 
I Is the relationship valid for chemicals in solid form? 
Asbestos exists in the form of insoluble solid fibres and in this 
physical state, exposure is linked to an i.ncreased risk of 
bronchogenic carcinoma (Doll 1955, Glynne 1935) and :nesothelioma 
(Selikoff rt al 1965, Mancuso and Coulter 1965) in exposed workers. 
Animal studies have also shown it to be carcinogenic (Reeves rt al 
1971, Wagner and Berry 1969) but little is known about the exact 
mechanism of carcinogenic action. It is possible that asbestos 
fibres act as tumour-promoters. Some support for this is provided 
by the fact that malignancies in asbestos workers develop twenty 
to thirty years after repeated exposure to asbestos and some 
asbestos workers do not develop malignancies in spite of exposure. 
It may be that this group of workers are exposed only to the tumour-
promoting action of asbestos without previous exposure to an appro-
priate initiator. Tobacco smoke could be a source of initiation 
and this could explain the increased risk of lung carcinoma amongst 
asbestos workers who smoke compared with those who do not (Doll 
1971, Berry, Newhouse and Turck 1972). 
Experiment I 
Comunrison of diffe rent types of ~ebestoe fibres 
Asbes tos fibres ~re complex silicates and are clas3ified eesenti~lly 
on the basiis of physical chnracteristico into two groups:-
(a) The Serpentines - Chrysotile (white asbestos ) is the most 
abundant form . Its fibres nre coil-like and sprinG{ in texture. 
(b) 'l'he Amphi boles - \,:hich inc ludo crocidoli te (blue asbestos ), arnosite 
(brown asbestos), anth.•ophyllite, actinolite and tremolite . These 
fibres are short, sharp and rigid wi th pointed ends. 
In view of their possible tumour-promoting activity, the different types 
of asbestos fibres were compared for ability to produce depigmentation. 
Suspensions of different asbestos fibres in norma l saline were injected 
intradermally into C57 Black mice using a similar procedure to that 
for chemicals in solution ( see Methodology, page 46). 
TABLE 49 
F~FECTS OF DIFFERENT ASBESTOS FIBRES 
Injection Fibre Wt No of Depigmentation:-No Type of Asbe3tos Volume (ing) Sites No of (ml) Positive Sites 
1. Crocidolite 0.05 2.5 12 0 
2. Chrysotile A 0.05 2.5 12 0 
3. Chrysot i le B 0.05 2.5 12 0 
4. Anthophyllite 0.05 2.5 12 0 
5. Amosite 0.05 2.5 12 0 
No depigmentation resulted from injection of the five types of asbestos 
fibres ehown above. 
fa,periment II 
Comuarison of --:round and unr;rounr:l fi brcs 
The difficulty in producing aven suspensions of some asbestos fibres 
dccrca:ied the accuracy of the amount cf fib res injected . The exper -
mcnt with chrysotile A was therefore repeated using ground chrysotile 
16G 
A fibres to fo rm an even suspensi on containing 3.3% chrysotile A. The 
results are as shown in Table 50 wi th no depigm~ntE>tion noi:ed even after 
thirty weeks observation. 
'rABLE 50 
COMPARISON OF GROUND AND UNGROL'ND CHRYSOTILE A FIBRES 
Injection Fibre Wt No of Depigmentation:-No Type of Asbestos Volume (mg) Sites No of ( ml) Positive Sites 
1. Chrysotile A 0. 05 2.5 12 0 
2 . Chrysot ile A 0 . 05 1.7 12 0 
(ground ) 
Ne ither coarse unground chrysotile A fibres nor finely ground chrysotile 
A fibres i n saline suspensions produced depigmentation. It has been 
suggested that the carcinogenic activity of asbestos fibres is related 
to the physical characteristics of the fibres (Timbrell 1973). Grinding 
up the fibres allows the preparation of an even suspension for injection 
and increases the accuracy of the actual amount by weight of asbestos 
injected. However, the process of grinding may alter the physical 
characteristics of the fibre s (Stanton and Wrench 1972) and this may 
alter the carcinogenic potential and the potential to produce depigment-
ation, if present . 
Exper i non t II I 
Fretre~tmcnt with Urethane 
Urethane (e t hyl car bamat cl ha s been use d as a n initiator in two-stage 
carcinogenes is (Sal a ma n and Roe 1953) . It wa s used to pretreat c57 
Bla ck mice before int radermal injections of a sbestos fibres were made. 
Urethane was g iven a t a dose of 1 gm/kg body weight in distilled woter 
to make a 10,6 solution a nd injected intraperi toneally on the first, 
second and fourth da y of the experiment. Suspensions of ground 
asbestos fibres in saline were injected intradermally on the fourth day 
of the experiment. This allowed sufficient time for the urethane to 
exert its initiating effects on the mouse skin before the asbestos 
fibres were injected. 
TABLE 51 
THE EF'F'ml'S OF PRE-TREATME'IT WITH URErHANE 
Depigttentation 
Total Dose Injection Fibre Total 
No of Urethane Type of Asbestos Volume Wt tlo of No of 
cig/Mouse (ml) (mg) Sites Positive Latent 
Sites Period 
1 . 0 Chrysotile A 0. 1 2.5 32 0 -
(Ground) 
2. 75 Chcysotile A 0.1 2.5 48 0 -(Ground) I 3. 0 Crocidolite 0.05 2.5 32 2 ) (Ground) ) 16 
4. 75 Crocidolite 0.05 2.5 4J3 9 
~Weeks 
(Ground) ) 
... 
~ 
Clu·ysot i le A (ground) as a 5% cuspem:: ion was too concent ra ted for 
in,jection . A 2 . 5% sus pension was used a t double the injection volume 
i.e. 0.1 ml to introduce 2 . 5 mg of fibre at ench site . 
The results show that no depi gmentation occurred when chrysotile A was 
used, whether or not the mice were pretreated with urethane. However, 
in mice pretreated with urethane and inj!"cted with ground cro cidoli te , 
slight depigmentation was seen in nine out of fo1·ty-eight sites. 
Similar depigmentation was noted in two out of thirty-two sites in mice 
not pretreated and injected with ground crocidolite. The degree of 
depigmentation was minimal and the latent period before its appearance 
prolonged when compared with chemicals causing depigmentation e.g. TPA 
and nitrogen mustard. The significance of this slight depigmentation 
is not clear. As depi gmentation appears related to tumour-promoting 
activity, this suggests that ground crocidolite (blue asbestos) acts 
as a tumour-promoter. However, unground crocidolite when tested at 
twelve sites was negative. It is possible that the change in physical 
characteristics of the fibres as a result of grinding may affect its 
carcinogenic potential by increasing tumour-promoting activity. This 
can be confirmed by following up the urethane pretreated mice injected 
with ground crocidolite. 
The injected mice were followed up for more than fifty weeks, to see 
whether any skin tumours developed at the 11i te of injection. The mice 
pretreated with urethane have initiat ing action of the mouse skin. The 
asbestos fibres are retained at the site of injection and a constant 
contact with the area of skin concerned should provide conotant tumour-
promoting action if asbestos is a tumour-promoter. Tho si tuation is 
akin to the two-stage carcinogenesis experiments on mouse skin and 
local tumours would be expected . However, no akin tumo urs wore noted 
,md the possible explmwt ion is that usbestos ls a we.:ik tumour-
pror.1oter or that the dose of ure thane was jneffective ns initiator. 
II Is the relationshin affec ted by retinoids? 
Vitamin A and its natural and synthetic analogues prevent chemic!ll 
carcinogenesis ( Becci ct & 1978). The absence of these retinoids 
has led to squrunous metaplasia in trachea and bronchial epithelium 
( Harris, Sporn a...~d Kaufman 1972, Wolbach and Howe 1925). Hypoplastic 
and anaplastic changes induced by carcinogens in cultured prostate 
gland tissue have been reversed by retinoids (Chopra and Wilkoff 1975). 
If retinoids can prevent chemical carcinogenesis, it is possible that 
other effects relevant to carcinogenesis may be inhibited e.g. tumour-
promotion and its induced depigmentation in C57 Black mice. 
Experiment I 
Cis-retinoic acid diet and its effect on chemically-induced 
depig-rnentation 
The addition of cis-retinoic acid to the diet of C57 Black mice was 
investigated to see whether it would inhibit the development of depig-
mentation due to croton oil and TPA and para-tertiary butyl phenol 
(Pl'BP ) which causes occupational leukoderma but whose tumour-promoting 
activity has not been investigated. Groups of mal e c57 Black mice were 
allocated to one of six treatment procedures as shown in Table 5?• 
TABLE 52 
ALLOCATION OF DIEl' AND NUt!BERS OF MIC:E USED 
Substances for 
Iri.tra-dermal Injections 
Diet 
Croton Oil TPA P.T.B. P . 
(a) Cis-retinoic acid diet e, 8 8 
(b) Placebo diet 8 8 8 
The mice were fed on the standard diet 11-~til the start of the experi-
ment when this was replaced by the cis- retinoic acid (240 mg cis-
retinoic acid in 1· kg of diet ) or the placebo diet . The new diet was 
continued for a week before intradermal injections were performed on 
all the mice. Different dilutions of either croton oil. TPA or PTBP 
dissolved in methyl sulphoxide were injected at four sites on the 
ventral surface of each mouse. One o f the four sites was injected 
17 1 
with dimethylsulphoxide alone as control . The mice were then examined 
twice weekly for ten weeks for any macroscopic changes at the injection 
sites without the assessor knowing from which cage the animals hed come . 
The cis-retinoic acid diet and the placebo diet were disconti nued four 
weeks after the injections were performed and the animals were given 
the original standard diet. Previous experiments had shown th~t dep ic-
mentation due to such injections usually occurred within four weeks 
after injection (Aw and Boyland 1978). Hence, the different diets 
would be able to exert their effect, if any, during the latent period 
before d~pigmentation appeared. 
PROPORTION OF SITES OF DEPIGMENTATION AFrER TEN \·'EEKS 
FOLLOWING INTRADF:Rl!AL INJECT IONS 
Pr~port ion of Sites 
with Depi gmenta tion 
Substance 
Injec ted Amount/ Cone: 
Cj.s-Rctinoic Placebo 
Acid Die t Diet 
TPA 0.008 }lg 1/8 0/8 
o.o4 }.lg 3/8 5/8 
0.2 µg 7/8 7/8 
1.0 )-lg 6/8 8/8 
Control 0/8 0/7 
Croton 0.02% 1/8 1/7 
Oil 0. 1% 4/8 3/7 
0.5% 7/8 7/7 
Control 0/3 1/4 
PI'BP 0.2% 0/3 2/4 
1.0% 1/3 3/4 
5.0% 0/3 2/4 
TABLE 54 
SHORTEST LATENT PERIOD BEFORE APPEARANCE OF DEPIGMFJITA.TION 
Shortest Latent Period 
Substance 
In jected Cis-Retinoic Placebo 
Acid Diet Diet 
TPA 18 days 21 days 
Croton Oil 28 days 28 days 
Pl'BP 28 days 39 days 
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Nine mi ce injected with Pl'BP and one mouse i n jected wit h croton oil 
died wit hin one day of in j ec t i on . 
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There was no differenc e i n the proportion of posit ive depiementation 
noted i n mice fed with c is- r etinoic a cid diP.t compared with the placebo 
diet when cro ton o il or TPA waES injecteri . There was also no signifi-
cant d i ffer ence i n the leneth of the minimum latent period before 
depi gmentation occurr ed . Reservations about the sigy,_i ficanc e of 
di fferenc es i n latent pe r iods be f ore depigment a tion have been discussed 
(see page 88). 
Cis-retinoic ac id inhibited the appear ance of depi gmcntat ion by ?rBP. 
Only one site showed depigmentat ion out of twelve sites in three sur-
viving mice in j ected with PTBP and fed on the cis-retinoic acid diet. 
For the placebo diet eight sites showed positive depigmentat i on out 
of sixteen sites injected. Statistical analysis using t he method of 
Cox for combining information from several two by two contingency 
tables showed this difference to be statistically significant 
(p < 0.05, two-tailed test). 
Discuss ion 
Cis-retinoic acid given as described does not inhibit depigmenta tion 
induced by the known tumour-promo t ers, croton oil or TPA. Depigment-
ation due t o E'l;BP was inhi bit ed by cis-rotinoi c acid. It would b e of 
interes t and may be of pra ctica l use to see whether re tinoids mo.y be 
effective in i nhibit i ng other s ubstances known to cause occupational 
leukoderma (e.g. othe r a lkyl phenols a nd ca t echols). 
~.,~---~ 
" •". 
.. 1-~-
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III Would deuir:mentation ni,r,ear with the intrnde!·mnl in.icction 
of putrcscine ? 
Putrescine is a product of ornithine decarboxylase (ODC) action and 
ODC is increased by tumour-promoters . Hence , putrescine levels 
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could be increased by tumour-promoters which might exert their depig-
menting effect by means of increased putrescine levels . This hypothesis 
was tes ted by injecting putrescine intradermally into c57 Black mice. 
Experiment I 
Intradermal injection of nutrescine 
A 10% solution of putrescine was first prepared by reacting 1 gm of 
putrescine with 10 ml of 2N HCl to neutrali ze it as putrescine is 
strongly alkaline • . Some of this solution was then di l uted with saline 
to produce a 1% 0 . 1% and 0.01 % solution respectively. Intradermal 
injections of 0,05 ml of these solutions produced the following 
results. 
TABLE 55 
INJ~TIOH OF PUTRESC INE IN SALINE 
Volume No of Sites Concentration Amount No of Sites Showing 
(W/V) _µg Injected Injected Positive (ml) Depigmentation 
10% 5000 0.05 8 0 
1% 500 0.05 8 0 
0.1% .50 0.05 8 0 
0. 01% 5 0.05 8 0 
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Putrescine in the concc-ntrations used produced no depi e;rncntation. Hence 
raised putrcscine levels are unl ikely t o be the mechanism for depir,rnent-
ation caused by tumour-pr omoters in C57 Black mice . 
IV Would depi r;mentation o ccur with chel'l icals whi ch a r e known to cause 
occupational leukoderma? 
Occupat ional l eukoderma or vi t iligo occurs in workers exposed to chemi -
ca l s c a us i ng depi gmen t ed pa tches on the s kin. This usua lly occurs 
following contact with the chemicals a l t hough s imilar effects have been 
described following inha l a tion (Chumakov, Babanov and Smirnov 1962; Ito, 
Nishitani a."ld Hara 1968). Oliver, Schwa:-z a nd Warren ( 1939) described 
lcukoderma in tannery workers caus ed by hydroquinone monobenzyl ether. 
This is an antioxidant and was present in the rubber gloves of these 
workers. 
Para-tertiary butyl phenol (Pl'BP) is present in resin adhesives used in 
the boot and shoe industry. Malten ~ tl (1971) described leukoderma 
due to this compound in plant operatives and Calnan and Cooke (1974) 
noted similar cases in automobile workers using a neoprene adhesive 
containing Pl'BP. 4-tertiary butyl catechol (TBC) is an o.nticorrosive 
agent which caused leukoderma in tappet assembly workers (Gellin,Pos sick 
and Perone 1970). Other phenols and catechols ha ve been known to ca use 
occupational leukoderma (Hara and Nakajima 1969 ; Horio, Tanaka a nd 
Komura 1977). •Studies have also shown that such chemicals can caus e 
depigment a tion in laboratory anima ls (Riley 196 9 and 1971). 
Solutions of the following catechols and phenols were prepared in 
dimethyl sulphoxide (DMSO) and tes ted in C57 Black male mice by the 
procedure outline d on page 4.5 . 
TABLF. 56 
DEPIGMENTATION DUE TO CATECHOL (PYROCJ\TECHOJ,) IN DMZO 
Concent ration Amount Volume No of Si tes with (W/V) Injected Posit i ve Deni~~entat ion 
% )J g (ml) Total No of Gites Injected 
0.3 167 ) 7/8 
) 
0.03 16.7 ) 5/8 
) 0.05 
0.003 1.67 ) 3/8 
) 
Control ( DMS0 alone) 0 ) 0/8 
TABLE 57 
DEPIGMENTATION DUE TO 4-TERTIARY BUTYL CAT~"'CHOL IN DMS O 
Concentration Amount Volume No of Sites with (W/V) Injected Positive De~ip:rnentation 
% )lg (ml) Total No of Sites Injected 
0.75 375 ) 8/8 
) 
0.075 37.5 ) 2/8 
) 0.05 
0.0075 3.75 ) 1/8 
) 
Control (DMS0 alone) 0 ) 0/8 
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TABLE 58 
INJECTION OF MF:'THYL Ct.TEC!IOL IN DMSO 
Concentration Amount Volume No of Si t es with (W/V) Injected Pos itive Depi p;rnenta tion 
% ,ug (ml) Tot a l No of .Cites Inj ec t ed 
1.0 500 ) 0/8 
) 
0 .1 50 ) 0/8 
) 0.05 
0.01 5 ) 0/8 
) 
Control ( DMSO alone ) 0 ) 0/8 
TABLE 59 
DEPIGMENTATION DUE TO P-TERTIARY BUTYL PHENOL TN DMSO 
Concentration Amount Volume No of Sites with (W/V ) Injected Positive Deni ~entati on 
% )lg (ml ) Total No of Sites I njected 
10.0 5000 ) 2/5 
) 
1.0 500 ) 3/5 
) 0.05 
0.1 50 ) 0/5 
) 
Control (DMSO alone ) 0 ) 0/5 
1?8 
TAilLE C.o 
Df:PIGM~rl'l'ATION DUE TO B:JTYIJ\TF.D HYDfi.OXYAIIILSOLE ( Ill!'l') DMSO 
Concentra tion Amount Volume No of Sites with (W/V) Injected Positive Denigrnentation 
% ,ug (ml ) Total No o f Si '.:es In jected 
. 
1.0 500 ) 
) 7/8 
0 .1 50 ) 6/8 
) 0.05 
0.01 5 ) 6/8 
' J Control ( DMSO alone) 0 ) 0/8 
TABLE 61 
DEPIGMENTATION DUE TO HYDROQUINONE MONOBmZYL ~!ER IN DMSO 
Concentration Amount Volwne No of Sites with (W/V) Inj ected Positive Depip:mentation 
% )Jg (ml) Total No of Sites Injected 
10.0 5000 ) 3/8 
) 
1.0 500 ) 1/8 ) 0.05 
0.1 .50 ) 1/8 
) 
Control ( DMSO alone ) 0 ) 0/8 
TABLE 62 
INJECTION OF 8-HYDl:OXY Q.UH!OL!NE IN DMCO 
Concentration Amount Volume No of Sites with (W/V) Injected Positive Peoi l'.'l!lentation 
% µ g (ml) Total No of Sites Inject ed 
1.0 500 ) o/8 
) 
0.1 50 ) 0/8 
) 0.05 
0 . 01 5 ) 0/8 
) 
Control ( DHSO a lone) 0 ) 0/8 
Five ou t of the seven compounds tested produced depigmentation. The 
degree of depig:nentation is summarized in table 63. 
TABLE 63 
DEPIGME!'ITATION DUE TO CATECHOL.5 AND PHENOLS 
No Compound 
Degree of 
Depi gmentation 
1. Catechol + + 
2. 4-Tertiary butyl catechol (TBC ) + + 
3. p-Tertiary butyl phenol (Pl'BP ) + + 
4. .Butylated hydroxy-4nisole ( BHA) + 
5. Hydroquinone monobenzyl ether + 
6. 8-Hydroxy quinoline -
7. Methyl catechol -
Only 8-hydroxyquinoline and methyl catechol were negative . Senr] e 
(1972) produced depiementation in C'.]7 Black mjce by topical applic-
ation of 8-hydroxyquinol ine. Single applications resulted in isolated 
bands of depigmented hair . However, the effect was seen in fema le 
mice but not in male mice; the above results were obtained with ma le 
C57 Blac k mice. 8-hydroxyquinoline is a chelating agent and it has 
been shown (Allen_!! al 1957 ) to increase cancer of the urinary bladder 
in mice. Pliss and Volfson (1970) testP.d it in both r ats and mice 
and concluded that it was a weak carcinogen. It may be an indirect 
carc inogen and only active after metabolic activation. Hence , the 
negative result in the depigmentati.on test. There is no evidence 
that methyl catechol is carcinogenic. 
Catechol was shown by Van Duuren .:.!,~ (1973) to increase the carcin-
genic effects of benzpyrene on mouse skin. They concluded that 
catechol was co-carcinogenic but not a tumour-promoter. By producing 
positive results in the depigmentation test, this reduced the specif-
icity of the test for tumour-promoters. 
Hydroquinone alone ~,as tested in bladder implantation experiments in 
mice (Boyland.:.!,~ 1964). Using cholesterol pellets and 
hydroquinone increased the incidence of bladder tumours. However, 
ekin-painting experiments in mice using hydroquinone and croton oil 
showed that hydroquinone was inactive as an initiator of skin 
carcinogenesis (Roe and Salaman 1955). It may act as a tumour-promoter 
and/or co-carcinogen rather than as an initiator. Van Duuren (1 976 ) 
however found hydroquinone to have neither tumour-promoter nor co-
carcinogeni c properties. It is possible thnt hydroquinonc hos no 
carcinogenic effects nor tumour-promoting carcinogenic a ctivity on ti1e 
skin of mice but is a carcinogen to mouse bladder. 
Only 8 - llydroxyquinoline a nd me thyl cat.echol were negat ive . Senr]e 
( 1972 ) produced depit:;mentat i on i n C~7 Black nd ce by topical appl ic -
a tion of 8-hydroxyquinoline . Single appli cations resul ted i n i s olated 
~ands of depif;!11ented ha ir . However , the effect was seen i n f emale 
mi ce but no t in male mi c e ; t he above resul ts were obtained wi th male 
C57 Black mice . 8- hydroxyqui~oli ne i s a chelat ing D.gent and i t has 
been shown (Allen -~ al 1957 ) to increase cancer of t he urinary b ladder 
i n mice . Pl iss and Volfson ( 1970 ) tested it in bo th rats and mi ce 
a nd concl uded that it was a weak carc inogen. It may be an indirect 
carcinogen and only a ctive a f ter metaboli c actjva tion. Hence, the 
negative res ult in th e depigmenta tion t es t. The re i s no evidence 
that methyl ca techol is carcinogenic. 
Catechol was s hown by Van Duuren .!!_~ (1973) to increase the carcin-
genic effects of benzpyrene on mous e skin. They concluded that 
ca techol was co-carcinogenic but not a tumour-promoter. By producing 
positive results in the depigmentation test, this reduced the specif-
icity of the test for tumour-promoters. 
Hydroquinone a lone ,1as tested in bladder implantation experimen ts in 
mice (Boyland~!!_ 1964 ). Using cholesterol pellets and 
hydroquinone increased the incidence of bladder tumours . However, 
s ki n-paint ing exper iments in mice using hydroquinone and croton oil 
showed t hat hy droquinone was i nactive as an initiator of s kin 
carcino genesis ( Roe a nd Sal aman 1955). It may act as a tumour-promoter 
and/or co-carc i no gen r ather than as an initiator. Van Duuren (1 776) 
however found hydroqul.none t o ha ve neither t umour-promoter nor c o-
ca rcinogenic propertieo . It i s possible th.::it hydroquinonc has no 
ca r cinogenic effects nor t umour-promoting carci nogenic activi ty on tl, e 
s kin of mi ce but i e a ca rcinogen to mouse bladder. 
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Ach e son et i;i,l_ (1 970) found a high incidence of n usal tumours in the 
boot and shoe i ndust ry. The cnrcino r;en concerned could poosibl y be 
Pl'BP and , if so, the n the presence of t umour- promoting activity would 
fit in well with t he positive depigment a tion obtained. However, 
Boutwell a n d Bosch ( 1959 ) tested Pl'BP on mouse s k in and found it not 
to be a tumour-promoter . 
There is no evidence that 4-tertiary b•.1tyl catechol and butylated 
hydroxy-anisole are carcinogenic . However, because of the similarity 
in chemical structure to hydroquinone, hydroquinone monobenzyl ether 
and catechol, it is possible that they may be carcinogenic or possess 
co-carcinogenic and/or tumour-promoting activity. Butylated hydroxy-
anisole has been ;hown to cause epidermal micro-invasion simila r to 
early epithelial tumour of natural or chemically-induced origin 
(Riley and Seal 1974). 
TABLE 64 
CKOfICAL FO'RMTJLAE OF AGENTS CAUSING OCCUPATIONAL LEUKODERMA 
Catechol 
OH 
CJ·'"• 
Methyl catechol 
(0-hydroxy-anisole) 
Butylated 
hydroxy-anisole 
p-tert i ary 
butyl phenol 
OH 
d::1 
T 
OH 
Hydro qui none 
4-tertiary butyl 
catechol 
Hydroquinone 
monobenzyl ether 
Thus, these compounds may produce depigmentation because of possible 
tumour-promoting activity. It is more likely that depigmentation as 
induced by single intradermal injections of chemicals into C57 Black 
male mice is not confined to tumour-promoter:3 alone. Other groups of 
compounds may also produce positive depigmentation by a similar melano-
toxic action or by some other mechanism. Agents that cause occupational 
leukoderma would be one such group of compounds. Boyland and Sargent 
(195 1) suggested that compounds that liberate free radicals and hyper-
or hypo-tonic solutions are two other groups of chemicals which may 
produce a similar depigmentation effect. 
Free radi calG a re cap:1 ble of direct combination with cell constituents 
such as nucleic l'lc id. This is a feature akin to carcinogens - which 
mRy have tumour-promoting activity as in complete carcinogens. Also 
hypertoni~ solu tions have been shown to enhance tumours in rats 
(Tatematsu 1975 ). Hence, there iG still the possibility of tumour-
promoting activity being the ~o~~on link between chemicals and 
depigmentation in C57 Black male mice . 
V I1; the r<' l ,,t::.onc'h i n val id f or tumour-r,romot er s i.n .,-a s eous f orr.1 ? 
In i nhalo.tion atucl i eG on rats, Lo.skin .!:.!_ !!,l ( 1970) showed that 
ini ti o. l i:i:q-,osure to b 1>nzo( 11 )pyrene followed by repeated exposure to 
sulphur di oxide ( S0 2 ) re sulted in squa~ous cell carcinomas in five 
out of t wer.ty-one rats . The evidence suggests that SO? acts as a 
tumour-promoter. 
In order to test S02 for its a.bili ty to induce depigmentation in C57 
Black mice, solutions of sodium metabisulphi te (Na 2o5s2 ) were used. 
·rhis produces sulphurous acid (so2 + H2o----H2so3 ) in solution. 
sulphur 
dioxide 
TABLE 65 
sulphuroua 
acid 
INJECTION OF SODIUM MErABISULPHirE IN DISTILLED WATER 
Concentration Volume Proportion of Sites 
(W/V) Amount Injected with 
% ,ug (ml) Positive Depiinientation Total No of Sites Injec ted 
10 5000 ) 0/6 
) 
1.0 500 ) 0/6 
) 0.05 
0.1 50 ) 0/6 
) 
Control 0 ) 0/6 
No depigmentation occurred in the concentrations tested. This suggests 
that the relationahip may not be valid for tumour-promoters in easeous 
form. A total of eight mi ce were injected al togeth~r. Two died 
following formation of abscesses at the injection site where 10% 
eodium metabisulphite was injected. 
VI Does the c:ffcr, t :rnp] v to co-cnrc-inor:cns? 
Co-cnrcinoc;ens increase tumour-yield when regularly a pplied simult -
aneously with initiators . T!icy are cloncly related to tumour-promoters 
a.nd some compounds have both tumour-promot ing and carcinogenic activity. 
There is probably also a difference in the mode of action since not all 
co-carcinogens nre tumour-pro~oters and vice-versa . Table 66 
(modified from Van Duuren 1976 and incorporating some of the depigment-
ation test results) compares tumour-promot ing and co-carcinogenic 
activities of some tested compounds. 
TABLE 66 
COMPARISON OF TUMOUR-PROMOTING AND CO-CARCINOGENIC ACTIVITIES 
No Compound Tumour-Promoting Co-Carcinogenic Depigmentation Activity Activity 
1. TPA + + + 
2. Anthralin + + -
3. N-dodecane + + + 
4. Phenol + - + 
5. Catechol 
-
+ + 
6. Hydro qui none 
- -
+ 
7. Pyrogallol 
-
+ -
8. Pyrene 
-
+ -
9. Benzo(a)Pyrene - + -
For the above nine compounds: -
(a) Three or the four tumour-promoters showed positive depigmentation, 
theref~re, .sensitivity for tumour-promoters = 75%. 
VI 1)o,__,s the c!'fcr.t annlv to co-cnrc.i.nor,cns ? 
Co-cnrcinoc;ens increase tumour-yield when regulnrly Applied simult-
c>ncously with initiators. T!1 cy are closely related to tumour-promoters 
a!ld some compounds have both tumour- promoting and carcinogenic activity. 
'l'here is probably also a difference in the mode of ac tion since not al l 
co-carcinogens c>re tumour-pro~oters and vice-versa. Tabl e 66 
(modi fied from Van Duuren 1 976 and incorporat ing some of the depigment-
ation test results ) compares tumour-promoting and co-carcinogenic 
activities of some tested compounds. 
TABLE 66 
COMPARISON OF TUMOUR- PROMOTING AND CO-CARCINOGENIC ACTIVIT IES 
No Compound Tumour-Promoting Co-Carcinogenic Depigmentation Activity Activity 
1. TPA + + + 
2 . Anthralin + + -
3. N-dodecane + + + 
4. Phenol + - + 
5. Catechol 
-
+ + 
6. Hydroquinone 
- -
+ 
7. Pyrogallol 
-
+ -
8. Pyrene 
-
+ 
-
9. Ben::::o(a)Pyrene 
-
+ -
For the above nine compounds :-
(a) Three of the four tumour-promoters showed positive depigmentat1on, 
theref~re, sonsiti,;ity for tumour-promote1·a = 75%. 
T,:o of the five non- tumou r-promo ters showed posi t i ·:e depivnenta-
tion, the refore specificity for tummir-promoters = 6Cf;l 
(b) Three of the seven co-carcinogens s hO\ved posit ive depigmentation , 
t herefore, sensi ti vi ty for co-carcinogen s = 4 7 • • 
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Two out of two non-co-.::a rcinog ens showed positive depi gm,mtation , 
therefore specificity for co-carcinog ens= o% 
Using the above l i st of compounds which have been specifically tested 
for tumour-promotir.g and co-carcinogenic activity and which were tested 
f0r depigmentation, the depigmentation effect is more specific and 
sensiti\'e for tumour-promoting activity than for co-carcinogenic act-
ivity . 
CHAPI'ER 4 RESULTS ( Co~tinu d) 
Microscopic f turos 
Micros copy of hair 
Microscopy of ~in 
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5. 1-!ICR0.GC0PIC FF.NI'UPES 
The skin of mc1mmols consists of epidermis nnd with hnirs nrisinr: 
from huir bulbs in the dermis. Fie; 11 show:c:; a diu,:,;rnmmatic 
repre.uenta.i ion. 
FIG 11 
MA.MMALI/1.N SKIN 
C il ,:ti 
CrlrlN ,) 
/l~~Ct. 1,_. ,, I IL I 
1/1111~ /./,I 1: I}. 
, 1,111:, 1\,/ll} 
C 111'1 LI.fl/.''( 
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The specific features of th e mou:;e ,:;kin have been described by 
i;etala (1 960 ) a nd 'Tarin ( 1967 ) ond reviewed by Raick in 1973 . The 
essential fea tures of note are :-
(a) Th e epidermis of mouee skin is very thin with a high per-
centage of undifferentiated b asal cells . 
(b) The stratum corneum is clearly demarcated from the stratum 
granulosum . 
(c) The stratum basalis consists of basal cells with large 
nuclei containing single, small, compact, round or oval 
nucleol i lying close to the centre of the nucleus. The cyto-
plasm of these cells is relatively sparse . There are no 
intercellular spaces or bridges between ad jacent basal cells. 
(d) The melanocytes are interspersed between the basal cells and 
are also present in the hair bulbs. They give colour to the 
skin and hair. Melanocytes have numerous cytoplasmic proces-
ses and contain specific pigment granules called melanosomes. 
These are membrane-bound ovoid bodies containing melanin. 
(e) The interfollicular epidermis is one to two cells thick with 
the long axis of the nuclei of the first cell layer aligned 
perpendicular to the epidermal surface, and the second more 
superficial layer, if present, with the nuclei aligned 
parallel to the epidermal surface. 
Melanin is the high molecular weight pigment present in hair 
and skin. It is produced by the enzymatic oxi dation of 
phenolic compounds. Tyrosine, a colourless amino-acid which 
is first convert~d to dihydroxy phenyl11lanine (OOPA) 
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Fig 12 showH t he steps in melnni n s ynthesis . 
FIG 12 
MELANIN SYNTHESIS 
Tyrosine 
---------- DopaquinonP. 
,1. 
OOPA 
Leukodopachrome 
J, 
Dopa chrome 
J, 
5,6-dihydroxyindole 
J, 
Melanin.;;•---- Melanochrome ----- Indole.5,6-quinone (yellow) 
(From Fitzpatrick, Brunel and Kukita 1958) 
Tyrosinase and other copper-containing enzymes are involved. 
Melanin occurs as simple, uncombined melanin or in combination with 
proteins to form melanoproteins. It is present in melanoblas ts, 
melanocytes and pigment cells in hair. Melanoblasts are the parent 
pigment cells derived from the neural crest and give rise to 
melanocytes at the hair bulb. These melanocytes form pigment cells 
in the hair. The pigment cells are usually longitudinally arranged 
in the hair cortex and medulla. Air spaces or fusi present in 
between cells of the hair give sheen and colour tone to the hair 
by influencing the reflection of light (Montagna and Van Scott 
1958). These fusi are filled with fluid at the living portion of 
the hair near and at the bulb. As the hair grows, the fusi dry 
out and air replaces the fluid. Thus, the gross appearance of hair 
colour depends on the melanin and fusi. 
Melanoblaata also give rise to melanocytes which lie on the b<tse-
ment membrane of the epidermis. Melanocytcs have dop~ oxid~so 
activity (OOPA positive). The activity of melanocyt ea rather 
than actual numbors present determine ski n colour. 
Microscopy of Hair 
Fig 13 shows a high power view (x 100 magnification) of a normal 
black hair from a C57 Black male mouse. The translucent cuticle 
consists of a single layer of pigment-free scales that form the 
outer part of the hair shaft. The inner cortex consists of the 
pigment-containing cells with lighter air spaces in between • 
. --~ .. - - •· ...... .,. -:_, -- ..... 
. ,• 
~ - • 11.c" ..._ 
FIG 13 Normal Black Hair from C57 Black Mouse (x 100) 
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FIG• ~ Normal White Hair from Tyzzer Original White Mouse (x 100) 
~icroscopv of Hair 
:ii:= 1" sr.o,,s 9. high Fower Yiew (x 100 magnification' of s normal 
blac~ hair from a C5 Black male mouse. The tr"nslucent cuticle 
consists of a single layer of pigment-free scales tho1t form tr,e 
outer p9.rt of the hair shaft . The inner cortex consists of n,e 
oi~ent - containing cells with lighter air sp"ces in hetween. 
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, -ntd wni te Y.ouoe (" 100) 
Fig 1lt nhows a sir:iilar view of a white ho.ir from a 'l'yzzer originnl 
mouse . Beneath the cuticle of scales is the cortex with piemcnt-
free cortical cells c1nd air spaces in between. Some hnirs in this 
white mouse possess a few pigment cells scattered in the hair 
cortex. TIie hairs are , therefo re, not completely void of melo..nin. 
19?. 
Fies 15 and 15 show human black and white scalp hair for comparison . 
In the human black hair the cuticle is very thin and there are many 
more pigment cells in the hair cortex with hardly any air spaces 
seen. The white scalp hair shows the hair cortex beine relatively 
free of pigment while the medulla retains the pigment to form a 
central black core throughout the hair. 
Fig 17 shows a hair from a C57 Black mouse which had been injected 
with dimethyl sulphate. There is a distinct margin separating the 
well-pigmented part of the hair from the completely depigmented 
portion which is nearer the hair physically . This indicates an 
abrupt effect on pigmentation produced bytl1e chemical injected. 
A similar picture is seen with chemicals causing obvious(++) 
and marked(+++) depigmentation e.g. nitrogen mustard (HN2) TPA 
and carbon dioxide snow. There appears to be no difference in the 
histological picture of hair taken from C57 Black mice whether they 
are injected with dimethyl sulphate, HN2, TPA or CO2 snow. In any 
sample of hair taken from the sites of depigmentation, most of the 
hair will be completely depigmented or with the tips of the hair 
pigmented and the base depigmented (as in Fig 17 ). There will 
also be some hair3 with normal pigmentation and hairs with scattered 
patches of pigment loee, (as in Fig 18 ) • This 11'.riy reprc1Sent a 
difference in susceptibility and responne of tho pigment cells i n 
different hair papillae to the injected chemico) o. 
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FIG 15 Normal Human Black Scalp Hair (x 400) 
FIG 16 Normal Human White Scalp Hair (x 400) 
1 
FIG 15 Normal Human Black Scalp Hair ( x 400) 
FIG 16 Normal Human White Scalp Hair (x 400) 
FIG 17 D pigmented Hair from C57 Black House treated with 
Dimethyl Sulphate (x 50) 
F!O 18 Depipented Hair from C57 Black House treated with 
I henol (x 50) 
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FIG 17 Depigmented Hair from C57 Black Mouse treated with 
Dimethyl Sulphate (x 50) 
FIG 18 Depigmented llair from C57 Black Mouse treated with 
Phenol ( x 50 ) 
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Fig 18 shows a hnir from a C57 Black mouse which had been injected 
with phenol, alongside a normal black hair. Here, the depi gment-
ation is patchy wi th retention of some pigment in scattered areas 
along the hair shaft. There is no abrupt loss of pigment. Such 
hairs are seen with the chemicals causing only slight depigmentation 
(+) e.g. phenol, saccharin, dodecane and Tween 20. ~~lile a 
majority of hai rs from depigmented si tes due to these chemicals 
show this picture, a few hairs will be normal and there will also 
be some with complete loss of pigment. The reason again js likely 
to be a difference in pi gment cell susceptibility. Searla (1972) 
noted similar depigmented hair together with normal hair in depig-
mented sites in C57 Black female mice treated with 8-hydroxy-
quinoline by local skin application. 
No banding of hair was observed, as might be expected if melano-
genesis was only transiently affected. The loss of pigment in all 
the experiments producing positive depigmentation was permanent 
and the effect was still present even after a year from the initial 
intradermal injection. 
Transverse sections of hair follicles were also examined by light 
and electron microscopy. 
Fig 19 shows a normal hair follicle from a C57 Black mouse. The 
lighter multicellular outer sheath surrounds the darker inner 
sheath. The hair is seen within the inner sheath with its cuticle 
and pigment within cells of the hair cortex clearly visible. 
Fig 20 is a similar section taken from a C57 Black mouse injected 
with TPA. There is loss of pigment from the inner ~hoot h ond only 
very little pigment in the hair cortex. 
FIG 19 Tranaverse Section of Hair Follicle from No~ CY? 
Black Howse (x 6oo) 
FIG 20 Tranaver•• Section of Hair Follicle from C5? Howse which 
had been injected with TPA (x 600) 
FIG19 Transverse Section of Hair Follicle from Normal C57 
Black Mouse (x 600) 
FIO 20 Transverse Section or Hair Follicle from C57 Mouse which 
had been injected with TPA (x 600) 
Microscopy of Skin 
Examination of skin sections under the light microscope and 
electron microscope showed a decrease in melanocytes in the 
epidermis and around the hair follicles. 
Fig21 shows an electron micrograph of an area of skin where TPA 
was injected. The stratum corneum is clearly seen as a separate 
layer of compressed desquamated cells. There are a number of 
basal cells with large nuclei and single small nucleoli. No 
melanocytes are seen. 
FIG 21 Area ot Skin from TPA-Injected C57 Black House 
Electron Micrograph (x 5000) 
Microscopy of Skin 
Examination of skin sections under the light microscope and 
electron microscope showed a decrease in melanocytea in the 
epidermis and around the hair follicles. 
Fig21 shows an electron micrograph of an area of akin where TPA 
was injected. The stratum corneum is clearly seen as a separate 
layer of compressed desquamated cells. There are a number of 
basal cells with large nuclei and single small nucleoli. No 
melanocytes are seen. 
FIG 21 Area ot Skin Crom TPA-Injected 057 Black Mouse 
Electron Micrograph (x 5000) 
Microscopy of Skin 
Examination of skin sections under the light microscope and 
electron microscope showed a decrease in melanocytes in the 
epidermis and around the hair follicles. 
Fig21 shows an electron micrograph of an area of skin where TPA 
was injected. T~e stratum corneum is clearly ~ecn as a separate 
layer of compressed desquamated cells. There are a number of 
basal cells with large nuclei and single small nucleoli. No 
melanocytes are seen. 
FIG 21 Area of Skin from TPA-Injected C57 Black Mouse 
Electron Micrograph (x 5000) 
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FIG 22 No~ Helanocyte from C57 Black Mouse 
Electron Micrograph (x 12,600) 
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FIG 23 Area of Skin Around Hair pilla in No~l C'Yl Black Mouse 
Electron Micrograph (x 1600) 
FIG 22 Normal. Mel nocyte from C57 Black Mouse 
Electron Micrograph (x 12, 600) 
f'I Z Are o! Skin Around lloir l' pilla in Normol C57 Bl ck Mou e 
ec ron Mi c ro ph (x 1600) 
Fie 22 sho1-1s /ln electron microeraph of 11 melanocyte taken from an 
aren of normal 3kin . This mel:'.l.l1ocyte has an irree;ular cell margin 
due to cytoplasmic processes. Several ovoid melanin granules arc 
present in the cytoplasm. The nucleus is large and irregular and 
contains more than one nucleoli . 
Fig 23 shows an electron micrograph of the area of skin around a 
hair papilla in a normal c57 Black mouse. Melanocytes incorpor-
ating melanin pigment into the growing hair are present. In mice 
injected with depigmenting agents, there is a lack of melanocytes 
in the area of the papillae . 
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CHAPI'Ert 5 GE::ERAL DISCUSSION 
Mechanism of depigmentation by tumour-promoters 
Uses and limitations 
Suggestions for further studies 
DISCU5SION 
1 . Mechnni.sm of Dcnir,:mentation by Tumour-Promot ers 
The rea son for the observed relationship between injected. tumour-
promoters and depi gmentation of hair is not known. Indeed, for a 
large proportion of depigment ing agents in general , the e.ctual 
mode of act ion is obscure, (Searle and Riley 1978 ). 
The exact mechanism by which tumour-promoters exert their effect is 
also not known. There is an abundance of theories though on how 
tumour-promoters act. 
Boutwell (1974) suggested that tumour-promoters may act as gene 
activators to transform initiated cells to dormant tumour cells. 
Repeated exposure to tumour-promoters will then stimulate cell 
division by the dormant cells to produce a neoplasm. An alternative 
mechanism proposed by Boutwell is that tumour-promoters inhibit DNA 
repair. Initiators react with DNA and inhibition of proper repair 
leads to expression of a damaged or altered gene. However, this 
alternative is unlikely because it implies that tumour-promoters need 
to be applied soon after initiation for them to be effective. Yet, 
tumour-promoters can be effective in producing tumours when applied 
several months after an initiator (Weinstein, Wigler and Pietropaolo 
1977). 
Frankfurt and Raitcheva (1972 ) suggested that tumour-promoters ac t 
on initiated epidermis to give certain cells a selective advantage. 
The basal cells in particular were noted to have a shorter mitotic 
cycle and an increased proliferation rate. It is possible thnt 
melanocytes are amongst the cells not given this selective ndv~nt age 
by tumour-promoters. Their activity may be inhibited or reduc ed and 
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this could explnin the depigmcntation effect . 
Other theories include the epidermal chalone theory (Murks ~ al 1972) 
which mnintains that a mitosis-inhibiting substance te rmed chal one is 
inactivated by tumour-promoters. Depressed immunological activity is 
another theory of tumour-promotion (Nat i onal Cancer Institute Mo noeraph 
1922 ). Ho wever, these t heories are not well supported nnd do not 
appear relevant to the depigmenta tion effect. 
Most of these theories are based on a v ariety of effects produced by 
tumour-promoters. The difficulty is in distinguishing be tween those 
effects essential for tumour-promotion and those that are not. Amongs t 
those observed effects are:-
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(a) The inhibition of differentiation of cells in culture (Raick 1974, 
Weinstein and Wigler 1977). Dedifferentiated cells remain inactive 
and retain their ability to divide. A continued alteration in the 
proportion of these cells to differentiated cells present can lead 
to an increase in cell division of immature cells typical of a 
neoplastic effect. This observation supports Frankfurt o.nd Raitcheva's 
suggestion that tumour-promoters give some cells a selective advantage. 
A single exposure to tumour-promoters may cause a reversible effect 
but repeated exposures can maintain the increase in immature cells. 
Inhibition of different i ation has been shown in chick embryo myo-
blasts (Cohen~~ 1977), Friend erythroleukaemic cells ( Yamasaki 
~ & 1977) and neuroblastoma cells (Ishii ,!!. .!! in press). The 
effect on neuroblastoma cells is of interest because neuroblae toma 
cells originate embryologically from the neural crest and this is 
also the source of melanocytes . The depigmenta tion effect due to 
tumour-promoters may be an i nhibition effect on different iation of 
melanocytes . 
(b) An incrca::;e in the enzyme ornithine decarboxylasc (ODC) wh ich 
correlates well with tumour-promotin1s activity (Boutwell 1977 ). 
20j 
High leveli, of ODC have also been noted in skin ci,.rcinomas , hepatomas 
and other malicn:mt cells ( Boutwell 1978, Rus::;ell 1973 , Will iruns-
Ashman , Coppoc and Weber 1972) and lower levels in papillomas . 
Raised ODC l evels lead to an i ncrease in cellular polyan:iues &nd 
these are known to stimulate cellular division. The increase in 
polyamines may be responsible for the growth advantage of t rans-
formed cells exposed to tumour-promoters compared with non-exposed 
cells. Putrescine (tetra-methylene diamine) is a produce of ODC 
action and intracellular levels of putrescine are increased in 
mouse skin on exposure to TPA (Weinstein and Troll 1977). To 
investigate whether putrescine may be responsible for the depigment-
ation effect caused by tumour-promoters, solutions of putresci ne 
were injected intradermally into C57 mice (see page 174for details). 
No depigmentation was observed and this suggests that raised putre-
scine levels caused by tumour-promoters is not the cause of the 
observed depigmentation. 
(c) An increase in the enzyme plasminogen activator (Wigler and Weinstei n 
1976). This is a protease which is also secreted by neoplastic cells 
(Reich 1975). It has been suggested that plasminogen activator may 
break down proteins and u.~block genes altered by initiation. It, 
therefore, allows the expression of these genes which may l ead to 
tumour formation. It is possible that depigmentation due to tumour-
promoters is a result of plasminogen activator acting on proteins 
responsible for melanin synthesis. However, this appears unl ikely 
because increased plasminogen activator seems to be confined to 
phorbol eaters and not other tumour-promoters (Marx 1978). 
(d) Other enzymes arc also increased by tumour-promoters e . g . 
S-adenosyl methionine decarboxylase (O' Brien , Simsiman and 
Boutwell 1975) . cyclic AMP (adcnosine mono-phosphate (Mufson, 
Simsiman and Boutwell 1979) cyclic GMP(guanosine mono-phosphate) 
(Estensen .=! ~ 1973 ). However, the correlation with tumour-
promot ing activity is poor and they have not been a5 well studied 
as ODC. It is unlikely that any of these enzymes form the link 
between tumour-promoters and depigmentation. 
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Depigmentation results from a reduction in the amount or ab~ence of 
melanin present. This could occur because of inhibition of one or more 
enzymea involved in melanin production. Inhibition of tyrosinase results 
in decreased melanin pigmentation of hair, and this together with mental 
deficiency occurs in phenylketonuria. This is a Mendelian recessive 
disease which primarily causes a decrease in L-phenylalanine oxidase 
activity in the liver. The enzyme lack causes a decrease in the con-
version of phenylalanine to tyrosine and the build-up of phenylalanine 
inhibits tyrosinase activity (Fitzpatrick!!_ al 1958) . Tumour-promoters 
may, therefore, cause depigmentation by a similar mechanism. 
Boyland and Sargent (1951) investigated possible tyrosinaee inhibition by 
nitrogen mustard (HN2). Nitrogen mustard is a complete carcinogen and, 
therefore, would possess initiating and tumour-promoting propert ies . It 
caused a strongly positive result in the depigmentation teat. Depigmen-
tated hair in Black mice was first produced by local injection of nitrogen 
mustard (HN2). Dihydroxy phenylalanine (OOPA) was then injected intra-
dermally at the same site. If HN2 acts by inhibiting tyrosinase and 
therefore decreasing the conversion or tyrosine to OOPA, then the s ub-
sequently introduced DOPA should reverse the depigmentation. This did 
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not occur . Henc e , for liN2-induced depigr..entation , tyrosinase inhibition 
is not the mednnism. 
Searle (1 972 ) investigated the possibility of direct inter!'erence with 
copper-dependent en::ymes e . g . tyrosinase as a possible mechanism of 
chemically-induced depigmentc1.tion . Local appl ication o:f copper chelat::.ng 
agents ,·iz oe-benzoin oxime, 2,2-biquinolyl D.nd 2,9-dimethyl 1,10-
pr.enanthroline did not cause depigmentation . Inhibition of such enzymes 
is, therefore, unlikely to be a mechanism for depigr.,cntation . 
Searle (1 972 ) also suggested that toxic complexes formed may~~ respons-
ible for chemical depigr.ientation. He produced local depigmentation by 
using 8-hydroxyquinoline which is a chelating agent, but was negative in 
our depigmentation test . Diethyl dithiocarbamate which is also a chelat-
ing agent was tested by the depigmentation test and this also produced 
no depigmentation (see page 156 ) • Both 8-hydroxyquinoline and diethyl-
dithiocarbamate form stable metal complexes with copper. Diethyldithio-
carbamate has been used experimentally to treat Wilson's disease which 
is a genetically recessive metabolic disease where there is a progressive 
increase in total body copper with consequent damage to the tissues of 
the brain, liver and renal tubules. Some limited studies suggest that 
8-hydroxyquinoline may be carcinogenic but the International Agency for 
Research on Cancer concluded on review of the available data that such 
data was insufficient to suggest definite carcinogenicity (IARC 
Monographs). Diethyldithiocarbamate is not known to be carcinogenic. 
Both these chelating agents do not produce depigmentation in our test, 
and this suggests that metal chelation to form toxic complexes is 
unlikely to be the mechaniern !or depigmentat ion. 
It is possible that tumour-promoters exert their effect by virtue o! 
t heir irritant nature and that thi s is also r esponsible for drunar,e to 
mel anocytes therefore causing depicmentation. HowevP.r, irritant 
chemicals tend to cause hair loss and depilation does not co~relate 
with depi(l'l!lentation . Compounds that can cause excessive skin damage are 
not necessarily tumour-promoters e.g. styrene, dimethylhydrazine and 
Lewisi te. There are also compounds which are tumour-promoters which do 
not cause gross signs of tissue damage nor hair loss e.g. 5% phenol and 
some s urface-active agents (Boutwell and Bosch 1959 ). These tumour-
promoters, however, cause depigmenta tion. Hence the link between tumour-
promoters and depigmentation is not because of a common abi lity to cause 
tissue damage . 
It is possible that tumour-promoters cause depigmentation by several 
different mechanisms. Boyland and Sargent (1951) showed that substances 
which might liberate free radicals e.g. ascorbic acid, perbenzoic acid 
and benzene diazinium hydroxide cause depigmentation when injected intra-
dermally into mice. Ascorbic acid was positive in only three out of 
sixteen injected sites. There is no data on whether these may be tumour-
promoters. 'l'he authors also suggest that solutions which are either 
hyPotonic or hypertonic may cause cellular changes which can result in 
depigmentation. Distilled water caused depigmentation in 25% of sites 
in C57 Black mice. Concentrated (3 molar) sodium chloride caused depig-
mentation in 40% of sites injected but there was no depigmentation with 
1 molar sodium chloride. Attempts have been made to induce gastric 
cancers in s.nimals by ealted foods in order to investigate the high 
incidence of stomach cancer in Japan where salted foods are frequently 
consumed (Sato_!! tl 1959), The results have been negative. However. 
Tatematsu .!!_tl ( 1975 ) found that using N-methyl-N'-nitro-N-nitroso-
guanidine or 4-nitroe;u inoline-1-oxide as initiator, repeated applica tiono 
or hypertonic sodium chloride increaoed the incidence of gastric tumours 
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i n i ·o.ts . This demontitrates the tumour-promoting action of hypertonic 
r,al ine and since hypertonic saline has caused depigrnentation this is 
aeain evidence in support of a relationship between tumour-promotion 
o.nd depigmentation. 
Boyland (1 949 ) suggested that the greying of hair induced by radiation 
and chemicals may be a somatic mutation effect. This is because it 
represented a discontinuous permo.nent change in part of the soma. . 
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Theories on the possible action of tumour-promoters on genes have been 
mentioned earlier (pege201). Davidson and Dawson in 1976 produced 
depigmented patches in the offspring of female mice fed with the carcino-
gen benzpyren?.. This could be due to a mutation effect on colour genes. 
Fahrig (1975) noted the alteration of pigment cells in mouse embryo due 
to x-rays and chemicals and proposed the effect as a spot mammalian test 
for mutagens. Hence, it is possible that the mechanism of depigmentation 
by tumour-promoters is by a somatic mutagenic effect on pigment cells. 
The most likely explanation for the link between tumour-promoters and the 
depigmentation effect is th'.l.t tumour-promoters have a selective toxic 
action on melanocytes. This results in a reduction or absence of melanin 
in the skin and hair. The skin in C57 Black mice is white and therefore 
the effect is more prominent on the hairs which are black. This effect 
is selective because other cells do not seem to be permanently altered. 
The main ultrastructural change in the mouse skin treated with tumour-
promoters is hYJlertrophy of the epidermal layers especially in the basal 
cells (Raick 1973a and 1973b). Similar features were noted with croton 
oil (a tumour-promoter) and 3-methylcholanthrene (an indirect carcinogen) 
(Burki ahd Bresnick 1975). These fea tures appear to be transient and non-
specific. A single application of TPA resulted in reversion to the normal 
208 
histological features after 120 hours. Lack of me lanin in tho hnir was 
not described by Raick (1 973b) 'A'ho concentrated on the features seen only 
up to f our weeks after application of TPA to female Swiss-Webster mice. 
Lack of melanin was noted in this present study at least three weeks after 
single injections in cases where definite depiBmentati on occurred. 
Depi gmentation in c57 Black male mice starts throe weeks after injection 
with TPA and remains as such even after six months . Phorbol esters 
have produced a delay in the expression of melanogenesis by melanoma cells 
in tissue culture (Mufson .£!. al 1978) Other phor1::ol derivativee which 
are tumour-promoters also had the same effect but non-tu."!lour-promoters 
did not. The effect on the melanoma cells is abolished by dexamethasone 
which also abolishes skin tumour-promotion. It has therefore been 
suggested that phorbol esters which are tumour-promoters interfere with 
cellular differentiation. Depigmentation would then result if cellular 
differentiation of melanocytes is affected. It could be possible that 
all other tumour-promoters interfere with cellular differentiation and 
therefore cause depigmentation in the same way as the phorbol esters. 
There has however been a suggestion that non-phorbol tumour-promoters 
e.g. anthralin, limonene and iodoacetic acid, may have a different mode 
of action because they do not mimic the effecte of TPA on chick embryo 
fibroblasts (CEF) (Driedger and Blumberg 1978). Anthralin, limonene 
and iodoacetic a.cid when tested by the depigmentation test were all 
negative. In summary, many possible mechanisms may exis t for chemically-
induced depi gmentation in dark-haired mice but the most likely link 
between tumour-promoters and depigmentation is the selective toxic action 
of tumour-promoters on melanocytes. 
2 . Uses anj Limitations 
The Use of the Depir:mentation Test as a Screening Test for 
Tumour-Promoters and its limitntior.s 
The practical implication of the observat ions on the depigmentation 
effect i s in the ccreening of substances that are possibly carcino-
genic. The need for a rapid short-term screening test for carcino-
gens has been d.iscussed . The aim of screening in chemical carcino-
genesis should be not only to separa te carcinogens from non-
carcinogens but to try and develop tests for detecting special 
class~s of compounds involved in the carcinogenic process e.g. the 
initiators, promoters, direc t carcinogens and indirect carcinogens . 
The depigmentation effect was investigated and found not to be 
related to all carcinogens but there was a good correlation with 
' 
tumour-promotion. It may thus be applied as a short-term screening 
test for tumour-promoters. 
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Any short-term screening test should be cheap, easy to perform and 
produce rapid results. The depigmentation test is relatively 
inexpensive. The main costs come from obtaining the pure-strain 
C5? Black mice (£1 - £2 each) and from feeding and keeping them for 
the duration of the test. Other expenses are in the uee of dispos-
able laboratory equipment such as gloves, syringes and ne edles . The 
current cost for a test on one compound using fifty mice would be 
about £200. 
The test is also easy to carry out, needi ng only one person to 
prepare the compounds and animals, and to inject the mice on one 
occasion only and then to regularly ex~mine them. Depigmentation 
appears in three to six weeks from initial injection. The only 
exception is ground crocidolite where minimal depigmentation 
was noted after sixteen weeks. This period is still ~uch shorter 
than the time needed for results to appear in conventional long-
term ar,imal tests for carcinogens. 
As for screening tes ts used in the detection of disease in human 
popluati ons, screening tests for chemical tumour-promoters should 
have a high index of validity and reliability. 
The validity of u screening test is the accuracy with which it 
indicates positives and negatives. It has two components:-
(a) Sensitivity - which is the ability to detect true positives 
correctly. 
(b) Specificity - which is the ability to detect true negatives 
correctly. 
The sensitivity of the test was calculated at 53% to 60% and the 
specificity at 79% to 89% (see Table13 ). 
The reliability of a screening test is tho precision with which it 
gives consistent results. This depends on the variation inherent 
in the method and an observer variation. For the depigmentation 
test, the variation in the method includes difference between the 
mice used such as age , source, diet and weight. This could all be 
standardized as much as possible. 
Differences also arise during the preparation of small concentra-
tions of the test compounds and in the injecting of a precise 
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0.05 ml or test solut i on intradermally. Precision in the preparation 
of :;;olution;; depends on the accuracy of appo.ratuG u:;;ed. Inj ection 
techniques may be difficu lt to standardize and a device which delivers 
a precise -✓olur.ie and Gpecific distance into the skin would be us efu l . 
However , variability in skin thickness and movement of the mice would 
mai<e such a device impracticsl . Intra-observer and inter-observer 
veriation exists espec i~lly in the s ubjective decision of the absence 
or presence of depigr.;enta tion and its extent. An a ttempt to minimize 
this was made by using a single 'blind ' method of examining the mi ce 
and be requiring slight depie;mentat ion to be confirmed on three con-
secutive daily examinations before it is recorded as positive depi gmen-
tation . An improveroent in t his would be to use an objective method 
to asses s depigmentation. Instruments for such objective assessment 
are available (Ferroro and Basi le 1979) and one such instrument uses 
diffuse reflectance spectrometry with an incorporated interferometer 
(Fuller and Griffith 1978) . Other limitations of the present s tudy 
include:-
(a) The small numbers of mice used to test each comoound 
2 1 1 
This ranged from four to fourteen mice injected at two to s ix sites 
per mouse. The mice were also obtai ned from two different sources. 
The main reasons for this were the cost and availability of the 
test animals and the limited financial resources fo r this study. 
Ideally, a t least twenty mice should be used to test each compound 
with as much standardization as possible in the mice and procedure 
used . Four sites can be used per mouse with one site as control . 
Hence, the total number o! test sites would be 3 x 20 • sixty 
sites per compound. 
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(b) Th e ne lrcl i on of r hr micnlo for tcstin~ 
(c) 
A random method a s discussed in the methodolo gy wan not pract i c,'ll . 
Chemi cnls for testine 1,ere selected according to their knO\m anrl 
suspected properties with reeards carcinogenesis . So!!le decree of 
bias may have been introd~ced in the selection of these chemicals . 
Howe•rer, this may in fact be the preferred method of selecting 
tumour-promoters for testing . Selection based on published reports 
of possible tumour-promotir.g activity would appear more useful 
than random selection of chemicals, especially since the number 
of Y.nown and nuspected tumour-promoters are limited at the present 
moment. 
The interpretation of the results. 
The observation of the link between tumour-promoters and depigment-
ation is of use. However, what is not known is whether this is an 
essential property ,of all tumour-promoters or if this effect 
is also produced by many other groups of compounds w~ich are nat 
tumour-promoters. Some agents which cause oc~upational leukoderma, 
such as methyl catechol, 4-tertiary butyl catechol (TBC) and para-
tertiary butyl phenol (PrBP) have produced a positive depigmentation 
result. These have not been tested for tumour-promoting activity 
tnd there are no published reports on a possible tumour-promoting 
effect. Wowe u 01; ~ha : elatJcl!i uompam:18. "' ra1atusohal lial!!J 'eeen akown 
&.• : __ c twaoat p10111uiiz:g coli. ii' (Hl!II\ 9':tttren, Ka1us a111i 8oldachmidt 
19,13) ernd 411,epefepe further tests on methyl catechol, TBC and Pl'PB 
S'-'<k 
may also show I fl r activity. 
One of the main uses of the depigmentation test would be to indicate 
those chemicals that need to be subjected to further tests to con-
firm tumour-promoting activity. Such further confirmatory test s 
could be bas ed ou a skin paintinF, technique using mouse skin pre-
treated wi th an initiator , such as 7 , 12 dimethyl bcn~.'.lnthracene 
or urethane (e thyl ca rbamate) and then repeated paintinr; with the 
test chemical to see whether tumours develop significantly more 
than an appropri ate similar control system. 
( d) The relevnnce to hnman populations 
A test for tumour-promoters based on intradermal injections in 
mouse skin may be relevant only to chemica ls that ha ve tumour-
promoting act ion on mouse skin. Most of the studies on tumour-
promotion have been performed using mouse skin because it provides 
the best model for s tudies on initiation - and promotion. Mice 
are the most widely used animal$for cancer research (Mitruka, 
Rawnsley and Vadhera 1976) and the mouse skin is also susceptible 
to extrinsic turnourogenic agents (Setala 1960). Studies on the 
mouse skin allow gross changes to be easily observed and followed 
and carcinogens, co-carcinogens, tumour-promoters and any other 
test chemicals can be applied directly to the site of study and 
tissue specimens for histological and other analytical s t udies 
are easily obtained. However, a chemical with tumour-promoting 
action on mouse skin may cause positive depigmentation by the 
technique described, but it may not be a relevant tumour-
promoter for human populations or other animal species. The same 
arguement holds true though for any other test for carcinogens 
or tumour-promoters and co-carcinogens based on animal studies. 
The relevance to man must be considered with some reservation. 
Studies on human populations are only limited to a few time-
consuming epidemiological studies and therefore for practical 
purposes a nimal stud ies must be used to indicate eubstancee wh ich 
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may have turnour-prornotin5 action in hun;:i.ns . The depigment a t ion test 
would be one such test to be used with c1wc1reness of the li:ni tat ions 
discussed . 
Other Uses of the Deni~mentation Effect 
(a) Tumour-promoters, because of the observed melanotoxic effect , 
could be used in the treatment of melanomas. It may seem par&-
doxical to sui;gest the possible treatment of a malign~.'l'lt tumour 
with a turr.our-promoter but anti -cancer drugs such as chlcr:tmbucil, 
myeleran ( Busulphan ru1d other alkylating agent8 are by 
themselves carcinogenic. The use of radiation in the treatment 
of lung cancer, carcinoma of the cervix and lymphomas is similar . 
(b) The depigmentation effect may also be used to screen chemicals 
that are capable of causing occupational leukoderma. Some of 
these agents have been shown to produce positive results by the 
depigmentation test. A few of these agents may, in addition, have 
tumour-promoting activity. The use of the depigmentation test 
for industrial chemicals would indicate chemicals which are 
leukodermogenic and/or tumour-promoters and hence a possible 
chemical hazard may be identified and appropriate measures 
instituted for their safe handling before irreversible harmful 
effects are caused . 
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3 . Bu,•:restions For Further Studic:::: 
The results of the e xper i ments performed i ndicate that several areas 
may be usefully i nvestiga ted in further studies. 
Studies on Othe r Comnounds 
With increasing evidence of more compounds having tur.iour- pror~ot ing 
activity a nd some with possible tumour-promoting a c tivity, studies 
directed towards such compounds nnd their effect on hair pigment-
ation may provide further confirmation of the link between tumour-
promoting activity and depigrnentation. Such compounds include :-
(a) Some dyes which have produced local sarcomata when injected 
into mice may do so by means of a tumour-promoting effect. 
Such dyes include Patent Blue V, Blue VRS (2%) (Grasso and 
Golberg 1966 ). 
(b) Substances which have a tumourogenic effect but do not seem 
to rea ct with DNA. Such substances include saccharin, pheno-
barbitone, chloroform, carbon tetrachloride, dieldrin, DDT, 
thioacetamide, thiourea and 3-aminotriazole. These were 
termed epigenetic carcinogens by Ashby~~ (1978). It ia 
possible tha t these epigenetic carcinogens act by tumour-
promotion. Saccharin, phenobarbitone and chloroform were 
tested and chloroform was positive(++), saccharin weakly 
positive(+) a..~d phenobarbitone negative (-) for depi gmentation . 
The r emaining compounds mentioned above could be tested. 
(c) Steroids ( Belman and Troll 1972), retinoida ( Becci ~ .!!, 1978 ) 
and prostaglandin inhibitors have all been shown to inhibit 
tumour-promoting activity for carcinogenes is. 13-cis r ~t inoic 
acid was investi6ated for its ability to inhibit depigmentation 
It did not prevent depir;mentation due to TPA or croton oil. 
Steroids , prostn6land jn inhibitors and any other substances which 
may inhibit tumourogenesis may be similarly investigated to see 
whether depigmentation by tumour-promoters in inhibited. 
Repen t Experiments Us inp; I mproved Techniques 
Some of the experiments performed may be repeated using impr oved 
techniques such a s an ob jective method of assessing depir;rnentation 
and an increased number of test animals for e ach test chemical. The 
limitat ion again is in the finances available. 
Tests Usin ~ Unknown Compounds 
One way of assessing the usefulness of the depigmentation effect to 
distinguish tumour-promoters from non-promoters is to use pairs of 
compounds unknown to the investigator. These pairs should ideally 
consist of a known tumour-promoter and a chemically similar non-
promoter. An effective test should identify the tumour-promoter 
correctly from the pairs tested. The problem about such a procedure 
is in the selection of appropriate pairs. The lack of information on 
what are definite tumour-promoters also makes this approach difficult. 
Even for carcinogen testing where much more information is available 
there are difficulties in the selection of appropriate pairs for test-
ing (Boyland 1978a and 1978b). 
A simpler procedure would be not to use paired compounds but to test 
a group of compounds which contain tumour-promoters and non-promoters 
to see whether the depigmentation test picks out the promoters correctly. 
This should be done without the investigator knowing the identity of 
the compounds tested. The depigmentation test has been included as one 
of the non-genetic testa i n an international progr~mme for the ev3lua-
tion or short-term tests for carcinogenicity. The progr3mme compRrec 
twenty-five ass.:iy systemu for their efficacy in dis tinguishing forty-
two reference c.1rc ino5ens and non-cnrcinogens (Mutat ion Research 
Announcement 1978 ). Wh en completed , this would indicate the relative 
usefu lness of the depiemcntation test, when comp.1ired with other test s 
for screening carcinogens . P..•elimina ry tests on five of the forty-
two referenc e chemicals produced the results in Table 67 . 
These preliminary result s suggest that the test may not be useful to 
distinguish carcinogen from non-carcinogen. However, 4-dimethylamino-
azobenzene-4-sulphuric acid (Na salt) may be positive because it 
possesses tumour-promoting activity . Compound Ne 1 ( 11-dimethyl-
aminoazobenzene) gave a doubtful positive result in two out of six 
sites injected. The results may be better assessed when all tests are 
completed. 
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TABLE67 
TrnTS ON ~CE CHDITCA.LS 
Amount Degree of Code No I Chemical I In jected 
µg Depigmentation 
4- Dimethyl aminoazobenzene I 1000 + -(Butter yellow) 
,0 I 4-Dicethyla::rin08.2.0benzene- I 1CXX) I + 
4-sulphocic ac:.d (Sodiu:i salt) 
8 I 4-~i troquinoline- N-oxide 1000 
-
15 I }-~'.ethyl-4-nitroquinoline- 1000 -
::-oxide 
4 I Hydrazine sulphate 500 -
Proportion of Sites 
Wi t h Depin:ientation 
Total !lo of Sites Injected 
2/ 6 
I 4/6 
0/6 
0/6 
0/ 6 
• 
"' ..... 
0: 
:3l<in P·dntinc 1'€' ::;t:; on Comnounds Sho•.1in :, Positi v e Dcpj.<~ment:ition 
Another wa y of confirmine the relationship betwe e n t umour-promoters 
and positive d epi r;mentntion is to tes t those compounrls which cause 
depi gmentation for tumour-promoting activity, where such tests have 
not been done before e. g . positive dcpicrmen tation was obtained with 
p-ter itary butyl phenol, methyl catechol a nd p-teriary butyl catechol. 
All these phenols have not been adequately tested for tumour-
promoting activity , Tests for tumour-promoting nc tivity could be 
performed using mouse skin (C57 Black male mice would be appropriate 
in this instance) and a n initiator such as 7, 12-dimethylbenzanthracene 
or ethyl c arbamate (urethane ) 
Tests Related to Enzyme Levels 
Ornithine decarboxylase (ODC) and plasminogen activator (PA) are two 
enzymes which seem to correlate with tumour-promoting activity. Com-
pounds which cause depigmentation may be tested for their ability to 
increase levels of these enzymes in mouse skin. The finding of a 
common link between tumour-promoters, depigmentation and raised ODC 
and/or PA levels would be of interest. 
21 ') 
220 
CHAPI'ER 6 CONCLUSIONS 
CQrlCLUSIONS 
The following conclusions can b e made from the results of all .the 
experiments performed. 
1. Permanent localized areas of depigmentation of hair may be pro-
duced by single intradermal injections of 0 .05 ml solutions of 
different chemi cals into C57 Black male mice. Dimethyl sulphoxide 
and saline were mainly used as solvent/medium. 
2. Depigmentation appeared after a latent period of three to six 
weeks. This would be expected to vary depending upon the stage of 
the hair cycle at the time of intradermal injections. Ground 
crocidolite was an exception producing minimal depigmentat ion after 
a long latent period of more than sixteen weeks. 
3. Of the sixty-six chemicals tested, depigmentation occurred more 
with tumour-promoters than carcinogens , co-c a rcinogens or non-
carcinogens. 56% of tumour-promoters tested were positive 
compared with 24% of carcinogens and 17% of substances not known 
to be carcinogenic or tumour-promoters. 
4. Prominent depigmentation (+ + +) occurred with the promoters 12-
0-tetradecanoyl-phorbol-1 3-acetate (TPA) and carbon dioxide snow 
and the complete carcinogen - nitrogen muotard (HN2 ) which would 
have tumour-promoting activity . The promoters saccharin, do<lecune 
and Tween 20 produced slight depiementation (+). Weak tumour-
promoters ns Tween 40 , Tween 80 , limonene and iodoacetic ar.id 
produced no dopigmentation. 
5. Indirect carcinoceno ,:;uch uo polycyclic 11rom11tic hydrocnr'bono llnd 
n romutic :,min ca were ncgn ti vc . D1.rcct-octinr.: carci nocc-110 which 
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would possess both initiating and tumour-promoting activity 
such as nitrogen mustard (HN2), methyl iodide and benzyl chloride 
were pos itive. 
6. Four compounds not known to have tumour-promoting activity were 
positive. These were pyrocatechol, 4-tertiary butyl catechol, 
para-tertiary butyl phenol and butylated hydroxyanisole. All 
belong to a group of chemicals known to ca us e occupational 
leukoderma. Seven such compounds were tested and five were 
positive. The fifth compound is hydroquinone m·onobenzyl ether 
which may have tumour-promoting activity . 
7. The ED50 was statistically estimated by legit transformation 
analysis for three compounds - nitrogen mustard (HN2), 'J'Pt. and 
chloroform - and was 0.018 µg, 0.18 µg and 101 µg respectively. 
8. The relationship between dose and effect for positive compounds 
showed two patterns. One, with increasing dose causing a greater 
proportion of injected sites being depigmented . This occurred 
in a sigmoidal dose-respons e relationahi p with HN2 , TPA, carbon 
dioxide snow, croton oil, chloroform, dimethylsulphatE:t and ph,mol. 
The other rela tionshi p was a dose-response curve with rui optima l 
doa e (which was not the maximum dose u3ed ) effect as o ccurred with 
1-fluoro-2 ,4-dinitrobenzene , saccharin nnd dodccane . 
9 . Tho opecifici t y of the t est was calculated at 53% t o 60% , ru1d t ho 
sens'livity at 79% to 89% depending on different criteria uoed f or 
the cl aoai fi cation of t umour-promoters, curcinogon:, and non-
carcinogona. 
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10. Depigmentation due to similar doses of nitrogen mustard was 
most prominent for C57 Black mice, less so for CBA nrown mice, 
and no depigmentation was observed with Tyzzer Original White 
mice. No obvious difference in depigmentat ion was noted between 
male and female mice tested. 
11. The use of enzyme-inducers as phenobarbitone and 3-methyl-
cholanthrene to pre-treat mice before intradermal injections of 
indirect carcinogens such as 1,2:5,6-dibenzanthracene, 9,10-
dimethyl-1,2-ben zanthracene, benzanthracene, 2-naphthylamine 
a...~d benzidene did not result in any depigmentation. 
12. Cis-retinoic acid did not inhibit the depigmentation due to the 
known tumour-promoters, croton oil and TPA. It inhibited 
depigmentation due to para-tertiary butyl phenol which is not 
a known promoter but has been known to cause occupational 
leukoderma. The practical implications of this is that Vitamin 
A analogues such as cis-retinoic acid may prevent occupational 
leukoderma. 
13. Asb~stoe fibres injected as chrysotile A and B, crocidolite , 
amosi te and anthophylli te in saline suspensions produced no 
depigmentation. Grindine up the fibrcu produced minimal 
depigrncntation with crocidolite , but not with chrysotile A. 
•rhe use of an initiator urethane ( ethyl co.rbamnte) to pre-treat 
mico boforo intradermal injections with aebestoe did not alter 
th~ dopigmentation effect nor result in the production of ony 
tumours . 
14. Light and el~ctron microscopy of depigmented hair showed a loss 
of pigment with an otherwise intact hair structure. This was 
similar for all positive chemicals injected - the only variation 
being in the extent and abruptness of pigment loss. This ranged 
from a sudden complete loss of pigment as with dimethyl sulphate 
to a more gradual partial scattered areas of lack of pigment 
along the hair shaft as for phenol. Microscopy of skin showed 
a relative decrease in melanocytes around the hair bulbs and in 
the epidermis. The skin of C57 Black mice is white (only the 
hairs are black) and few melanocytes are normally present. 
15. The observed depigmentation is not due to an irritant effect nor 
due to a direct effect of an increase in dermal putrescine, 
histamine or adrenaline. It has been suggested that it may be 
a somatic mutaGenic effect. A direct toxic action on suseptible 
melanocytes is a likely mechanism . Whatever the reason for the 
observed depigmentation effect, the relationship with tumour-
promoting activity may allow it to be used as a screening test 
for tumour-promoters. 
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CIIAPI'~R 8 A El'IDIX 
APPENDIX 1 
Composition of Di ets used for Test Animals 
(R) Diet 86 (Dixons) - Used for all mice up to 30th August 1978. 
Manufacturer: E Dixon and Sons (Ware)Ltd 
Crane Mead Mills, Ware Herts 
Crude Oil % 2.03 
Crude Protein % 19.29 
C1·ude Fib1·e % 3.01 
Digestible Crude Oil. % 1.44 
Digestible Crude Protein % 15.73 
Digestible Crude Fibre % 1.9() 
Digestible Carbohydrate % 50.83 
Gross Energy Gals/kg 3,942 
Metabolizable Energy Cals/kg 3,548 
Saturated Fatty Acids % o.42 
Linole,;,c Ae :.. i % 0.72 
Other Unsaturated Acids % o.88 
Calci11m % 1.o6 
Phosphorus % 0.91 
Sodi um Chloride % 1.26 
Magnesium % 0.26 
Potassium % 0.76 
Sulphur % 0. 23 
Tr·on m!"./kg ~29 
Copper mg/kg 9.60 
Mttngane:,;e mP'/kg 29 .76 
Cobol t ug/kg 75. 84 
:/'.inc ffl!"/kg 21 .1 2 
Ioriine ug/kg 457 
2 8 
i\rp,in.i.ne 
Lysine 
Methionine 
Cystine 
Tryptophan 
Glyci ne 
!list Ldi ne 
Threonine 
Jsoleu cine 
Leucine 
Phenylalanine 
Valine 
'l'yrosine 
Aspartic Acid 
Glutamic Acid 
Pro line 
.Serine 
Vi t,,mi n A 
Vitnmi n D3 
Carotene 
Vitumin B1 (Thiamine) 
Vi tum in 82 ( Ri bo flavine) 
Vitamin A6 (Pyridoxin) 
Vi 1 nmin B12 
Vi tnmin E 
Vit11min K 
fo'oli c Acid 
Nicoti rdc Ac i d 
% 
% 
% 
% 
% 
% 
% 
% 
% 
% 
% 
% 
% 
% 
% 
% 
% 
IU/Kg 
IU/Kg 
mg/kg 
mg/kg 
mg/kg 
mg/kg 
ug/kg 
mg/kg 
mg/kg 
mg/kg 
mg/k! 
1.05 
1.06 
0.37 
0. 33 
0.21+ 
1.19 
0. 39 
0.70 
0.85 
1.33 
0.85 
0.92 
0.61 
1. 29 
3.51+ 
1 . 25 
0.79 
23 ,953 
2 ,937 
12.19 
9.14 
5 .13 
6 .07 
15.21+ 
31+. 78 
15. 28 
2.23 
73.17 
259 
260 
Pantotl,enic Acid mg/kg 16.87 
Choline Chlori d e gm/kg 1 . Lt 1 
Eio t in mg/kg 0.21 
Inosi tol gm/kg 2.24 
26 1 
(b) BP (Expanded) No 1 - Use:i for all m.i.ce after 30th August 1978 . 
Manufac turer: P Nutrition (UK) Limited 
Stepfield, Wilt ham, F..ssex CM8 3AB 
Cruue Oil % 3.0 
Crude Protein % 14.8 
Crude Fibre ~ 4.0 
Ash 
'i'; 4.8 
Crude Carbohydrate % 63.6 
Di~estible Crude Oil % 2.1 
Digestible Crude l:'rotein % 12.0 
Dir;estilllP- Crude Fibre % 
o.8 
Di~e::;tible Crude Carbohydrate % 
56.5 
Gross Energy 
Cal/kg 3 ,390 
Metabolizuble Energy Cal/kg 
3 ,1 20 
Digestible &iergy 
Cal/kg 2,810 
Myri stoleic Acid 
,,, 0.02 
Palmitoleic Acid 
% 0.1 3 
'J6 0.92 
Oleic Acid 
Linoleic Acid 
'J6 0. 92 
'J, 0.10 
Linolenic Acid 
Arachidonic Acid 
% 0.1 9 
% 0.02 
Lauri e Acid 
'J, 0.16 
Myri stic Acid 
'J, o.47 
Pulrnitic Ac id 
"' 
0.10 
Stearic Acid 
% 0.74 
Arp:in,. ne 
% 0.75 
Lysine 
% 0. 28 
Methio11 i ne 
262 
Cyi::tine % 0.25 
Tryptophan % 0.19 
His tidine % 0. 33 
Threonine % o.54 
Isoloucine % 0.61 
Leuc.i.ne % 1.10 
Phenylalanine % 0.70 
Valine % 0.75 
'l'yrosine % 0.50 
Glycine % 0. 92 
Asparti..: Acici. % 0.81 
Ulutamic Acid % 3.00 
Proline % .1.15 
Serine % 0.57 
Alanine % 0.13 
Calcium % 0.90 
Phosphorus % 0.50 
!Jodi um % 0.25 
Chlorine % 0.38 
Magnesium % 0.14 
Pot11esium % 0.72 
Sulphur % 0.19 
Iron mg/leg 70 
Copper mg/leg 9 
Manganese mg/~g ?'-• 
~ inc mg/kg 76 
Cobu l t mcg/kg 57 
J or! inc mcg/kg 811 
2 3 
Seleni..im mcg/kg 
117 
Fluorine mg/kg 
2 
Vi t am.i. n A IU/kg 
6 ,610 
Vitamin I) IU/kg 
6o3 
Vi tamin B1 mg/kg 
7.2 
Vi tamin 132 mg/kg 
11. 3 
Vi t a min B6 
mg/leg 5.5 
Vi t Rmin B12 
mcg/kg 7.7 
Vitamin r.: 
mg/kg 66.2 
Vi t amin K 
mg/kg 10.5 
Fol i c Acid 
mg/kg o.8 
Ni c otinic Acid 
mg/kg 57 .0 
Pantothenic A.cid 
mg/kg 23.8 
g/kg 1.60 
Cho line 
g/kg 2.55 
Inositol 
mcg/kg 265.0 
Biotin 
m(Vkg 0.36 
Caroi:enP 
Xanthophyll 
mg/kg 1.20 
( c ) Placebo diet fo r cis - t' etinoic acid experiment 
R & M No 1 Expanded 
Manufac~urer: B P Nutrition (UK) Limited 
Step field, Wi 1 tharn, Essex 1JM8 3AD 
Moisture % 11.9 
Crude Fa l % 3.5 
Crude l-':.•otein % 13.6 
Crude Fibre % 2.a 
Ash % 4.34 
Ca lcium % 0.52 
Phosphorus % o.68 
Sodium % 0. 24 
Chlorine % o.64 
Potassium % 0.87 
Magnesium % 0. 20 
l ron mg/kg 168 
Copper mg/kg 22 
M,m gan.,se mg/kg 68 
~i nc mg/kg 68 
Seleni um mg/kg <0. 02 
f'luo r ine mg/kg 10.0 
Nitrite mg/kg (1. 0 
VitHmi.n A IU/kg 3500 
Vi t a mi n F. mg/kg 1~3 
Lead mg/kg <2.0 
Arsen ic mg/kg < 0 . 2 
Ca dmi um mg/kg 0. 25 
Mer c ury mg/kg < 0.01 
264 
Total Aflatoxins 
To tal P.C.B. 
Total I.J .D.T. 
Di eldrin 
Lindane 
ll e pta chlor 
1-'.ala th ion 
~o t~l Viable Organism 
Mesophilic Spores 
~a lmonellae Species 
Presumptive F. Coli 
E Coli Type 1 
mg/kg 
mg/kg 
per gm 
per gm 
None detected 
None detected 
0.001 
None detected 
0.003 
None detected 
None detected 
25 X 103 
< 1 X 10
2 
None detected 
Nc-ne detected 
None detected 
( d ) Cis -retinoic Acid Diet - , s for (c) above with the addition o f 
? 40 mg of cis-retinoic ac id per kg of diet. 
APPF!'IDI X 2 
Procedure for Preparin~ Specimens for Electron Microscopy 
1. Fix in 3% glutara ldehyde in o.o66M cacodylata for two hours. 
2 . Wash with o.o66M cacodylate three times (ten minutes each time) 
and overnight. 
3 . Post- ~ix with 1% osmium tetroxide in o.o66M cacodylate for 
thirty minutes. 
➔- Wash with o.o66M cacodylate buffer three ~imes (ten minutes 
each t ime). 
7• Wa sh with 3CIJ{, methanol twice (five minutes each time). 
6 . Stain with 0.05% ura nyl acetate in 34)% me thanol for thirty 
minutes . 
7. Dehydrate with 30%, 6CIJ{,, 70'!, , 80% , ~ and then 100% m h nol 
twice (approximately five minutes withe ch concentration), 
8 . Infiltra te wi th:-
(a) propylene oxide twice (ten minutes each time). 
(b) 50 : 50 propylene oxide/ardldite for thirty minutee. 
( c) Araldite for thirty minutes and then overn~ght. 
9 . E:mued i n f l a t moulds in fres h a raldite. 
